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A B S T R A C T
M a l a r i a  is t he  m o s t  p r e v a l e n t  p a r a s i t i c  d i s e a s e  in t he  w or l d  and  the  
e m e r g e n c e  o f  d rug  r e s i s t a n t  s t r a i n s  o f  P l a s m o d i u m  f a l c i p a r u m  has ma de  
t h e  s e a r c h  fo r  n e w  a n t i m a l a r i a l  d r u g s  i m p o r t a n t .  P r o t e i n  k i n a s e s  p l ay  an 
i m p o r t a n t  ro l e  in c e l l u l a r  f u n c t i o n  and  the  p h o s p h a t i d y l i n o s i t o l  3 - k i n a s e  
( P I 3 K)  s i gn a l  t r a n s d u c t i o n  p a t h w a y  is i m p l i c a t e d  in d i v e r s e  c e l l u l a r  
p r o c e s s e s  such  as g l u c o s e  t r a n s p o r t ,  ce l l  s u r v i v a l  and  p r o l i f e r a t i o n .  A 
h o m o l o g y  b a s e d  a p p r o a c h  i d e n t i f i e d  an o pe n  r e a d i n g  f r ame  ( ORF)  
c o d i n g  for  t h e  c a t a l y t i c  r e g i o n  o f  p a r t  o f  t he  6 .4  Kb ORF o f  P F E 0 7 6 5 w  
g e n e  s e q u e n c e  f o u nd  at  p l a s m o D B .  T h e  ORF c o n s i s t e d  o f  1 758 base  
pa i r s  w h i c h  c od ed  for  a 586  a m i n o  a c i d  p r o t e i n  wi th  a m o l e c u l a r  we ig h t  
o f  68 .5  KDa.  T h e  P f P I 3 K  ORF was  a m p l i f i e d  f r om P . f a l c i p a r u m  DNA,  
s u b c l o n e d  in to  an e x p r e s s i o n  v e c t o r  and  the  s e q u e n c e  ve r i f i ed .  A n a l y s i s  
o f  t he  e x p r e s s e d  p r o t e i n  o b t a i n e d  by W e s t e r n  b l o t t i n g  and  p r o b i n g  wi th  
a n t i - H i s  m o n o c l o n a l  a n t i b o d y  s h o w e d  a p r o t e i n  o f  68 .5  K D a  as wel l  as 
s o me  s m a l l e r  p r o d u c t s .
The  e f f e c t s  o f  t he  P I 3 K  i n h i b i t o r s ,  w o r t m a n n i n  and L Y 2 9 4 0 0 2  and the  
i n d i r e c t  a c t i v a t o r s  o f  t he  P I 3K  p a t h w a y ,  f o r s k o l i n  and  1 , 9 - d i d e ox y -  
f o r s k o l i n  on t he  in v i t r o  g r o w t h  o f  t he  c h l o r o q u i n e  s e n s i t i v e  ( 3D7)  
s t r a in  o f  P. f a l c i p a r u m  were  d e t e r m i n e d  u s i ng  the  [ ^ H ] - h y p o x a n t h i n e  
i n c o r p o r a t i o n  a s say .  T h e  c o m p o u n d s  i n h i b i t e d  p a r a s i t e  g r o w t h  wi th  I C 50 
v a l ue s  w i t h i n  t he  m i c r o m o l a r  r a ng e  in c o n t r a s t  to c h l o r o q u i n e  and 
q u i n i n e  w h i c h  i n h i b i t e d  g r o w t h  in the  n a n o m o l a r  r ange .  L Y 2 9 4 0 0 2  was 
the  m o s t  a c t i v e  o f  t he  t wo  P I 3K  i n h i b i t o r s  t e s t ed .  The  a d e n y l a t e  c y c l a s e  
a c t i v a t o r ,  f o r s k o l i n  was  t he  l e as t  a c t i ve .  T h e  i ne r t  a n a l o g u e  of  
f o r s k o l i n ,  1 , 9 - d i d e o x y f o r s k o l i n ,  i n h i b i t e d  t he  p a r a s i t e  g r o w th  wi th  an 
I C 50 v a l u e  s i m i l a r  to t h a t  o f  L Y 2 9 4 0 0 2 .  The  i n f o r m a t i o n  o b t a i n e d  in 
thi s  s t ud y  ma y  l ead  to f u r t h e r  s t u d i e s  in v a l i d a t i n g  PI3 k i n a s e  as a 
p o t en t i a l  d r u g  t a r g e t  in P. f a l c i p a r u m  and  e l u c i d a t i n g  its f u n c t i o n  in the  
pa ras i t e .
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1.0 INTRO DUCTIO N
Mal a r i a  r ema ins  a ma jo r  p r ob l em in d e ve l op i ng  coun t r i e s ,  where
O. 7-2.7 mi l l i on  people  die f rom ma l a r i a  each year ,  wi th  over  75 % of  
these  be ing  ch i l d ren  and p regnan t  women  (Wea t he ra l  et al ,  2002;  
Mai t l an d  et al ,  2003) .  This  is l ike ly  to i nc rease  due to a b r eakdown  
in h ea l t hca re  sys t ems ,  an i nc rease  in d rug  re s i s t ance  by the  pa ras i t e  
to cu r r en t  t he rapeu t i c  agent s  and the d e ve l op m en t  o f  r e s i s t ance  to 
i n sec t i c id e s  by the mosqu i t o  vec t o r  (Ho ug a rd  et al ,  2002) .  The 
p ro to z oa n  pa ras i t e  P la sm o d iu m  fa l c i p a r u m  is the main  causa t ive  
agent  o f  d i s ease  and dea th  f rom malar i a .  Thi s  p r o t o z o a  pa ras i t e  
causes  mu l t i p l e  c omp l i ca t i on s  such as cerebra l  malar ia ,  
h yp o g l y c a e mi a ,  me t abo l i c  ac idos i s  and r e s p i r a t o r y  d i s t ress .  Cerebra l  
ma la r i a  is pa r t i c u l a r l y  d ange r ous  wi th up to 30 % o f  in fec t ed  pat ient s  
dying (Adams  et al ,  2002) .  The p r e va l en c e  o f  ma la r i a  caused  by
P. f a l c i p a r u m  is o f  major  concern  to Af r i ca  due to its e f fect  on 
produc t i v i t y .  The me t hods  cu r r en t ly  a va i l ab l e  to cont ro l  ma la r i a  have  
p roven  to be inadequa te .  F u r t he r mo r e  P. f a l c i p a r u m  r e s i s t ance  to 
ch l o r o q u i ne  and the an t i fo l a t e s  ( p y r i me t h a m i n e  and p roguan i l )  is now 
wi de sp rea d  ( G in sb u rg  et al ,  1999;  Ma i t l and  et al ,  2003) .  A more 
r ecen t  r epo r t  o f  a r t e mi s in i n  and me f l oqu i ne  re s i s t ance ,  now poses  an 
urgen t  c ha l l enge  for  the d e ve lo p m en t  o f  a f f o r dab l e  and more  potent  
drugs  ( R amac ha nd r an ,  2002) .  M or eo v e r  the i mmed i a t e  p rospec t s  o f  a 
usefu l  vacc ine  r ema i n  uncer t a in  (Ri ch i e  & Saul ,  2002) .
1.1 The Plasmodium fa lc ip a ru m  life cycle
There  are four  spec ies  o f  P la sm o d iu m  r e spons i b l e  for  human  malar i a ,  
P. f a l c i p a r u m , P. v ivax ,  P. m a lar iae  and P. ovale  (Mi l l e r  et al,
2002) .  P. f a l c i p a r u m  causes  the  mos t  severe  fo rm of  m a la r i a  in 
humans ,  namel y  ce rebra l  ma la r i a  which  is a l i fe t h r ea t en i n g  di sease.
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The  p r o t oz oa n  pa ras i t e s  in the  genus  P la sm o d iu m  have  a complex  l ife 
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Figure  1.1: The l i fe  cycle  o f  P la sm o d iu m .  An i n fec t ed  female  
A n o p h e le s  mos qu i t o  in jec t s  s po r oz o i t e s  into the  human hos t  when 
t ak ing  a b lood  meal  (1) .  The  spo r ozo i t e s  t hen  infec t  the  h e pa t oc y t e s  
(2)  and ma tu re  into s ch i zon t s  (3).  The  sch i zon t s  then rup t u r e  and 
r e l ease  me roz o i t e s  (4)  which  infec t  e r y t h r ocy t e s  (5)  c on s t i t u t i ng  the  
e r y t h r oc y t i c  cycle  (B).  Some i mmat u r e  t r ophoz o i t e s  may d i f f e r en t i a t e  
into g ame t ocy t e s  (7)  which are t aken  up by a f ema l e  A n o p h e le s  
mos qu i t o  dur ing  a b lood  meal  (8).  The  male  and f emale  gamet es  fuse 
to fo rm zygo tes  (9)  wi th in  the  m o s q u i t o ’s s tomach.  The zygotes  
ma t u r e  into ook ine t e s  (10)  which deve l op  into oocyst s  wi th in  the 
m o s q u i t o ’s mi dgu t  wal l  (11) .  Matu r e  oocys t s  r e l ease  sporozo i t es  
which  remain  in the sa l i vary  g l ands  unt i l  i no c u l a t i on  into ano ther  
hos t  (12)  ( http.7 / www.  dpd.  cdc.  g o v ).
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The p a t h og en i c i t y  o f  thi s  p a ra s i t e  is t h o u g h t  to be as a resu l t  f rom its 
rapid  ra te  o f  a sexua l  r e p ro d uc t io n  in the  hos t  and its ab i l i t y  to 
s eques t e r  in smal l  b lood  vesse l s  (Cowman  et al ,  2000) .  The asexual  
phase  o f  the  l i fe  cyc le  t akes  p l ace  in the  ve r t eb r a t e  hos t  whereas  the 
sexual  phase  occur s  in the f ema l e  A n o p h e le s  mosqu i t o  (Lobo & 
Kumar ,  1998).  In f ec t i on  in the  human  hos t  begins  wi th the 
i nocu l a t i on  o f  s po r oz o i t e s  f rom an in fec t ed  female  A n o p h e le s  
mo sq u i t o  dur ing  a b lood  meal .  Upon  ent ry,  the  spo r ozo i t e s  are 
t r an sp or t e d  to the  l iver  where  they  invade  the h epa t ocy t e s ,  mul t ip ly  
and ma t u r e  into s ch i zon t s  which  r e l ease  mer ozo i t e s  upon rupture  
(Weathe ra l  et a l ,  2002) .  In the case  o f  P. f a l c i p a r u m  and P. m alar iae ,  
the  me roz o i t e s  i nvade  red blood cel l s  i n i t i a t i ng  the i n t r a - e r y t h r ocy t i c  
cyc le  ( F i gure  1.1 B). In P. ova le  and P. v ivax  some sporozo i t e s  
remain  d o r ma n t  in the  h e pa t oc y t e s ,  wh i l e  the  r e ma in d e r  deve lop  into 
s ch i zon t s  and enter  the e r y t h r oc y t i c  cycle .  The  e r y t h r oc y t i c  cycle  
s tar t s  wi th  the  i nvas i on  o f  me ro z o i t e s  which form r ings  tha t  mature  
to form t r ophoz o i t e s  ( Lee t e  & Rubin ,  1996).  The pa ras i t e  then 
d eve l ops  into s ch i zon t s  which  ru p t u r e  to re l ease  8-32 merozo i t e s  that  
in fec t  new e r y t h r oc y t e s  (F igure  1.1, 6) (Wea t he r a l  et  a l ,  2002) .  The 
c l in ica l  s ympt oms  tha t  ensue  upon rup tu r e  i nc lude  headache ,  myalgia ,  
chi l l s ,  f ever  and swea t i ng  a s s oc ia t e d  wi th the  f e ve r ( Wo n g s r i ch a na l a i ,  
2001;  Wea t he r a l  et al,  2002) .  Some asexua l  pa ras i t e s  can 
d i f f e r en t i a t e  into g a me t o cy te s  wh i ch  are c r i t i ca l  for  t r a ns mi s s i on  of  
the  pa r a s i t e s  to new human  hos t s  t h r ough  the f ema le  A n o p h e le s  
mo sq u i t o  (Phi l l ips ,  2001;  Wea t he r a l  et al,  2002) .  In P. f a l c ip a r u m  
the p r ocess  o f  a sexua l  d e v e l o p m e n t  t akes  up to 48 hours  and is 
r epea t ed  in the human  hos t  i f  not  con t a i ned  by an t i ma l a r i a l  drugs  or 
by the  h o s t ’s immune  system.
The t r a ns i t i o n  o f  the pa ras i t e  f rom one s t age  o f  its complex  l ife cycle  
to the  next  is i n f l uenc ed  by many fac tor s  which r esu l t  in changes  in 
gene  exp r e ss io n  and cel l  cyc l e  p r og r es s i on .  The con t ro l  o f  these  
va r i ous  ac t i v i t i e s  r emains  poor l y  und e r s to o d ,  a l t hough  they are
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t h ou gh t  to i nvo lve  s ignal  t r an s du c t i on  cascades  in the  pa ras i t e  
(Doer ig ,  1997).  An u n d e r s t a nd i ng  o f  the  mo l e cu l a r  m e ch a n i sms  
co n t r o l l i ng  p a ra s i t e  g rowt h  and d i f f e r en t i a t i on  may lead to the  
d e v e l o p m e n t  o f  new t h e ra peu t i c  agents .
Signa l  t r a n s d uc t i o n  is a p rocess  whe reb y  ex t erna l  chemi ca l  or  
phys i ca l  s ignal s  f ac i l i t a t e  a ser ies  o f  i n t r ac e l l u l a r  me tabo l i c  
r esponses .  In m u l t i c e l l u l a r  euka r yo t es  e x t r a ce l l u l a r  s ignal  molecu les  
such as ep ider mal  g rowth  fac tor ,  p l a t e l e t  de r ived  growth  fac tor  and 
insu l in  bind to r ecep tor s  l oca l i sed  on or  in the cel l  membrane  
( S n a a r - J a g a l s k a  & Schenk ,  1999) .  B ind ing  o f  a l igand (s ignal  
mol ecu l e )  to its r e c e p t o r  can resu l t  in the ac t i va t i on  o f  a t r ansduc i ng  
pro te in  fo l l owed  by the m od u l a t i o n  o f  i n t r ac e l l u l a r  enzyma t i c  
act ivi ty .  Ac t iva t i on  o f  i n t r ac e l l u l a r  p ro t e ins  may lead to the 
a c t i va t i on  or  i nh ib i t i on  o f  ‘e f f ec t o r  p r o t e i n s ’ . The  t r a ns du c i ng  
p ro t e ins  are usua l l y  p r o t e i n  k inases  t ha t  are ac t i va t ed  upon 
p h o s ph o r y l a t i o n  by o the r  pro t e in  k inases  and can lead to a l t e red gene 
express ion .  Thi s  f u r the r  l eads  to the  s t i mul a t i on  o f  cel l  su rv iva l  and 
d i f f e r e n t i a t i o n  ( S n a a r - J a g a l s k a  & Schenk,  1999).  E l emen t s  o f  severa l  
s ignal  t r a n s d uc t i o n  pa t hways  have  been  i den t i f i ed  in P. f a l c i p a r u m  
(Doer ig ,  1997).  Ev i dence  ex i s t s  for  the  p r e s ence  o f  the cyc l i c  
adenos i ne  m o n o- p h o s p h a t e  d e pe nd e n t  pa t hway  ( cAMP) ,  the cycl i c  
g uan i de  mono-  pho sp h a t e  d e pe nd e n t  pa t hway  ( cGMP) ,  the  mi togen  
ac t i va t ed  pro t e in  k inase  pa t hway  ( MAPK) ,  the  ph o s ph a t i dy l i n os i t o l  
cycle  and ca l c i um s i gna l l i ng  (Doer ig ,  1997).
The  a va i l ab i l i t y  o f  a c omp l e t e  a nn o t a t ed  ma la r i a  g e no me  has led to 
the  i de n t i f i c a t i o n  o f  many P. f a l c i p a r u m  p ro te in  k inases .  The 
i n fo rma t i on  o f  the  g e no me  can be exp lo i t ed  t h r o u g h  molecu la r  and 
b io chemi ca l  s tudies  to de f ine  the  roles  o f  spec i f i c  p ro t e in  kinases .  
F u r t he r m o re ,  p ro t e in  k inases  can be i n v e s t i ga t ed  as po t en t i a l  d rug  
t a rge t s  l e ad i ng  to the  i den t i f i c a t i on  o f  lead compounds  for  drug 
design.
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1.2 P rotein  k inases
Pr o t e i n  k i na se s  are enzymes  tha t  can t r a ns fe r  pho s ph a t e  g roups  f rom 
ATP to an amino acid r e s i due  o f  a pro te in .  Pr o t e i n  k inases  are found 
in s igna l  t r a ns d uc t i o n  pa t hways  where  they  r egu l a t e  the ac t i v i ty  o f  
many  e f f e c t o r  mo l e cu l e s  (Hanks ,  2003) .  Ph o s ph o r y l a t i o n  is an 
i mp or t an t  m e ch a n i s m o f  r e gu l a t i o n  o f  p ro t e in  act ivi ty .  
P h o s ph o r y l a t i o n  can e i t he r  a c t i va t e  or  inh ib i t  the  ac t i v i t y  o f  an 
enzyme  and is t h e r e fo r e  cent ra l  to ce l l u l a r  s igna l  t r ans duc t i on .  The  
p rocess  can be r ead i ly  r eve r sed  by pro t e in  p h os pha t a s es ,  mak ing  the 
con t ro l  o f  p h o s p h o r y l a t i o n  s t a t es  o f  p ro t e i n  k inases  f l ex ib le  
( S na a r - J a g a l s k a  & Schenk ,  1999).  Pr o t e i n  k inases  are e ssen t i a l  for  
the  r eg u la t i on  o f  d ive r se  ce l l u l a r  p r o c es s es  i nc l ud i ng  me t abo l i sm,  
s t ress  r e sponses ,  t r a ns c r ip t i o n ,  t r a ns l a t i o n ,  DNA r ep l i c a t ion  and 
c e l l - cyc l e  cont rol .  In the  m u l t i c e l l u l a r  euka r yo t es  they are also 
invo lved  in more  evo lved  f unc t i ons  such as neurona l  s i gna l l i ng ,  
apop tos i s  and ce l l - ce l l  c om m u n ic a t i o n  (Hanks ,  2003) .
In con t r a s t  to the i r  i n v o l ve me n t  in norma l  c e l l u l a r  func t ion ,  prote in 
k inases  have  also been i mp l i c a t e d  in severa l  d i seases  such as cancer  
and ma l a r i a  (Doe r i g  et a l ,  2002) .  The i r  po tent i a l  as oncogenes  has 
r esu l t ed  in p ro t e in  k i na se s  be ing  imp l i ca t ed  in severa l  human 
cancer s ,  and have  thus  been i nve s t iga t e d  as po t ent i a l  d rug  targets .  
Seve ra l  p ro t e in  k inase  i nh i b i t o r s  are c ur r en t l y  in c l in ica l  
d e v e l o p m e n t  and some pro t e in  k inase  i nh i b i t o r s  such as imat in ib  
mesy l a t e  and s i ro l imus  are a l r eady  in c l in ica l  use ( Bong i o rno  et al,  
2003) .
1.2.1 Prote in  k inase  groups
Pr o te i n  k inases  were  o r i g i na l l y  subd i v i ded  into f ive major  groups  
a cco r d i ng  to s i mi l a r i t i e s  in t he i r  ca t a l y t i c  domains ,  modes  o f  
r eg u l a t i o n  and subs t r a t e  s pec i f i c i t i e s .  The  f ive  g roups  cons i s t ed  o f
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the  AGC g roup ;  the CMGC group ;  the  pro t e in  t y r os in e  g roup ;  the 
c a l c i um ca l modu l i n  k inase  g r oup  and the ‘o ther  k inases  g r o u p ’ .
The  AGC group  is co mp o se d  o f  the  p ro t e i n  k inase  A, p ro t e in  k inase  
G, p ro t e in  k inase  C, the  G- p r o t e i n  c oup l ed  r ec ep t o r  fami ly  and the 
r ibos oma l  S6 p ro t e in  k i na se  fami ly.  The  AGC gr oup  is r egu la t ed  by 
cycl i c  n uc l eo t i de s  and ac t i va t ed  upon the r e l ease  o f  s econdary  
messenger s .  The  CMGC gr oup  is c om p o s ed  of  the cycl in  dependen t  
k inases ,  m i t ogen  ac t i va t ed  p r o t e i n  k inase ,  g l ycogen  syn thase  k inase  3 
and cycl in  d e pen d e n t  k i na s e - l i k e  k inases  and loca t ed  down s t ream of  
mos t  s ignal  pa t hways  ( S na a r - J a g a l s k a  & Schenk ,  1999).  The prote in  
t y r os i ne  g r o up  inc ludes  k i na se s  tha t  p h o s p ho r y l a t e  t y r os i ne  res idues .  
The  ca l c i um ca l mo d u l i n  k inase  g r o u p  is r egu l a t ed  by ca l c ium 
c a l modu l i n  de pen d en t  p ro t e i n  k inases  ( r ev i e wed  by Hanks  & Hunte r ,  
1995) .  The  ' o t h e r  k i n a s e s ’ g roup ,  is made  up of  pro te in  k inases  that  
have  not  been eas i l y  c l a s s i f i ed  acc or d i ng  to modes  o f  r egu la t i on ,  
s ubs t r a t e  s pec i f i c i t i e s  and s i mi l a r i t i e s  in the  ca t a ly t i c  domain  (Hanks  
& Hunt e r ,  1995).
F o l l owi n g  the  c omp l e t i o n  o f  severa l  g e no me  p ro j ec t s ,  t h ree  
add i t i ona l  ma jo r  prote in  k inase  g r oups  have  been iden t i f i ed ;  the 
s t e r i l e  7, 11, 20 (STE)  k inases ,  case in  k inase  1 (CK1)  and the 
t y r o s i ne - k i n a s e  l ike  groups .  The STE group  is co mp ose d  o f  three  
c l as ses  o f  p ro t e in  k inases  ( S TE 7 / MA P2 K,  S T E 1 1 / M AP 3 K  and 
S T E 2 0 M A P 4 K )  that  are r e l a t ed  to MAPKs  and occur  s equen t i a l l y  
u ps t r e am o f  the  MAPKs  ( Mor r i son  et a l ,  2000) .  The STE group has 
been e x t ens ive l y  i den t i f i ed  in yeas t  s t er i l e  mutant s .  The  CK1 group 
is c om p o se d  o f  the  case in  k inase  1 fami ly  and play major  roles  in 
DNA repa i r  and cel l  d iv i s ion .  The  CK1 group  has been iden t i f i ed  in 
the  worm.  The t y r o s i n e - k i n a s e  l ike  g roup  is p h y l og e ne t i c a l l y  s imi la r  
to the t y r os i ne  k inases ,  h o w e v e r  it i nc ludes  the  s e r i n e / t h r eo n i ne  
k inase  r ecep t o r s  (Hanks ,  2003) .
6
1.2 .2  Features  o f  the  con served  p ro te in  k inase  c a ta ly t i c  dom ains
The s e r i n e / t h r eo n i n e  and t y r os ine  k inases  have  a s imi l a r  mode  of  
ac t i on  and have  many c ommon  f ea t u r e s ,  a l t hough they d i f f e r  in 
subs t r a t e  spec i f i c i t y .  The  ca t a l y t i c  domain  cons i s t s  o f  250-300  amino 
acids  which  are fu r the r  d iv ided  into twe lve  subdomai ns  i nd i ca t ed  by 
roman nume ra l s  (F i gure  1.2).  For  the  member s  o f  the s e r ine / t h r eon i ne  
and ty r os i ne  s up er f am i l i e s  the  sma l l e r  s ubdomai ns  conta in  
c ha r ac t e r i s t i c  pa t t e rns  o f  conse rved  amino acid r es idues  and are 
r a re ly  i n t e r r up t ed  by l a rge  amino  acid inser t i ons .  The ca ta ly t i c  
k inase  domain  forms  a t w o - l o b e d  s t ruc ture .  The  smal l e r  N- t e rmi na l  
lobe  i nc ludes  the  s u bd o ma i n s  I - IV and is r e s po ns ib l e  for  anchor ing  
ATP.  The  l a rger  C - t e r mi na l  lobe  whose  func t i on  is to bind the 
subs t r a t e  and i n i t i a t e  p h o sp h o t r a ns f e r ,  i nc ludes  the subdomai ns  VI-X.  
The  s ubdomai n  V f unc t i ons  as a l ink be tween  the N- t e rmi na l  lobe  and 
the C- t e rmi na l  lobe  o f  the ca t a l y t i c  r eg ion  (Hanks  & Hunte r ,  1995).  
The  f l e x i b i l i t y  be tween  the  two lobes  is due  to an i nduced  fit 
me c h a n i s m w he reb y  the t r a ns i t i o n  f rom an inac t ive  form to an act ive  
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F igure  1.2: An i l lu s t r a t io n  o f  a ty p ica l  s er in e / th r e o n in e  prote in  
kinase  c a ta ly t i c  dom ain .  The pro t e in  k inase  c a t a l y t i c  domain 
s ub di v i de d  into twe l ve  conse r ved  s ubdomai ns  is shown by Roman 
numera l s .  The  consens us  s eq ue nc es  in the sub d o ma i ns  are also shown 
( S n a a r - J a g a l s k a  & Schenk ,  1999)
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1.3 Signal transduction pathways in Plasmodium  
fa lc ip a ru m
1.3.1 c A M P -d e p e n d en t  pathw ay
cAMP is an i mpor t an t  s econda ry  m e ss en g er  in all eukaryotes .  Its 
e f fec t s  are exer t ed  t h r ou gh  the  ac t i va t i on  of  c A MP - d e pe nd en t  pro t e in  
k inases  such as p ro t e in  k inase  A. In P. fa lc ip a ru m  homol ogues  o f  the  
c A MP - d e p e n d e n t  pa thway  t ha t  inc lude  the me mbr a ne  bound adenylyl  
cyc l a se  and pro t e in  k inase  A genes  have  been i den t i f i ed  (Read & 
Mikke l sen ,  1991).  cAMP has been i mp l i ca t ed  in P. fa l c ip a ru m  sexual  
d i f f e r en t i a t i on  and the gene encod i ng  the  P. fa l c ip a ru m  prote in  
k inase  h o mo l o g ue  has been i s o l a t ed  and i den t i f i ed  us ing  the 
P l a s m o d i u m  Genome  Da taba se  ( P l a s moDB)
(ht tp : / /www.  p l a smodb.  org).
1.3.2 P h o s p h a t id y l in o s i to l  cycle
Bi nd i ng  of  s ignal  molecu les  to cel l  su r face  r ecep to r s  such as 
G-pro t e i ns ,  resu l t  in the  a c t i va t i on  o f  p h o sp h o l i p a s e  C which causes  
the  hydro l ys i s  o f  p h o s p h a t i d y l i n o s i t o l - 4 , 5 - b i p h o s p h a t e  ( P IP 2).
The h y d ro l ys i s  o f  P I P 2 resul t s  in t he  p r o d uc t i on  o f  two second 
me ss enge r s  namel y  d i a cy l gy l ce ro l  (DAG)  and i no s i t o l -1 , 4 , 5 -  
t r i p h o sp h a t e  (IP?).  I P 3 f a c i l i t a t es  the  t r an s mi s s i on  of  the  s ignal  by 
s t i mu l a t i n g  the  r e l ease  o f  ca l c i um ions s tored in the  endop l asmi c  
re t i cu lum.  DAG t r a ns mi t s  the  s ignal  by a c t i va t i n g  pro t e in  k inase  C 
which  p ho s ph or y l a t e s  and ac t i va t e s  other  pro t e in  k inases  such as 
p ho s ph a t i d y l i n o s i t o l  3 - k in a se  (PI3K)  and g l ycogen  s yn thase  k inase  3. 
The  p r e sen ce  o f  the  p h o sp h a t i d y l i n o s i t o l  cyc l e  has  been prev ious ly  
r epo r t ed  (Mar t in  et al ,  1994).  The s equen t i a l  a cc umu la t i on  of  
s econda ry  messenger s  I P 3 and DAG at the  e x f l a ge l l a t i on  s tage  of  
P. fa l c ip a ru m  gamet ocy t e s  s t rong ly  infers  tha t  the  
p ho s ph a t i d y l i n o s i t o l  cycle  is i nvo lved  in t he  p rocess  (Mar t in ,  1994).  
A gene  P f NS M  tha t  encodes  a p h o sp h o l i p a s e  C h omol ogue  in
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P. f a l c i p a r u m ,  has been i den t i f i ed  in the  P l a smoDB 
(ht tp  : / /w w w . p l a s m o d b . o r g ). The  gene  is exp re s sed  dur ing  the s tage  
p ro gr e s s i o n  f rom t r op h oz o i t e  to s ch i zon t  ( Ha nad a  et al,  2002) .  The 
p re sence  o f  p h o s p h a t i d y l i n o s i t o l - 4 , 5 - b i p h o s p h a t e  and membrane  
bound  p h o sp h a t i d y l i n o s i t o l  syn t hase  in P. kno w les i  i nfec ted 
e r y t h r ocy t e s  sugges t s  the  p re sence  o f  a compl e t e  p h o sp h a t i dy l i n o s i t o l  
cyc l e  (E l abbad i  et a l ,  1994).
1.3 .3  cGMP d e p e n d en t  p athw ay
The me mbr a ne  bound  pro te in ,  guanyl  cyc l a se  is a c t i va t ed  upon 
b ind ing  o f  s ignal  mo l ecu l es  r e s u l t i ng  in the p r o d uc t i on  o f  cGMP.  The 
cGMP then exer t s  its e f fec t s  by s t i mu la t i ng  c G MP - de pe n de n t  prote in  
k inases  which  lead to ac t i va t i on  o f  o t he r  pro t e in  k inases  and changes  
in me ta bo l i c  r eac t ions .  E x f l ag e l l a t i o n  in both  P. f a l c i p a r u m  and 
P. berg h e i  is s t i mu l a t ed  by cGMP and guanyly l  cyc l a se  ac t i va tor s  
such as n i t r o p ru ss i de ,  whereas  adeny l y l  cyc l a se  ac t i va tor s  have  no 
e f fec t  on the process .  Thi s  sugges t s  tha t  e l ement s  o f  the  cGMP-  
d ep en de n t  p a thway  are i nvo lved  in g a me t o g en e s i s  ( Kawamot o  et al,  
1990).  The cycl i c  GMP d e pe nd e n t  p ro t e in  k inase  has been iden t i f i ed  
in P. f a c i p a r u m  and found  to be expres sed  in the r ing s tages  o f  the P. 
f a l c i p a r u m  l i fe cyc l e  (Deng  & Baker ,  2002) .
1.3.4 C alc ium  s ig n a l l in g
Cal c i um re l eased  f r om the e n do p l a s mi c  r e t i c u l u m in euka r yo t es  is a 
s econda r y  m e s s e n g e r  in s igna l  t r a n s d u c t i o n  cascades .  In p lant s  
ca l c ium s t i mul a t ed  p ro t e in  k inase  ac t i v i t i e s  occu r  t h r ough  ca lc ium-  
d ep en de n t  pro t e in  k inases .  In P. f a l c i p a r u m  c a l c i um s i gna l l i ng  has 
been imp l i ca t ed  t h r ough  the p re sence  o f  c a l c i u m- d e pe n de n t  protein 
k inases  in the  asexua l  pa ras i t e s  (Read & Mi kke l sen ,  1990).  
F u r t h e r m o r e  i nves t iga t i ons  into the  role  o f  c a l c i um s igna l l i ng  in 
P. f a l c i p a r u m  and P. be rg h e i  have  shown that  c a l c i um an tagoni s t s  
such as TMB-8  and W-7 i nh ib i t ed  ex f l ag e l l a t i o n  in both  species
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( Ka wamo t o  et al,  1990).  A gene  e nco d i ng  a c a l modu l i n  h o m o l o g u e  in 
P. f a l c i p a r u m  was i den t i f i ed  in the  a sexua l  pa ras i t e s ,  where  
ca l mo du l i n  was p rev i ous l y  s hown to be an i n t r ace l lu l a r  r e c e p t o r  for  
c a l c i um (Ro bs on  & Jenn i ngs ,  1991;  Leese ,  1995).  Three  genes  
encod i ng  p red i c t ed  c a l c i u m - d e p e n d e n t  pro t e in  k inases  have  been 
i den t i f i ed  in P. f a l c i p a r u m  and they i nc lude ,  P f C D P K l  (Zhao et al,  
1993) ,  P f CDP K2  ( Fa r be r  et al ,  1997) and PfCDPK3 (Li et al ,  2000) .
1.3 .5  M itogen  a c t iv a ted  p ro te in  k in ase  pathw ay
The mi t ogen  ac t i va t ed  pro t e in  k inases  ( MA PK )  med ia t e  r e sponses  in 
many  s ignal  pa thways  such as g rowt h  ar res t ,  cel l  movement ,  cel l  
p r o l i f e r a t i on  and cel l  d i f f e r en t i a t i on  in eukar yo tes .  M AP K  can be 
ac t i va t ed  by mo l ecu l es  such as G-p r o t e i n  c oup l ed  r ecep to r s ,  r ecep tor  
t y r os ine  k inases ,  ac t i va t ed  ras ,  phorbo l  es t e r s  and pro t e in  k inase  C 
( Cobb  & Go l ds mi t h ,  1995).  In P. f a l c i p a r u m ,  a MAP K homologue ,  
namel y  P. f a l c i p a r u m  mi togen  a c t i va t ed  pro t e in  k inase  1 ( / ’/m a p  1) 
has been  i de n t i f i e d  and cha r ac te r i s ed  in two s epa ra t e  l abo r a t o r i e s  and 
re f e r r ed  to as e i the r  / ’/m a p -1  or P /M A P  (Doer ig  et al ,  1996;  Lin et 
al,  1996).  It is su gg es t e d  tha t  the  h o m o l o g u e  is l inked  to sexual  
d e v e l o p m e n t  due to the high level s  o f  exp r e s s ion  o f  the  gene  in 
g a me t o cy t e s  (Lin et a l ,  1996).  Ano t he r  hyp o t h e s i s  sugges t s  that  
P /m ap-1  has a role  in the d e ve lo p me n t a l  phase  l ead ing  to gameto-  
cy t ogenes i s  as the  dec i s ion  to d i f f e r en t i a t e  seems to be made  dur ing 
asexua l  d iv i s ion  (Doer ig ,  1997).  A s econd  MAP K homo lo g ue  P /m ap -2  
has also been i den t i f i ed  (Dor in  et al,  1999;  Doer ig  et al ,  2002) .
1.3.6  O ther  kinases  id e n t i f ie d  in P la sm o d iu m  f a l c i p a r u m
In e uka r yo t i c  cel l s ,  the ce l l - cy c l e  p r o g re s s i on  is con t ro l l ed  by cycl in 
d e pe nd e n t  k inases  (CDK)  which cons t i t u t e  an i n t r i ca t e  s igna l l i ng  
sys tem.  P. f a l c i p a r u m  c dc2 - re l a t ed  pro t e in  k inase  (Pfc rk-1)  with 
h om o l og y  to the p58 gene fami ly  which  are down regu la to r s  o f  cell  
d iv i s ion ,  has been iden t i f i ed  in P. f a l c i p a r u m . Pfcrk-1 may have  a
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role  in sexual  d i f f e r e n t i a t i o n  as s ugges t ed  by the high level  o f  
e xp re ss io n  o f  mRNA in g a me t o cy t e s  (Doer ig  et al ,  1995).
P. f a l c i p a r u m  CDK ac t i va t i ng  k inase  t e rmed  Pfmrk wi th 62 % 
sequence  s i mi l a r i t y  and 46 % iden t i t y  to human  CDK ac t i va t i ng  
k inases  has  a l so been i den t i f i ed  in P. f a l c i p a r u m .  Pfmrk  may be 
i nvo l ved  in sexua l  s t age  d e ve lo p m en t  as it is p r e do mi na n t l y  
exp r e s s ed  in g a me t oc y t e s  (Li  et al,  2000) .  CDK- re l a t ed  kinases  have  
been iden t i f i ed  and c ha r ac te r i s ed  in P. f a l c i p a r u m ,  they inc lude  
P. f a l c i p a r u m  p ro te in  k inase  5 (P fPK5)  a h o m o l o g u e  o f  cycl in 
de pen d en t  k inase  1 ( CDK1)  ( R o s s - Mc d on a l d  et a l ,  1994).  
F u r t h e r m o r e  a pro t e in  Pfcyc-1 wi th an open  read ing  f r ame  (ORF)  
e ncod i ng  a p r o t e i n  wi th h o m o l o g y  to cycl in  H f rom o the r  o rgani sms  
has been c loned  and ac t i va t es  PfPK5 in v itro  (LeRoch  et a l ,  2000) .
P. f a l c i p a r u m  p ro te in  k inase  6 (P f PK6)  has s equence  s imi l a r i t y  to 
CDKs and MAP Ks  and exh ib i t s  57 . 3% and 49.6 % s imi l a r i t y  o f  the 
ca t a l y t i c  domain  to h uman  CDKs and h uma n  MAP Ks  r e spec t ive ly  
( B r a c ch i - R i c a r d  et al ,  2000) .  A P. f a l c i p a r u m  k inase  wi th  h omol ogy  
to the N I M A / N E K  fami l y  o f  p ro t e i n  k inases  ( P f nek - 1 )  has al so been 
i den t i f i ed  and c loned  (Dor in  et al ,  2001) .  Sequence  data  f rom 
Pl a smoDB pred i c t s  tha t  P. f a l c i p a r u m  has genes  cod i ng  for  seventy  
pro t e in  k inases  ( h t t p : / / w w w . p l a s m o d b . o r g ).
1.4 The phosphatidyl inosito l  3-kinase pathway
P h o s p h a t id y l i n o s i t o l  3 - k i na ses  ( P I3Ks)  are a f ami ly  o f  l ipid kinases  
that  i n i t i a t e  s ig na l l i n g  cascades  by g e ne r a t i n g  three  membr ane  
p h os ph o in o s i t i d e s ,  P I 3 - P , P I - 3 , 4 - P 2 and P I - 3 , 4 , 5 - P 3. The PI3Ks  can 
also conver t  c e l l u l a r  p h os ph o i n o s i t i d e s  tha t  are g e ne r a l l y  p resent  
near  the  cel l  me mb r a n e  namel y ;  PI3-P,  4 - P 2, 5 - P 2 to P I - 3 , 4 ,5 - P 3. The 
PI3Ks  p a r t i c i pa t e  in a n u mb er  o f  c e l l u l a r  p rocesses  such as cell  
g rowt h  and t r a ns fo rma t i on ,  d i f f e r en t i a t i on ,  mot i l i ty ,  insul in act ion,  
cel l  su rv iva l ,  p r o l i f e r a t i on  and c a r bohydr a t e  me tabol i sm.  PI3Ks  have
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been found  in all euka r yo t es ,  i n c lu d in g  y eas t  and were  a l so ident i f i ed  
in D ro s o p h i la  ( r ev i ewed  by V a n h a e s e b r o e c k  et al ,  2001) .
The  P I 3Ks  p h os p ho r y l a t e  inos i to l  l ip ids  on the pos i t i on  th ree  o f  the 
i nos i t o l  h e a d g r o u p  (F i gure  1.3).
Figure  1.3: The s tr u c tu r e  o f  in o s i to l  l ip ids .  The inos i to l  l ipid 
cons i s t s  o f  a d i a c y l g l y c e r o l  l i nked  by a p h o s ph o d i e s t e r  bond to a 
i nos i t o l  head  group.  The  inos i to l  head g roup  is e xposed  to the cell  
cy top l asm,  whi l e  the d i a cy l g l yce ro l  is inse r t ed  in the  inner  l ayer  o f  
the me mb r a n e  b i l aye r  (Ste in ,  2001) .
1.4.1  C lasses  o f  p h o s p h a t id y l in o s i to l  3 -k in a ses
P13Ks are d iv ided  into three  main  c lasses :  I, II  and III.  They  are 
g ro up ed  on the basis  o f  s equence  h o mo l ogy ,  in vitro  subs t r a t e  
p r e fe rence ,  the  me thod  o f  a c t i va t i on  and r egu l a t i on  (F igure  1.4).  
Four  h o mo lo g ue s  o f  mammal i an  PI3Ks  have been de f ined  to be in 
c lass  l a  and b. PI3Ks  in c lass  II ( P I3 K- C2 )  have  an add i t i ona l  C2 
domain  d i s t i n g u i s h in g  t hem f rom the o the r  two c lasses .  Class  III 
( Vps 34)  has no r a s - b i n d i n g  domain  ( F i gu r e  1.4).
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Figure  1.4: S tru c tu r a l  fea tu res  o f  the c a ta ly t ic  dom ain  o f  the  
p h o sp h a t id y l in o s i t o l  3 -k in a se  fam ily .  The pro t e in  domains  are as 
fo l l ows :  r a s - b i nd i ng  si te (RBD) ,  he l i c a l  domain  (HD) ,  the  ca ta ly t i c  
domain  (CD)  and the C2 domain  (C2) ,  ( r ev i e wed  by Fr uman et al,  
1998).
1.4 .1 .1  Class  I p h o s p h a t id y l in o s i to l  3 -k in a se
Class  I P I 3Ks  are d iv ided  into two s ubc l a s se s  namel y  l a  and lb 
acc or d i n g  to t he i r  means  o f  ac t i va t i on .  The class  l a  P I 3Ks  i nc lude  the 
mammal i an  P13Ks,  p i  10a ,  p l i o p  and pi  105. The  mammal i an  
h om o l o g u e s  were  shown to share  42-58  % amino acid s equence  
ident i ty .  Class  I PI3Ks  have  also been iden t i f i ed  in D ro so p h i la  
m e l a n o g a s t e r , C a e n o h a h i t i s  e leg a n s  and D ic to te l iu m  d is co id eu m  and 
were  shown to have  t h ree  PI 3K ca t a ly t i c  subuni t s  (F igure  1.4) 
( r ev i e wed  in V a n h ae s e b ro e c k  et al ,  2001) .  The class  l a  PI3Ks 
cons i s t s  o f  a r egu l a to r y  and ca t a l y t i c  uni t .  The  ca t a ly t i c  subuni t  is 
110-120 KDa  in s ize  whi l s t  the  r e gu l a t o r y  s ubun i t  is no rma l ly  
85 KDa.  The class  I PI3Ks  main ly  p ro d u c e  PI -3 ,4 ,5-P3 in vivo.
The ca t a l y t i c  subun i t  has a ras b i nd i ng  domain ,  a he l i ca l  domain  and 
a C- t e rmi na l  c a t a l y t i c  domain  (F igure  1.4) (F ruman et al ,  1998).  
Mo s t  o f  the m e mb r a no u s  t y r os i ne  k inases  can ac t i va t e  class  l a  PI3K
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t h r o u gh  b ind i ng  o f  the S r c - h o m o l o g y  3 domain  found  in the 
r e gu la t o r y  subuni t .  Thus  r ecep t o r s  such as the insul in  and p l a t e l e t  
de r ived  g rowt h  f ac t o r  r e cep t o r s  s t rongly  ac t i va t e  c lass  l a  PI3Ks.  The 
class  l a  PI 3Ks  may also be r egu la t ed  by i n t e r ac t ion  wi th the  smal l  G 
p ro t e in  ras  wh ich  in t e r ac t s  d i r ec t l y  wi th  the ca t a ly t i c  subuni t .
The  m e ch a n i s m of  ac t i on  o f  the c lass  l a  PI3K upon ac t i va t i on  by 
ex t e r na l  s t imul i  is the  p h os p ho r y l a t i o n  o f  a n u m b e r  o f  d owns t ream 
e f f ec t o r s  such as p ro t e in  k inase  B and pro t e in  k inase  C, l ead i ng  to 
changes  in cel l  f unc t i ons  (Stein ,  2001) .  A p ro t e in  wi th  36 % ident i ty  
to p i  1 0a  which  be longs  to the c lass  lb,  was also c loned and t e rmed 
p l l Oy .  Class  lb PI3Ks  have  a c a t a l y t i c  subuni t  110 KDa  in s ize and a 
r e gu la to r y  s ubun i t  o f  101 KDa.  Class  lb k inases  are main ly  ac t i va t ed  
t h r o u gh  G-pro t e in  s i gna l l i ng  (Fry,  2001) .
1 .4 .1 .2  Class  II p h o sp h a t id y l in o s i t o l  3 -k in a se
Class  II P I 3Ks  are l a rge  p ro t e in  k inases  t ha t  are 170-210  KDa  in size.  
The  ca t a l y t i c  s ubun i t  con ta i ns  a he l i ca l  domain ,  a ca t a l y t i c  domain  
45 - 50  % s imi l a r  to class  I PI3Ks  and a ras b ind i ng  domain  (F igure  
1.4).  All the  c lass  II enzymes  have  e x t ens ions  to t he i r  amino acid 
s eque nc e  at bo th  the i r  N- and C- t e r mi n i  in co mp ar i so n  wi th c lass  I 
enzymes .  Class  II P I 3Ks  have also been  de s i gna t ed  C 2- c on t a i n i ng  
p h os p ho i n o s i t i d e  k inases  due to pos se ss in g  a C- t e r mi na l  r eg ion  wi th 
h om o l og y  to C2 domains .  The C2 domains  are p ro t e in  subuni t s  that  
f a c i l i t a t e  ca l c i um d e pe nd e n t  or ca l c i um i nde pen d e n t  p h os pho l i p i d  
b ind i ng  and have  been found  to be i nvo lved  in c a l c i um dependen t  
b ind i ng  o f  pro t e in  ves i c l e s  (S te in ,  2001) .  Class  II PI3Ks  inc lude  
PI3Ks  f rom D r o s o p h i l a , mice and C. e legans .  The  mammal i an  class  II 
i so fo rms  are P I 3 K - C 2 a ,  p and y which  are encoded  by three  separa te  
genes  ( r ev i e wed  in V a n h a e s e b ro e c k  et al ,  2001;  Fr uman et al,  1998).  
Ac t i va t ion  o f  c lass  II P I 3Ks  by mo l e c u l a r  i n t e r ac t i ons  t h rough
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ex t e r na l  s t imul i  is s t i l l  unc l ea r ,  a l t hough  c lass  II P I 3Ks  appea r  to be 
ac t i va t ed  by t y r os in e  k i na se  r e cep t o r s  (Ste in ,  2001) .
1 .4 .1 .3  Class  III p h o s p h a t id y l in o s i t o l  3 -k in ase
The th i rd  c lass  o f  the  f ami ly  o f  P I 3Ks  is s t r u c tu r a l l y  re l a t ed  to the 
p roduc t  o f  the  S a c c h a r o m y c e s  c e r e v i s ia e  gene,  Vps34  and the human 
h o mo l o g u e ,  Vps34p  (Wa t e r f i e l d  et a l ,  1997).  The 94 K Da  yeas t  
p ro t e in  Vps34 ,  is a s s oc ia t e d  wi th  ano t he r  p ro t e i n  V p s l 5  which is a 
s e r i n e / t h r e on i n e  kinase .  V p s l 5  recru i t s  Vps34  to the  cel l  membr ane  
l ead i ng  to the  a c t i va t i o n  o f  Vps34.  The a c t i va t ed  Vps34  is then 
i nvo l ved  in p ro t e in  t r a n s p o r t  t h r ough  the  vacuo l e  (Stein,  2001) .
P I 3Ks  o f  the  t h i r d  class  have  also been  iden t i f i ed  in D ro s o p h i la  and 
D i ty o s t e l i u m  ( Va n ha e s e b r o o ec k  et al ,  2001) .  A human  DNA encod ing  
30 % sequence  i den t i t y  to the  V p s l 5  gene  was c loned  and also found 
to r ec ru i t  Vps34  ( F r u ma n  et al ,  1998).  Class  III  P I 3Ks  mainly  
g ene r a t e  p h o s p ho i n o s i t i d e s  in vivo  (S te in ,  2001) .
1.4 .2  O ther  re la ted  l ip id  and prote in  k inases
Other  enzymes  wi th  ca t a l y t i c  doma i ns  t ha t  c lose ly  r e s embl e  PI3Ks  
i nc l ude  the  p h o s p h o i n o s i t i d e  4 - k i na se  and the p h o s ph o in o s i t i d e  
p ho sp ha t e  k inases  (Nor r i s  et al ,  1995).  The  p h o sp h o i n o s i t i d e  4- 
k inases  are i mp o r t an t  in r eg u l a t i n g  p h o s p h o in o s i t i d e  l evel s  but  have 
a m i no r  d i rec t  role  in s ignal  t r a n s d u c t i o n  (Stein ,  2001) .  The DNA- 
d e pe nd en t  pro te in  k inases  be l ong  to the PI3K fami ly  and have  a 
re l a t ed  k i na se  doma i n  wi th  a ca r boxy l  t e r mi na l  r eg ion  but  have  no 
o ther  reg ions  o f  homology .  The D N A - de p en d e n t  p ro t e in  k inases  are 
l a rge r  than the c lass  I P I 3Ks  wi th s izes  o f  200 - 400  KDa  and appear  to 
act  as a p ro t e i n  k inase  only.  The  DN A- de pen d e n t  pro t e in  k inases  are 
i nvo l ved  in the  a c t i va t i on  of  DNA repa i r  and the l ink ing  o f  this  to 
cel l  cyc l e  cont rol .  Other  pro t e in  k inases  r e l a t ed  to PI3Ks  inc lude  the 
t a rge t  o f  r ap amy c i n  (mTOR) .  The mTOR is i nvo l ved  in the  cont ro l  o f  
p ro t e in  syn thes i s  t h r ou gh  ac t i va t i on  o f  pro t e in  k inases  such as 
p 70 S 6 K (F ruman  et a l ,  1998).
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1.4 .3  The p h o sp h a t id y l in o s i t o l  3 -k in a s e /p r o t e in  k in ase  B pathway
The P I 3 K/ p r o t e i n  k inase  B p a th way  has  been e x t en s iv e ly  s tud i ed  
upon  d i s cove ry  tha t  PI3Ks  a c t i va t i on  preven t s  cel l  death and PI3Ks  
also have  a role  in cel l  g rowt h  r e g u l a t i o n  ( F ruman  et al ,  1998;  
Vi vanco  & Sawye r s ,  2002) .  The class  l a  PI 3Ks  are mos t ly  invo lved  in 
the  P I 3 K/ p r o t e i n  k inase  B pa thway  and the i r  ac t i va t i on  leads to cel l  
su rv iva l  or  apoptos i s  (F igure  1.5)  (Stein,  2001) .
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Figure  1.5: The p h o s p h a t id y l in o s i t o l  3 -k in a s e /p r o t e in  k inase  B 
pathw ay  (T o k er ,  2000) .
Li gands  such as insu l in ,  i n s u l i n - l i ke  g r owt h  fac tor ,  p l a t e l e t  der ived  
g rowt h  fac tor ,  ep ide rmal  g rowt h  f ac t o r  and basic  f i b r ob l as t  growth  
f ac to r  bind the r ecep t o r  t y r os i ne  k inase  ( F i gure  1.5).  This leads  to
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a u to p h o s p h o r y l a t i o n  o f  the  r e c e p t o r  t y r os i ne  k inase  r e su l t i ng  in the 
p r o du c t i o n  o f  p h o sp h or y l a t e d  t y r os i ne  res idues .  The p ho s ph o r y l a t ed  
r e s i dues  f ac i l i t a t e  the  r e c r u i t m e n t  and ac t i va t i on  o f  s econda ry  
k inases  such as P I 3K (F igure  1.5).  The  pho s ph o r y l a t ed  res idues  
r ec ru i t  k i na se s  tha t  con t a i n  the S r c - homol ogy  2 domains .  The 
ac t i va t i on  o f  P I 3K resu l t s  in the  p r od u c t i on  o f  p h o spho i nos i t i de s  
such as P I - 3 , 4 , 5 - P 3 at the cel l  membrane .  These  second messenger s  
med i a t e  s igna l  pa thways  by me mb r a n e  r e c r u i t me n t  and ac t i va t i on  of  
d ow ns t r e am  e f f ec t o r  p ro te ins  such as the  p ho s ph o in o s i t i de  dependen t  
p ro t e in  k i na se  (PDK)  (Ching  et a l, 2001) .  The ph o s ph o i n o s i t i d e s  bind 
PDK at its p l ecks t r i n  h o m o l og y  domain  and ac t i va te  it. Upon 
a c t i va t i on  PDK is able  to p h o s p ho r y l a t e  o the r  d o wn s t r e am e f fec tors  
such as p ro t e in  k inase  B, which  in t u rn  l eaves  the  p l a sma  membrane  
to p h o s p ho r y l a t e  i n t r ac e l l u l a r  subs t r a t e s  such as g l ycogen  synthase  
k inase  3 ( A n d je lk o v ic  et a l, 1999).
Ac t i va t ed  pro t e in  k inase  B can be t r a ns l oc a t e d  to the nuc leus  
r e s u l t i ng  in p h o s p ho r y l a t i o n  o f  t r a ns c r i p t i o n  f ac tor s  such as cAMP-  
r e s ponse  e l e m e n t - b i n d i n g  pro t e in  ( CREB) ,  f o r khead  t r a ns c r i p t i o n  
fac to r s  ( FKHL R)  and lead to the r e gu l a t i o n  of  gene t r ansc r ip t i on  
( Cof f e r  et a l, 1998).  PDK may al so p ho s ph o ry l a t e  pro t e in  k inase  C in 
the p re sence  o f  p h o s p ho i n o s i t i d e s  l ead i ng  to the  ac t i va t i on  o f  MAPK,  
which  l eads  to pro te in  syn t hes i s  (Chan t r y  et a l, 1997).
1.4 .4  E ffec ts  o f  the p h o s p h a t id y l in o s i to l  3 -k in a s e /p r o t e in  kinase  B 
pathway
The d ive r se  func t ions  o f  PI 3Ks  c on t r i bu t e  to mi togenes i s ,  ce l l u l a r  
g rowt h ,  cel l  su rv iva l ,  g l ucose  me ta bo l i sm and cel l  mot i l i t y  ( shown in 
F i gur e  1.6) (Stein ,  2001) .  PI3K has a con t r i bu t o r y  role  to cell  
s urv iva l  s igna l l i ng  t h r ou gh  its e f f e c t o r  p ro t e in  k inase  B. The pro-  
ap op t o t i c  bc l -2 a n t agon i s t  o f  cel l  cea th  (BAD)  is phos ph o ry l a t ed  and 
i na c t i va t ed  by pro t e in  k inase  B l ead i ng  to cel l  p r o t ec t i on  f rom 
apop t os i s  ( Vi vanco  & Sawyers ,  2002) .
17
Figure  1.6: Bi o l og i ca l  e f fect s  of  the p h os p ha t i d y l i n o s i to l  3 -k inase  
pat hway.  Thr ee  pos s i b l e  means  by which  PI3K is a c t i va t ed  are shown 
and the  d o w ns t r e a m  e f f ec t o r s  of  PI 3K have  been ident i f i ed .  The 
major  f unc t i ona l  pa t hways  for t r a n s m i s s i o n  of  P I 3K s ignal s  lead to 
cel l  su rv iva l ,  g l ucose  me t abo l i sm,  mi togenes i s  and cel l  mot i l i ty .  The 
a bb re v i a t i on s  used are  as fo l l ows ;  pro t e in  k inase  B (PKB) ,  mi togen 
ac t i va t ed  pro t e in  k i na se  k i na se  (MEK) ,  e x t r a ce l l u l a r  r egu la t ed  k inase  
(ERK) ,  c as pase  9 (Cas  9),  bc l -2 an t ag o n i s t  o f  cel l  dea th  (BAD),  
fo r khead  t r a ns c r i p t i o n  f ac tor  (FKHLR) ,  I k B  k inase  ( I k k ) ,  glycogen 
syn t hase  k inase  3 (GSK3) ,  B r u t o n ’ s t y r os in e  k inases  (Btk) ,  prote in 
k i na se  C (PKC)  (adap ted  f rom Stein,  2001) .
18
Pr o te i n  k inase  B has  also been shown to inhib i t  p r o - a po p t o t i c  ■ 
c ys t e i ne  p ro t ease ,  c a spase - 9  and f o r khead  t r a ns c r ip t i on  fac tors  
(F igure  1.6).  Studies  on f ib ro b l a s t s  show that  pro t e in  k inase  B 
inh ib i t s  p r o t ea se s  t ha t  s pec i f i c a l l y  c l eave  the  RNA po l ymer a se ,  thus  
p ro mo t i ng  cel l  su rv iva l  ( W oo d ge t t  et al ,  1996).  PI 3K ac t i va t i on  o f  
the  d o w ns t r e a m  e f f ec t o r  p ro t e in  k i na se  C t h r ough  PDK leads to the 
a c t i va t i o n  o f  r i bos oma l  S6 k inase  (p70S 6K) .  Ph o s ph o r y l a t i o n  o f  40S 
r ibos oma l  p ro t e in  S6 by p 7 0 S 6 K  leads  to the  t r a ns l a t i o n  o f  several  
mRNAs.  Thes e  mRNAs  e ncode  pro t e ins  ne ce s sa ry  for  the assembly  o f  
t r a n s l a t i o n a l  ma ch i n e ry  and i nc l ude  r i bosomes  and e l onga t ion  
fac tors .  Thi s  has led to the  conc l us i on  tha t  p 7 0 S6 K regu la t es  pro te in  
s yn t he s i s  (Toker ,  2000) .  Po t en t i a l  me c h an i s ms  by which  PI3K 
ac t i va t e s  M AP K  have been imp l i ca t ed .  P h o s ph o r y l a t i o n  o f  MAP K 
leads  to changes  in cel l  f unc t i on  such as gene  t r a ns c r i p t i o n  (Toker ,  
2000 ) .
1.5 Protein  kinase inhibitors
The i mp o r t an c e  of  P I 3K ac t i v i t y  in many o r gan i s ms  has been 
i n ve s t i ga t ed  and p r op os ed  t h rough  the use o f  spec i f i c  p ro t e i n  k inase  
i nh i b i t o r s  such as wo r t ma nn i n  and L Y 294002  (Stein,  2001) .
Fi gure  1.7: Chemi ca l  s t ruc t ure  o f  w or t ma nn i n  (Powis  et al ,  1994) .
19
W or t m a nn i n  a l so r e fe r red  to as SL -2052  is a s t e r o id  me tabo l i t e ,  f i r s t  
i so l a t ed  f rom the funga l  spec i es  P e n ic i l lu m  f u m i c u l o s u m  (F igure  1.7).  
It was  l a t e r  found  to be p r o d uc ed  b.y o ther  fungi  such as M y r o th ec iu m  
r o r id u m  and F u sa r iu m  o xysp o ru m  (Abbas  & Mi rocha ,  1988).  
Wo r t ma n n i n  has  been an i nva l uab l e  too l  in e l uc i da t i ng  the role  o f  
P I 3K in s igna l  t r a n s d uc t i o n  pa t hways  in ma mma l i a n  cel l s  as wel l  as 
in many  p r o t o z o a  such as E n ta m o e b a  invadens  and Trypanosoma  
cruzi .  In E. in va d en s  P13K is i mp l i c a t e d  in var ious  ce l l u la r  r esponses  
which  i nc l ude  encys t a t i on .  Wo r t ma nn in  was shown to inhib i t  
e ncy s t a t i o n  and p r o tozoa l  g r owt h  o f  E. invadens  in a dose  dependen t  
ma n ne r  (0.5 pM-10  pM)  ( Ma k i ok a  et a l ,  2001) .  Pa ras i t e  invas i on  was 
a l so - i nh i b i t ed  in a dose  d e pe nd e n t  manner  when n o n - p h a go c y t i c  and 
ma c r o p h ag e  cel l s  were  t r e a t ed  wi th wor t mann i n .  P I 3K was shown to 
be a c t i va t ed  upon invas i on  by T. cruz i  in the  hos t  cel l s  ( Wi l kowsky  
et al ,  2001) .  Kine t i c  s t ud i es  show that  wo r t ma nn i n ,  a n o n ­
co mp et i t i ve  and i r r ev e r s ib l e  i nh i b i t o r  o f  PI3K ki l ls  cel l s  at a much 
h i gh e r  c o n c e n t r a t i o n  (2-58 pM)  than  the i so l a t ed  enzyme  (4.2 nM) 
(Powi s  et al ,  1994).  Wo r t ma nn in  has  al so been shown to i nh ib i t  PI3K 
enzymes  i so l a t ed  f r om c a l f  t hymus  cel l s  wi th  an I C 50 va lue  o f  2 nM 
(Vlahos  et al, 1994).
1.5.2 L Y 2 94 0 02 (  2 - ( 4 - Mo r ph -o l i n y l ) - 8 - ph e ny I - 4H - l -b e nz op y r an  
-4 - one )
L Y 2 94 0 02  has been e x t en s i v e ly  app l i ed  to rabb i t  smoot h  muscl e  cel ls  
to i nve s t iga t e  the  b io l og i ca l  f unc t i ons  o f  PI3K ac t i va t i on .  Studies  
have  shown tha t  LY2 9 4 0 0 2  acts as a , co mp e t i ve  i nh i b i t o r  o f  ATP at 
the  ca t a ly t i c  s i te  o f  PI 3K and was found  to inhib i t  P I 3K in r abbi t  cell  
l ines  wj th I C 50 va lues  o f  10-20 pM (Stein,  2001;  Vlahos  et al,  1994).  
L Y 2 9 40 0 2  has al so been shown to decr ease  the  g rowt h  o f  ovar i an  
c a r c i n o m a  and asc i t e  f o r ma t i on  in a mouse  model  o f  ovar i an  cance r  
( Ja f f e - e t  al,  2000) .  2 - ( 4 - M o r p h o l i n y l ) - 8 - p h e n y l - 4 H - 1- be nz opyr an - 4 -
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one ( L Y2 9 40 0 2 )  is a s yn t he t i c  mo r ph o l i ne  de r i va t i ve  o f  the  broad 
s pec t r um k inase  i n h i b i t o r  que rce t i n  ( F i g u r e  1.8).  Que rce t i n  is a 
na t u r a l l y  oc cu r r i n g  f l avono i d  in a lgae  and vege t ab l e s  tha t  can inhibi t  
a b road  range  o f  p ro t e in  k inases ,  wh i l s t  LY294002  was d e ve l ope d  as 
a s e l ec t i ve  P I 3K i n h i b i t o r  (Vlahos  et a l ,  1994).
Fi gure  1.8-: Chemi ca l  s t ruc t ure  o f  LY294002  (Vl ahos  et a l ,  1994) .
1.6 Indirect  modulators o f  the phosphatidylinosito l  
3-kinase /prote in  kinase B pathway
1.6.1 Forsko l i n  and 1 , 9 - d id e ox y f o r s k o l i n
Fo rsk o l i n  ( 7 - b e t a - a c e t ox y - 8 ,  13 - e p o x y - 1-a lpha)  also r e f e r red  to as 
c o l f o r s in  or  co l eono l  is a l ip id  so lub l e  d i t e rp e no i d  i so l a t ed  f rom the 
plant  C oleus  f o r s k o h l i i  (F igure  1.9)  (Seamons  & Daly,  1986).  Many 
o f  i ts known b io l og i ca l  e f fec t s  are due  to its ac t i va t i on  o f  adenyla t e  
cyc l a se  which  re su l t s  in an i nc rease  in i n t r a ce l lu l a r  cAMP 
c on ce n t r a t i on s  in the  cel l  and an a c t i va t i o n  o f  p ro t e in  k inase  B which 
is usua l l y  ac t i va t ed  by PI 3K ( Seamons  & Daly,  1986).  For sko l in  is 
p repa r ed  f r om root s  o f  the C. f o r s k o h l i i . Fo r sk o l i n  was shown to 
cause  an i nc rease  in i n t r a ce l lu l a r  cAMP re su l t i ng  in an ac t i va t i on  o f  
p ro t e i n  k i na se  B in a P I 3K i n d e pe nd e n t  manner  (Cof f e r  et al ,  1998).
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Fi gure  1.9:  Chemi ca l  s t ruc ture  of  for sk o l i n  and  
1 , 9 - d i d e o x y f o r s k o l i n  (S eamons  & Daly,  1986) .
cAMP is i nvo l ved  in d e ve lo pm en t  and d i f f e r en t i a t i on  in a n u mb e r  o f  
lower  e u ka r yo t i c  spec ies  i nc l ud i ng  P. f a l c i p a r u m  (Read & Mikke l sen ,  
1991) .  Fo r sk o l i n  has also been shown to inhib i t  e ry t h r o c y t i c  hexose  
t r a n s po r t  and a l ter  vo l t age  d e pe nd e n t  po t a s s ium channe l s  in a c lonal  
p h e o c h r o m o c y t o m a  cel l  l ine  ( Wa dl e r  & Huang  Yang,  1991).  For sko l in  
was a l so shown to r everse  acqu i r ed  r e s i s t a nc e  in mur i ne  s a r coma  cell  
l ine.  Acqu i r ed  r e s i s t a nc e  was shown to be as a r esu l t  o f  the  expu l s i on  
o f  drugs  by the p r e s ence  o f  the  p l a s m a  me mb r a n e  a ssoc i a t ed  P- 
g ly c op r o t e i n  ( Wa dl e r  & Huang  Yang,  1991)
In m a mma l i an  cel l s  P - g l yc op r o t e i n s  are e n e r g y -d ep e nd e n t  membrane  
p ro t e ins  t ha t  t r a n s p o r t  ions and sugars ,  howe ve r  may also act  as drug 
t r a ns po r t e r s  t ha t  a c t i ve ly  pump a wide  va r i e ty  o f  d rugs  out  o f  the 
cel l s  such as do x o ru b i c i n  (Cr anda l l  et al ,  2000) .  Studies  have  shown 
that  fo r sko l i n  i nh ib i t s  MAP Ks  in rat  a d i pose  cel l s  r e su l t i ng  in the 
i nh i b i t i o n  o f  g l ucose  t r a ns p o r t  l ead i ng  to dec r ea sed  growth  of  cel ls  
( Joos t  et al ,  1988).
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Other  p h a r m a c o l o g i c a l  in vivo  ac t i ons  wi th t he rapeu t i c  s i g n i f i ca nce  
i nc l ude  f i r s t l y ,  the  ab i l i t y  o f  a low c on ce n t r a t i o n  (2 nM) o f  t op i ca l l y  
app l i ed  f o r sko l i n  to l ower  i n t r a - o c c u l a r  p re s su re  and reverse  
g l a u co m a  wi th in  sys t emic  c a r d i o v as c u l a r  ef fect s .  Secondly ,  f o r sko l i n  
is capab l e  o f  p ro d u c i n g  smoot h  musc l e  r e l axa t i on  in lung t i s sue ,  thus  
this  b r o n c ho d i l a t o r y  e f fec t  sugges t s  it migh t  be s u i t ab l e  as an a n t i ­
a s t hmat i c  agent .  Th i rd ly ,  fo r sko l in  p roduces  r eve r s i b l e  pos i t ive  
i n o t r op i c  and c h r o n o t r o p i c  e f fec t s  in in v ivo  exper imen t s ,  as wel l  as 
be ing  a po t en t  a n t i h y pe r t e n s i v e  agen t  p r opos ed  to be as a resul t  o f  a 
d ec r ea se  in p e r i p he ra l  r e s i s t a nc e  caused  by the r e l axa t i on  o f  the 
a r t e r i o l a r  smooth  muscle.  H ow ev e r  t he rapeu t i c  po t en t i a l  is l imi ted 
due to its shor t  h a l f  l i fe  (Seamons  & Daly,  1986).
1 . 9-  D i d e o xy f o r s k o l i n  ( 7 b - A c e t o x y - 6 b - h y d r o x y - 8 , 1 3 - e p o x y - l a b d - 1 4 -  
e n - l l - o n e )  is an iner t  a na l ogue  o f  f o r sko l i n  wi th  r e spec t  to adenyla t e  
cyc l a se  a c t i v a t i o n  and p r oduced  by Coleus  f o r s k o h l i i .  The  minor  
chemi ca l  d i f f e r en ces  be tween  these  two compounds  (F igure  1.9) 
r e su l t s  in 1, 9 - d i d e ox y f o r s ko l i n  be ing  unab le  to s t imula t e  adeny la t e  
cyc l a se  and is use f u l  as a neg a t i ve  cont ro l  for  f o r sko l i n  (Seamons  & 
Daly,  1986) .  As for  f o r sko l i n  p r e v i ous  s tudies  have  shown that
1. 9 -  d i d e o xy f o r s k o l i n  i nh ib i t s  the  a c t i va t ed  anion channe l s  and 
c h l o r i de  channe l  i n de pe nd e n t l y  o f  t he i r  i n t e r ac t ions  wi th the 
P - g l yco p r o t e i n s  ( C h e s n o y - M a r c ha i s ,  2003) .  B ind ing  of
1. 9 -  d i d e o xy f o r s k o l i n  to the  P - g l y c op r o t e i n  l eads  also to a r eversa l  in 
acqu i r ed  r e s i s t ance  to do x o r ub ic in  ( Wa dl e r  & Huang  Yang,  1991).
1.7 Chloroquine and quinine
C h l o ro q u i n e  is ma i n l y  e f f ec t i ve  aga ins t  the  i n t r ae ry t h r o cy t i c  s t age  o f  
P. f a l c i p a r u m . Howev er  due to the onset  o f  r e s i s t ance  the re  has been 
an u r gen t  need  to obta in  o ther  an t i ma la r i a l s  t ha t  are e f f ec t ive  aga ins t  
the  i n t r ae r y t h r oc y t i c  s t ages  o f  the ma l a r i a  paras i t e .  In this  s tudy
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c h l o r oq u in e  and qu in ine  are used as s t anda rd  an t i ma l a r i a l s  for  
c omp ar i so n  aga i ns t  s e l ec t ed  compounds  tes ted.
The  a n t i ma la r i a l  ac t i v i t y  o f  any drug  i nc lud ing  ch l o r o qu i n e  re l i es  on 
the i r  a c c um u l a t i o n  wi th in  the  p a ra s i t i s e d  e ry throcy tes .  Ch l o r oqu i ne  
is a h y d r o p h i l i c  weak base  which  a cc umul a te s  in the  p a r a s i t e ’s acidic  
food  vacuo l e  a long  a pH gradient .  Heme  also r e fe r red  to as 
f e r r i p r o t op o r p h y r i n  IX (FPIX)  a ccumul a t e s  as a resu l t  of  
h a e m o g l o b i n  d ige s t ion  in the  food vacuole .  The  drug  in te r fe rs  wi th  
the  c on v er s io n  o f  f ree  heme  to haemozo i n .  P o l y m er i s a t i o n  o f  FPIX 
into h a emozo i n  is the  m e ch a n i s m by which  the pa ras i t e  is pro t ec t ed  
f rom the tox ic  p rope r t i e s  o f  FPIX.  The f ree  FPIX can lyse  membranes  
l e ad i ng  to the g e ne r a t i o n  o f  r e ac t i v e  oxygen  i n t e r med i a t e s  tha t  can 
inh ib i t  o t he r  me t abo l i c  p rocesses  in the  pa ras i t e  (G i n s bu r g  et al, 
1999).  Ch lo r o qu i n e  inhib i t s  the p o l y m e r i s a t i o n  o f  FPIX into 
h a emo z o i n  by fo r mi n g  a complex  wi th  FPIX.  An a ccumul a t i on  of  
F P I X - c h l o r o q u i n e  haemo l y t i c  c omp l ex  wil l  even t ua l l y  ki l l  the 
pa ras i t e  ( G i n s b u r g  et al, 1999).  Q u i n i n e ’s an t i ma l a r i a l  ac t ion is 
be l i eved  to be s imi l a r  to the an t i ma la r i a l  ac t i on  o f  ch loroquine .
1.8 Gene identi f icat ion  using homology based methods
The DNA and amino acid s equence  da t abases  con t inue  to g row in s ize 
thus  p r ov i d i ng  usefu l  i n f o r ma t ion  in the  ana lys i s  o f  newly  s equenced  
genes  and prote ins .  The ava i l ab l e  d a tabases  i nc l ude  the P l a smoDB 
the o f f i c i a l  da t aba se  o f  the ma la r i a  pa ras i t e  g e no me  pro jec t  
(ht tp  : / /w w w . p i a s m o D B . o r g ), En t rez  and the GENBANK.  The 
P. f a l c i p a r u m  g enome  p ro j ec t  p rov ides  the  f i n i shed  s equence  for 
P. f a l c i p a r u m  (3D7 s t ra in) .  The  h o m o l og y  based approach  involves  
the  use  o f  a set  o f  a l go r i t hms  such as the  BLAST (Bas ic  Local  
A l i gnmen t  Search  Too l s )  p r og r amme ,  i n t r oduced  in 1990.  The BLAST 
p ro g r a mm e  compar es  a query  s equence  to all the sequences  in a 
spec i f i ed  da tabase .  Co mp a r i so n s  are made  in a pa i rwi se  manner  and
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given a score  r e f l e c t i n g  the  degree  o f  s i mi l a r i t y  be tween  the query 
and the s eque nc e  be ing compar ed .  The h i ghe r  the  score ,  the g rea t e r  
the degree  o f  s imi l a r i t y .  The  a l i g n me n t s  made  may e i t he r  be g loba l  or 
local .  Globa l  a l i gnment s  i n c lu d e  char ac t e r s  f rom each s equence ,  
whi l e  a local  a l i g n me n t  i nc ludes  only the  mos t  s imi l a r  local  regions .  
D i s t i n g u i s h in g  be twee n  real  and a r t i f ac tua l  ma t ches  is done  us ing an 
e s t i ma t e  o f  p robab i l i t y ,  t ha t  the  match  might  occur  by chance.  The 
p r ob ab i l i t y  va lue  is known as the  p va lue ,  where  the  mos t  h ighly 
s i g n i f i ca n t  va lues  wi l l  be c lose  to zero.  The e xpec t a t i on  value  may be 
used where  the lower  the  e xp ec t a t i on  va lue  the  more  s ign i f i c an t  the 
score  (Al t s chu l  et al ,  1997).
1.9 Aims o f  this study
P I 3K is an i m p o r t an t  enzyme  for  i n t r ac e l l u l a r  s igna l l i ng  and is 
i mp l i c a t ed  in cel l  g rowt h ,  p r o l i f e r a t i o n  and d i f f e r en t i a t i on .  A s tudy 
to ver i fy  the  s eque nc e  p re sence  and f unc t ion  o f  this  enzyme  in 
P. f a l c i p a r u m  wi l l  co n t r i b u t e  t owa rd s  the u n d e r s t an d in g  o f  s ignal  
t r a n s d uc t i o n  pa t hways  in P. f a l c i p a r u m . T he re fo r e  the spec i f i c  aims 
o f  this  s tudy  are;
1. To c lone  and ver i fy  the  s eq u e nc e  c od i ng  for  the  ca t a l y t i c  r eg ion  o f  
the  PI 3K in P. f a l c i p a r u m .
2. To i nve s t iga t e  the  e f fec t s  o f  s pec i f i c  P I 3K pro t e in  k inase  
i nh i b i t o r s  such as w o r t m a n n i n  and LY2 9 4 0 0 2  on the in v itro  
g rowt h  o f  P. f a l c i p a r u m .
3. To i nves t iga t e  the e f fec t s  o f  i nd i r ec t  s t i mu l a t i o n  o f  the 
p h o s p h a t i d y l i n o s i t o l  3 -k i na se  p a thway  by f o r sko l i n  and its 
i nac t ive  c on g en e r  in P. f a l c ip a r u m .
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2.0 METHODS
2.1 In vitro culturing o f  Plasmodium fa lc iparum
2.1.1 Pr ep a ra t i on  of  comple te  cu l ture  medium
I nc om p le t e  cu l ture  med ia  was p r epa r ed  by mixing  10.4 g RPMI 1640,  
5.9 g N - 2 - h y d r o x y e t h y l p i p e r a z i n e - N ’- 2 - e t h a n e - su l f o n i c  acid (HEPES)  
buf fer ,  4.0 g g lucose ,  44 mg h y p ox a n t h i ne  and 50 pg/ml  gen t ami c i n  
to one l i t re.  The  med i a  was s t e r i l i s ed  by f i l t r a t i on  t h r ough  a 0.22 pm 
me mb r an e  and s tored  at 4°C unt i l  r equi red .  Compl e te  cu l ture  media  
was p r e pa r ed  by add ing  10 % (v/v)  hea t  i nac t iva t ed  human  p lasma  
and 4.2 ml o f  5 % (w/v)  NaHCC>3 to i ncompl e t e  cu l tu re  media .  All  the 
buf fer s ,  med i a  and so lu t ions  were  p r epa r ed  wi th Mi l l i -Q® water .
2.1.2 Pr ep a ra t i o n  of  p lasma
Thr ee  bags  o f  human  p l a sma  f rom the South  Af r i can  N a t i ona l  Blood 
Serv ices  were  p oo l e d  into a one l i t re  Scho t t  bo t t l e  and i nac t iva t ed  at 
56°C for  2 hours .  The in ac t iv a t e d  p l a sma  was c en t r i f u g e d  at 1 750xg  
in 50 ml tubes  at 25°C for  10 mins.  The s up e r na t a n t  was decan t ed  and 
a l i quo t ed  into s t er i l e  50 ml t ubes  and s tored  at -20°C.
2.1 .3  Pr ep a ra t i o n  of  e ry t hrocy t e s
Whole  blood wi th a n t i c o ag u l a n t  acid c i t r a t e  dex t rose  (ACD)  was 
ob t a ined  f rom the South  Afr i can N a t i ona l  Blood Serv ices  and s tored 
at 4°C for  a m a x i mu m per iod  o f  three  weeks.  For  the  dai ly cul ture  
ma i n t en an ce ,  e ry t h r oc y t e s  were  washed  three  t imes  wi th phospha t e  
buf f e red  sa l i ne  (PBS)  buf f e r  (pH 7.2)  (8 g NaCl ,  0.3 g KC1, 0.73 g 
Na2HPO4.2H20 and 0.2  g KH2PO4 to one l i t re)  by c en t r i f u g i n g  at 
4 0 0 xg  for  5 mins  at 25°C.  The s up e r n a t an t  was r emoved  a long with 
the  thin l ayer  o f  wh i t e  b lood  cel l s .  An equal  vo lume  o f  cu l ture  med ia  
was added  to the washed  e ry t h r o c y t e s  and s tored  at 4°C for two 
weeks.
26
2.1 .4  Pr ep a ra t i o n  of  a P. f a l c i p a r u m  cul ture  from  
c r y op re ser ved  s tock
A c ry o pr e se rv ed  s tock o f  the 3D7 s t ra in  o f  P. fa lc ip a ru m  was t hawed 
in a p r e he a t e d  wa t e r ba t h  at 37°C ( s ec t i on  2 .1 .8) .  The cu l tu re  was 
then a sep t i c a l ly  t r a ns f e r r e d  to 15 ml ca l i b ra t ed  tubes  (Elkay,  U.S.A) .  
For  every mi l l i l i t r e  o f  t h awed  s uspe ns i on  0.1 ml o f  12 % (w/v)  NaCl  
was s lowly  added  and mixed  gent ly .  The s u spe ns i on  was lef t  to s tand 
for  5 mins  at room t empe r a t u r e .  Nine  vo l umes  of  1.6 % (w/v)  NaCl  
was s lowly  added to the s uspens i on  which  was then cen t r i f uged  for  
5 mins  at 400xg .  The pe l l e t  was r e su sp e nd ed  in 9 vo lumes  of  a 0.9 % 
(w/v)  NaCl  and 0.2 % (w/v)  g lucose  so lu t ion .  After  a fur ther  
c en t r i f ug a t i on  step at 4 0 0 x g  for  5 mins ,  the pe l le t  was  r e s uspended  in 
compl e t e  med ia  c on t a i n i ng  20 % (v/v)  hea t  i nac t iva t ed  human  p lasma 
to obta in  a 5 % haematoc r i t .  The  s u sp en s i o n  was t r ans f e r r ed  to a 
f l ask  and gassed  wi th a mix tu r e  o f  3 % O 2, 92 % N 2 and 5 % C O 2.
The  f l ask  was then  incuba t ed  at 37°C (Freese  et al ,  1988).
2.1 .5  Cul t ure  ma i n te na nc e
The 3D7 P. f a l c i p a r u m  s t rain is a c loned  c h lo ro qu i ne - s e ns i t i ve  s t rain 
ob t a ined  f rom C. Doer ig ,  Inse rm U511,  Paris ,  Fr ance ,  which  was 
cu l tu red  in v itro  a cco rd i ng  to the  me t hod  de sc r i bed  by Jensen  & 
Tr age r  (1977)  and modi f i ed  by Fr eese  et a l  (1988) .  The P. f a l c ip a r u m  
3D7 cul ture  o f  25 ml was ma i n t a i ned  in 175 c m 2 cu l tu re  f lasks  at a 
5 % haematoc r i t .  The cu l tu re  med i a  was a sp i r a t ed  and rep l aced  every 
24 hours .  The p a r a s i t a e mi a  was ma i n t a i ned  be tween  5-10 % and 
de t e r mi ned  dai ly  by p r e pa r i n g  G i emsa  s t a i ned  thin b lood smears .  
When the pa ras i t e  p e rc en t ag e  was >8 %, 80 % of  the cul ture  was 
t r a ns fe r r e d  to a 50 ml cen t r i f uge  t ube  (Nunc,  De nmar k )  for  
h a r v e s t i n g  by c en t r i f u g a t i o n  and s aponin  lys i s  ( s ec t i on  2 .1 .9) .  The 
ha rv es t e d  pa ras i t e s  were  r ep l aced  wi th f r esh ly  washed  e ry throcy tes  
( sec t i on  2 .1 .3) .  The  suspens i on  was then r e s uspended  in 25 ml 
compl e t e  cu l t u re  med i a  and gas sed  for  one minute  wi th a 5 % CO 2,
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2.1 .6  De t er mi n a t i o n  of  p e rcent age  pa r as i t a e mi a
Gi emsa  s ta in  (Merck ,  Ge rmany)  was d i l u t ed  f i ve - f o ld  in phos pha t e  
buf f e r  (pH 7 .2)  which  was p repa red  by d i s so l v i ng  3.5 g K H 2P O 4 and 
14.5 g N a 2H P 0 4. 1 2 H 20  to one l i t re.  The  buf f e r  was au t oc l aved  and 
s tored  at 4°C.  Thin  b lood  smears  were  p r epa r ed  f rom cul tured 
pa ras i t e s  and a i r -d r i ed  be fore  be ing f ixed wi th 100 % methanol .  The 
blood smears  were  again  a i r -d r i ed  and s t a i ned  in 20 % (v/v)  Giemsa  
s ta in  (Merck ,  Ge rmany)  for  20 mins.  The s l ides  were  r insed with 
water  and dr ied.  The sl ides  were  exami ned  mi c r os co p i ca l l y  to 
de t e r mi ne  the p e rcen t age  p a r a s i t a e m i a  and pa ras i t e  mo r pho l ogy  at a 
1000X ma gn i f i c a t i o n  u nde r  oil i mme rs io n  ( Jensen  and Trager ,  1976).  
The pe rc en t ag e  p a r a s i t a e m i a  was de te r mi n e d  as fol lows:
% P a r a s i t a e m i a  = In fec t ed  RBC x 100
In f ec t ed  + Un i n f e c t ed  RBC 1
Wher e  RBC = Red b lood  cel ls
2.1 .7  S y n c h ro n i sa t i o n  of  the cul ture
P. f a l c i p a r u m  3D7 cu l tu res  were  s y nch r o n i s ed  us ing the p r ocedur e  
d esc r i bed  by L a mbr os  & Va nd e r b e r g  (1979) .  Cul tu res  in the ear ly 
r ing s tage  were  cen t r i fu g ed  at 4 0 0 x g  for  5 mins  at room t empe r a t u r e  
in 50 ml c en t r i f ug e  tubes .  The s up e r n a t an t  was d i s ca r ded  and the 
pe l l e t  was  r e s u s p e nd ed  in 20 ml o f  s t e r i l e  5 % (w/v)  D-so rb i to l  and 
incuba t ed  for  20 mins  at r oom t empe ra t ure .  The cu l tu re  was then 
c en t r i f uge d  for  5 mins  at 4 0 0 x g  at 25°C.  The sup e r na t a n t  was 
a sp i r a t ed ,  the  pe l l e t  r e su s pe n de d  in c ompl e te  cu l tu re  media ,  
t r a ns fe r r e d  back to a cu l tu re  f l ask,  gassed  and r e tu rned  to the 
i ncuba t o r .  To ma in t a in  a s y nc hr o n ou s  cu l tu re  s ynch r on i s a t i on  was 
r epea t ed  every  48 hours  when the pa ra s i t e s  were  in the ear ly r ing 
s tage.
3 % O2 and 92 % N 2 gas mixture and incubated at 37°C.
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2.1 .8  Cr yo p r e s e r v a t i o n
P. f a l c i p a r u m  3D7 cu l tu res  were  c ry o pr e se rv ed  acco rd i ng  to the 
me t hod  de sc r i bed  by Freese  et a l  (1988) .  The f r eez i ng  so lu t i on  was 
p repa r ed  by d i s so lv i ng  7.2 g NaCl ,  1.48 g N a 2 H P 0 4. 2H20  and 0.44 g 
K H 2P 0 4 in 100 ml o f  s t er i l e  water .  Of  the f r eez i ng  so lu t ion  7.2 ml 
was mixed  wi th 28 ml g lycero l  and f i l t e r  s t e r i l i sed .  A cul ture  in the 
r ing s tage  was c en t r i f uged  at 4 0 0 x g  for  5 mins  at 25°C.  The 
sup er na t a n t  was a sp i r a t ed  and the pe l l e t  r e s usp e nd ed  in a 1:1 rat io 
wi th the f r eez i ng  so lu t ion .  The s u sp en s i o n  was a l i quo t ed  into 1 ml 
c ryo t ubes  (Nunc ,  Denmark) .  The tubes  were  lef t  to s tand for  10 mins 
at room t e mp e ra t u r e  and were then p l aced  in l iquid  ni t rogen.
2.1 .9  Harves t i n g  of  paras i tes
The 3D7 P. f a l c i p a r u m  cu l t u re  was ma in t a i ned  as desc r ibed  in sec t ion 
2.1.5.  Cul tu res  wi th a 10 % pa ra s i t a e mi a  o f  p r e domi na n t l y  
t ro ph o zo i t e s  were  used for  ha rves t i ng .  The pa ras i t e  cu l tu re  was 
c en t r i f uge d  in a 50 ml c en t r i fuge  tube  (Nunc ,  Denmar k)  at 4 00 x g  for 
10 mins.  The sup e r na t a n t  was a sp i r a t ed  and the pe l l e t  r e su sp e nd ed  in 
30 ml o f  0 .015 % (w/v)  s aponin  to lyse the e r y t h r ocy t e s  and re lease  
the  P. f a l c i p a r u m  paras i t es .  The  s u spe ns i on  was cen t r i fuged  at 
10 0 0 0 x g  for  10 mins ,  the pe l l e t  r e suspe nd  in 5 ml PBS buf fer  and 
c en t r i f uge d  again  at 10 OOOxg for  10 mins.  The sup e r na t a n t  was 
a sp i r a t ed ,  the  pe l l e t  r e su sp en d ed  in PBS buf fe r  (1 ml) and t r ans fe r red  
to a 1.5 ml mi c r o f ug e  tubes  (Eppendor f ,  Ge rmany)  and cen t r i f uged  at 
13 OOOxg for  5 min at 4°C.  The s up e r na t a n t  was  a sp i r a t ed  and the 
mi c r o f ug e  tube  con t a i n i ng  the pa r a s i t e  pe l l e t  f rozen  in l iquid 
n i t r ogen  and then s tored  at -70°C.
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2.2 Molecular methods
2.2.1 Data  mi n i ng  of  the P la sm o d iu m  f a l c i p a r u m  genomi c  da t abase
A h om o l og y  based a pp r oa ch  was used to ident i fy  an ORF coding  for  a 
k inase  wi th  h igh h o m o l o g y  to PI 3K in the  ma l a r i a  genomi c  da tabase .  
The me th od  is based  on the fact  tha t  p ro t e ins  wi th  s imi l a r  func t ions  
are k nown  to have  c onse r ved  reg ions  at t he i r  c a t a ly t i c  si tes.  The 
m a la r i a  s eque nc e  da t abase  at NCBI
( h t t p : / / w w w . n c b i . n l m . n i h . g o v / m a l a r i a / p l a s m o d i u m b l . h t m l ) was 
sc r eened  us ing  the BLAST p ro g r amme ,  t b las tn ,  which  compar es  a 
spec i f i c  p r o t e i n / a mi n o  acid query s eque nc e  ob t a ined  f rom the Ent rez  
pro t e in  da taba se  a ga i ns t  a d y n a m ic a l l y  t r ans l a t ed  nuc l eo t ide  
da t abase .  The  con t igs  c o n t a i n i ng  n u c l e o t i d e  s equences  wi th 
s t a t i s t i c a l l y  s i gn i f i c an t  s i mi l a r i t y  ( l ow E values)  were  then  subjec ted  
to an ORF sea rch  us ing  the open  r ead i ng  f r ame  f inder  at the  NCBI  
webs i t e  ( h t t p : / / w w w . n c b i . n l m . n l m . n i h . g o v / g o r f . h t m l ). The  ORF 
ob t a i ned  was c omp ar ed  to the G EN BA NK  us ing the BLAST 
p rog r amme ,  b las tp ,  which  compar es  an amino acid query s equence  
aga ins t  all  known pro t e in  s eq u e nc es  in the GENBANK.
2.2 .2  DNA i so l a t i on
The f rozen  i s o l a t ed  pa ras i t e s  were  r e s u s pe n de d  in 50 pi au toc l aved  
water  and 950 pi lys is  bu f f e r  (0.1 M EDTA,  0.5 % sod ium dodecyl  
s u l pha t e  (SDS) ,  10 mM Tr is  pH 8). EDTA is a che l a t i ng  agent  which 
che l a t e s  M g 2+ and C a 2 + ions r equ i r ed  as co fac to r s  for  DNase  act ivi ty.  
SDS is a d e t e r gen t  which  d i s rup t s  the  cel l  memb r a nes  (Brown,  1990).  
An equal  vo l ume  o f  phenol  (pH 8) was added to dena tu r e  and remove  
pro t e ins  f r om the DNA solu t ion .  Phenol  has  to be buf f ered  to an 
a lka l ine  pH to p reven t  the  DNA f rom be ing depos i t ed  at the  i n te r face  
o f  the o rgan ic  and aqueous  phases  ( S a m b r o o k  et al, 1989).  The 
s u sp e ns i o n  was then  mixed  to c r ea t e  an emul s ion .  The suspens i on  was 
c en t r i f u g ed  at room t e mp e ra t u r e  at 10 OOOxg for  15 mins  and the
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phenol  ex t r a c t i on  was r epea t ed  at l eas t  once to c lear  the  u ppe r  phase.  
The  uppe r  phase  was r emoved  to a f resh tube  and an equal  vo lume  of  
c h l o r o f o r m  was added  to r emove  phenol  and pro te in  c on t ami nan t s  and 
c en t r i f uge d  as before.
The u ppe r  phase  was then r emoved  to a f r esh  tube  and genomic  DNA 
was p r e c i p i t a t ed  by add ing  0.1 vo lume  of  3 M sod ium aceta te  
(pH 5.2)  and an equal  vo lume  o f  i ce-cold  i sop ropano l  fo l l owed by 
mixing.  The mi x t u r e  was i m me di a t e l y  cen t r i f uged  at 10 OOOxg for  20 
mins  at 4°C. The pe l l e t  was  washed  wi th  70 % (v/v)  i ce-cold  e thanol  
and c en t r i f uge d  again  at 10 OOOxg for  5 mins  at 4°C.  The pel le t  
ob t a ined  was r e su sp en ded  in 500 pi o f  l x T E  buf fer  (10 mM Tr i s -HCl  
and 1 mM EDTA,  pH 8.5)  and d iges t ed  wi th 50 pi o f  RNase  A with a 
f ina l  co n ce n t r a t i o n  o f  50 pg/ml .  The so lu t i on  was then i ncubat ed  at 
37°C for  30 mins.  The DN as e - f r e e  RNase  was p repa red  by d i s so lv ing  
the l yoph i l i s ed  RNase  in 10 mM Tr i s - HCl  (pH 7.5)  and 15 mM NaCl  
to a f inal  c on c e n t r a t i o n  o f  10 mg/ml .  The so lu t i on  was then boi led 
for  15 mins  to i na c t iva t e  the DNas e  and s lowly  coo led  to room 
t e mp e ra t u r e  before  a l i quo t s  were  s to red  at -20°C (Sambr ook  et al. 
1989).
This  was fo l l owed  by a r e - ex t r a c t i on  o f  DNA as be fore  wi th phenol  
(pH 8) and c h l o r o f o r m  to r emove  the RNase.  The u ppe r  aqueous  
phase  was r e co v e r e d  to a f resh tube.  The high mo l ec u l a r  we i gh t  DNA 
was p r ec ip i t a t ed  by add ing  0.1 vo l ume  o f  3 M s od i um ace ta te  
(pH 5.2)  and 2.5 vo lumes  of  i ce-co ld  100 % e thanol  and lef t  at -70°C 
overn igh t .  The  DNA pe l l e t  was c o l l e c t ed  by c en t r i f uga t i on  at 
10 OOOxg at 4°C for 20 mins  and washed  wi th i ce-cold  70 % (v/v)  
e thanol .  The  pe l l e t  was ai r  dr ied in a s t er i l e  f low cab ine t  and 
r e s u sp en de d  in 50 pi o f  a u t oc l ave d  water .  To de t e r mine  the pur i t y  
and c on c e n t r a t i o n  o f  the DNA p re pa ra t io n ,  a UV s p e c t r o p h o t o m e te r  
was used to scan a 10- fold  d i l u t ed  DNA sample  be tween  200 and
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300 nm. An a bso r bance  peak o bs er ved  at 270 nm i nd i ca t ed  the 
p re sence  o f  phenol  c on tami na t i on .  The a bso r bance  measu red  at 
260 nm was used to ca l cu l a t e  the  DNA c on cen t r a t i on  where  an A260 
read ing  o f  1 is e qu i va l en t  to 50 pg/ml  o f  DNA ( S amb r oo k  et al,
1989) .  The c on c e n t r a t i o n  o f  DNA was ca l cu l a t ed  as fol lows:
DNA c on ce n t r a t i on  ( fj.g/fj.1) = A260  x 50 pg/ml  x di lu t ion  fac tor
1000
The rat io ob t a ined  be tween  the  abso r ban c e  read ing  at 260 nm and 
280 nm ( A2 6 0 / A2 8 0)  is an e s t i ma t i on  o f  pur i ty  o f  the  DNA 
p r epa ra t i on .  This  i nd i ca t es  an a bsence  o f  r es idua l  phenol ,  sal t s  and 
prote in .  Pur e  p r e pa ra t ions  o f  DNA have  A260 / A280  values  o f  >1.8.  
Co n t a mi n a t io n  wi th p ro t e in  and phenol  dec r eases  the  A260 /A280  
ra t io  ( S am b r o o k  et a l ,  1989).
2.2 .3  The po ly mer as e  chain reac t ion
The p o l yme ra se  cha in  r eac t i on  (PCR)  is a rapid  p r o c e d u r e  for  in vitro  
e nzyma t i c  a mp l i f i c a t i on  o f  a spec i f i c  s egmen t  o f  DNA. The  ORF f rom 
the 3D7 P. f a l c i p a r u m  cu l t u re  was a mpl i f i ed  by PCR us ing  the PCR 
Mas t e r  Kit® and E xpand  High  F i de l i t y  PCR System® (Roche  
Mo le c u l a r  B i oc hemi ca l s ,  Germany) .  All r eagen t s  were  t hawed  and 
t h o r o u g h l y  mi xed  before  the  e xp e r i men t  and the r eac t ions  were  
p re pa red  on ice in 0.2 ml PCR tubes  ( Mo le cu la r  Biop roduc t s ,  U S A).
2.2 .3 .1  Pr i mer  des ign
Spec i f i c  p r i mer s  were  de s i gned  f rom the ORF ob ta ined  for  the sense 
and an t i s ense  s t rands .  N uc l eo t i d e s  c o r r e sp o nd i n g  to the  Bam HI  
r e s t r i c t i on  s i te  were  added  to the  5 ’-end o f  the  pr imer  for  the sense  
s t rand.  Nu c leo t i de s  c o r r e s p o nd i n g  to the  H in d  I I I  r es t r i c t i on  si te 
were  added to the  5 ’-end o f  the pr imer  for  the  an t i s ense  s t rand to 
f ac i l i t a t e  d i r ec t i ona l  c lon ing  into the exp r e ss io n  vector .
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A few n u c leo t i d e s  were  added to the  pr imers  be t ween  the  5 ’-ends  and 
r e s t r i c t i on  s i t ed to serve  as a s up p or t  for  the  r e s t r i c t i on  enzyme  
dur ing  d iges t i on .  The i r  omi s s i on  would  p reven t  the enzyme  f rom 
c l eav i ng  the  DNA (Inni s  et al ,  1988).  The  pr imers  were  manua l ly  
ana l ysed  for  c om p l i me n t a r i t y  be t ween  the 3 ’-ends  to p revent  p r imer -  
d imer  a r t i f ac t s .  The  pr imer s  were  s yn t he s i s ed  by I n t eg ra t ed  DNA 
T e c hn o l og ie s  ( IDT) ,  Inc,  U S A. IDT uses  the  Al lawi  and San t aLuc i a  
set  o f  n ea r es t  n e i g h b o u r  t h e rm o d y n a mi c  p a r amet e r s  for  the equat ion 
to de te r mi ne  the  me l t i ng  t e mp e ra t u r e  ( T m) o f  the  o l i gonuc l eo t i de s  
(h t t p : / / w w w . i d t n a . c o m ).
T m = AH_______ - 273.15 + 12.0 l o g [ N a +]
AS + R In (C)
where ,  T m = Mel t ing  t e mp e ra t u r e
AH = Sum o f  the nea r es t  n e i g h b o u r  en tha l py  changes  
AS = Sum o f  the near es t  n e i g h b o u r  en t ropy  changes  
R = Mola r  gas cons t an t  (1 .987  cal.  K ' 1 m o l e ’1)
C = Mola r  co n ce n t r a t i o n  o f  o l i go n u c l e o t i d e
2 .2 .3 .2  The PCR Ma s t er  Enzyme reac t i on
The PCR M a s t e r  E n z yme  r eac t ion  was used to op t i mi se  the PCR 
r eac t ion  by d e t e r mi n i ng  the op t i mu m annea l ing  t emp e ra t u r e ,  pr imer  
and DNA c oncen t r a t i on .  The PCR Mas t e r  Kit® (Roche  Mol ecu l a r  
B i oc hemi ca l s ,  Germany)  c on t a i ned  all the r eagen t s  for  the PCR in a 
p re mi xe d  double  c on cen t r a t ed  Mas t e r  mix.  The PCR reac t ions  were 
p e r f o r m ed  in a Pe rk in  E l mer  Sys t em 2400  the rmal  cyc le r  (Perkin  
Elmer ,  U. S. A. )  The  PCR r eac t ion  wi th a f ina l  vo lume  of  25 pi,
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cons i s t ed  o f  1 p.g o f  t emp l a t e  DNA,  p r i mer s  to a f inal  c on c e n t r a t i on  
o f  0.5 pM and nuc l e a s e - f r e e  wa te r  to di lu te  the  PCR Mas te r  by 
t wo- f o ld .  The  f inal  conce n t r a t i on s  o f  the  PCR Mas t e r  mix 
c omp on en t s  were  1.5 mM M g C h ,  0.2 mM o f  each o f  dATP,  dGTP,  
dCTP and dTTP,  10 mM Tr i s - HCl ,  50 mM KC1, pH 8.3 and 1.25 U 
Taq  DNA p o l yme ra se  in 0 .005 % (v/v)  Bri j  35.
The  p r o g r a mm e  used was as fo l l ows :
Step T em p e ra t u r e
(°C)
Time (mins) Numb er  of
cycles
De na t u ra t i o n 94 2 1
Dena t u r e 94 0.30 35
Anneal 54 - 64 1
El onga t i on 72 1
Final  e x t ens i on 72 7 1
The g en e r a t i o n  o f  t e m p l a t e - i n d e p e n d e n t  a r t e fac t s  l ike p r i mer - d i mer s  
and n on - s p e c i f i c  a mp l i f i c a t i on  can o c cu r  at room t e mp e ra t u r e  once 
all  the  r eagen t s  are mixed.  This  can be avo ided  by means  o f  a 
mod i f i ed  h o t - s t a r t  me thod  (Ke l l og  et al ,  1994).  The tubes  were  kept  
on ice unt i l  the  t he r ma l  cyc l e r  had r eached  a t e mp er a t u r e  o f  90°C.  
Thi s  was also done  for  the  Expand  High  F ide l i t y  PC R react ions .
2 .2 .3 .3  The Expand High Fide l i ty  PCR System®
The E xpand  High F ide l i t y  PCR System® conta ins  a t h e rm o s t ab l e  Taq 
DNA p o ly m e r a s e  and Pwo DNA p o ly m e r a s e  which  has a 3 ’- 5 ’ 
e x on uc l ea se  p r o o f  r ead ing  ac t i v i ty  which  mi n i mi se s  nuc l eo t ide  
m i s i nc or po r a t i o ns .  Thus  the Expand  High  F i de l i t y  PCR System® 
resul t s  in a 3 - fo ld  inc reased  f i de l i t y  o f  DNA synthes i s .
Two sepa ra t e  mas t e r  mixes  were  p r epa r ed  to p reven t  the enzyme mix 
i n t e ra c t ing  wi th  p r imers  or t e mp l a te  DNA wi t ho u t  dNTPs.  The 
i n t e ra c t ion  be tween  the enzyme  mix and dNTPs  may lead to 
d eg ra da t i o n  o f  p r imer  and t emp l a t e  DNA t h r ough  the
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3 ’ -5 ’ ex o n uc l ea se  ac t i v i t y  o f  the Pwo  p r o o f  r ead i ng  po lymerase .  The 
r eac t ion  mi x t u r es  were  p r epa r ed  on ice in PCR tubes  and were ca r r i ed  
out  in a f inal  vo l ume  o f  50 pi.
Mas t e r  mix 1 cons i s t ed  o f  dNTPs ,  t e mp l a te  DNA,  pr imers  and s ter i l e  
water  to a f ina l  vo l ume  o f  25 pi. The  f ina l  conce n t r a t i on s  o f  the 
r eagen t s  used in the  mas t e r  mix were:  0.2 mM each o f  dATP,  dCTP,  
dGTP and dTTP,  0.5 pM o f  each p r imer ,  1 pg t empl a t e  DNA and 
lx  Expand  HF® buf f e r  ( c omp o s i t i on  is p r opr i e t a ry ) .  The  reagent s  
were  t h o ro ug h l y  mixed and kept  on ice.
Mas t e r  mix 2 cons i s t ed  o f  l x  E xpa nd  HF® buf f e r  wi th  a f inal  
c o n ce n t r a t i o n  o f  1.5 mM M g C h ,  2.6 U enzyme  mix  and s t e r i l e  water  
to a f inal  vo l u me  o f  25 pi. The  r eagen t s  o f  the  mas t e r  mix 2 were 
t h o r ou gh l y  mixed  and also kept  on ice. The  two mas t e r  mixes  were 
comb in e d  and mixed  wel l  j u s t  be fo re  t r a ns f e r r i n g  the  PCR tubes  to 
the t he r ma l  cycler .  The  PCR tubes  were  kept  on ice unt i l  t hermal  
cyc l e r  had reached  94°C. The f ina l  c o nc e n t r a t i o n  o f  the r eagen t s  used 
were:  0.2 mM each o f  dATP,  dCTP,  dGTP and dTTP,  0.5 pM of  each 
pr imer ,  1 pg t empla t e  DNA,  l x  E xpa nd  HF® buf fer  wi th  a final  
c o n c e n t r a t i o n  o f  1.5 mM M g C h  (pH 8.3)  and 2.6 U o f  enzyme  
mixture .
The  p ro g r a mm e  used for  the Expand  High F ide l i t y  PCR System® was 
as fo l lows:
Step Te mp e r a t ur e
(°C)
Time (mins) Number  of  
cycles
D en at u r a t i o n 94 2 1
De na t u r e 94 0.30 35
Anneal 63 0.30
El onga t i on 72 1
Final  Ex t ens i on 72 7 1
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The ex ten s i o n  t e m p e ra t u r e  for  both  Taq p o ly m e r a s e  and Pwo  
p o ly m e r a s e  enzyme  mix in the  E x p a nd  High  F ide l i t y  PCR S y s t e m 41 is 
d ep en de n t  on the  l eng th  o f  a m p l i f i c a t i o n  produc t .  The  op t i mum 
e x t ens ion  t e mp e ra t u r e  for  amp l i f i c a t i o n  o f  DNA sequences  up to 
3 k i l obases  is 72°C,  t h e r e fo r e  72°C was used as the  op t imum 
ex t en s i on  t e mp e ra t u r e  for  the r eac t ions .
2.2 .4  Agarose  gel  e l e c tr oph ore s i s
Agarose  gel  e l e c t r op h o r e s i s  was used for  the  ana lys i s  o f  the PCR 
produc t s  and p roduc t s  ob t a ined  f rom the r e s t r i c t i on  digest s .  A 
1 % (w/v)  agarose  gel  was p repa red  in l x  TAE buf fer  (0 .02 M Tris,
0 .04 ml o f  0.5 M EDTA,  0.571 ml g lac i a l  ace t i c  acid to 500 ml water )  
and 1 pg/ml  e t h i d i um bromi de  was t hen  added  to the gel.  P r io r  to 
l oad ing  onto gel ,  g e l - l oa d i ng  buf f e r  (10 % v/v)  was added to the 
p roduc t s  be ing ana lysed .  The gel  l oad i ng  buf fer  c ompr i s ed  o f  0.25 % 
b r o mo ph e no l  blue,  0.25 % xy lene  cyanol  and 30 % g lycero l  in 
l x  TAE buffer .
The  gel  was s u bmer g ed  in 1 x TAE buf f e r  and e l ec t r ophor es i s  was 
ca r r i ed  out  at 30 V for  3 hours .  A 100 base pai r  mo l ec u l a r  weight  
ma r ke r  (Roche  Mo le c u la r  B i oc hem i ca l s ,  Ge r many)  was used to 
e s t i ma t e  the  s izes  o f  the  PCR and d i ge s t ion  produc t s .  The  bands  were 
v i ewed  us ing a W h i t e / U l t r a v io l e t  l i gh t  t r a n s i l l u m i n a t o r  UVP®.
2.2.5 DNA seq uenc i ng
DNA was s equenced  us ing  the T7 Sequenase  ve r s ion  2 .0™ DNA 
Se qu en c i ng  Ki t  ( Am e r s h am  Li fe  Sc i ence ,  Inc,  USA) which uses the 
d id eo x y- c ha in  t e rm i na t io n  me thod  d e ve l ope d  by Sanger  et a l  (1977) .
The  me thod  involves  the  in v it ro  s yn thes i s  o f  a DNA s t rand  by DNA 
po ly me ra se  us ing  a s i ng l e - s t r an d e d  DNA t empla t e .  The s equenc ing  
ki t  has a s eq u e na se  2.0 DNA p o l yme ra se  for  DNA s equenc i ng  wi th
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pr ope r t i e s  t ha t  i nc l ude  a r educ t i on  in nu c leo t id e  m i s in c or po ra t i on s  
( l nn i s  et a l ,  1988).  Synthes i s  o f  a DNA s t rand is i n i t i a t ed  at the  si te 
where  a p r i mer  annea l s  to the t empla t e .  The syn thes i s  is t e rmi n a te d  
by the i n co r p o r a t i o n  o f  a d ideoxy  a na lo gu e  tha t  wil l  no t  s uppor t  
c on t i nued  DNA e longa t ion  such as 2 ’ , 3 ’-d i d eo x y nu c l eo s i de  
5 ’- t r i ph osp h a t e s  (ddNTPs) .  The  ddNTPs  lack the 3 ’-OH group 
n ece s sa ry  for  DNA chain  e longat ion .  The nuc l e i c  acid sequence  o f  
PCR produc t s  and p l a smids  c o n t a i n i ng  inser t s  were  ver i f i ed  by 
s equenc ing .
2.2 .5 .1  P r e pa r a t i o n  of  s eq uenc i ng  gel
An 8 % ac r y l ami de  gel  o f  0.4 mm t h i ckness  was  cas t  in a Sequi -Gen® 
GT Nu c l e i c  Acid E l ec t r o ph or e s i s  Cel l  (B i o - Rad ,  USA).  Pr io r  to 
a s s emb l i n g  the  e l ec t r op h o r e s i s  cel l ,  the  g lass  p la tes  were  washed  
t h o r ou g h l y  and wiped  wi th 100 % e thanol  be fo re  the  pla tes  were 
a s s embl ed  wi th 0.4 mm spacers .  One of  the  p la t es  was  s i l i con i sed  
us ing  s i l an i s i ng  reagen t ,  Re pe l - s i l a ne  ES® ( Amer s ham Ph a r ma c i a  
Bio tech ,  UK) to f ac i l i t a t e  s epa r a t i on  o f  p la t es  and the r emova l  o f  the 
s eq ue nc in g  gel  a f t e r  e l ec t r ophor es i s .
The  8 % a c r y l ami de  gel  so lu t i on  was p r epa r ed  by d i s so l v i ng  7.6 g 
ac r y l ami de  and 0.4 g b i s - a c r y l am i d e  in 40 ml au t oc l aved  water .
To this  mi x t u r e  42 g u rea  and 10 ml o f  lOx TBE buf f e r  (108 g Tris 
base,  55 g bor i c  acid,  9.3 g Na 2E D T A . 2 H 20 )  was added.  After  the 
u rea  had d i s so lved  the so lu t i on  was a d j us t ed  to 100 ml wi th 
au to c l av e d  water  and d egas sed  for  10 mins  unde r  vacuum.  
P o l y m e r i s a t i o n  was in i t i a t ed  by add i ng  one ml o f  10 % ammoni um 
p e r su lp ha t e  (APS)  and 25 p.1 N , N , N ’x N ’ - t e t r am e th y l - e th l en e d i am i n e  
( TEMED)  j u s t  be fo re  the  gel  was cast .  The  gel  was lef t  to po lymer i se  
ove rn i gh t  at room t empe ra t ure .
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Before  use the  gel  su r f ace  was r insed  wi th l x  TBE buf f e r  and the gel 
a s s embl y  t r a ns f e r r e d  to the e l ec t r o p h o r es i s  a ppa r a t us  where  the 
s ha r k s t oo t h  comb was i nser t ed  to fo rm wel ls .  The  buf fer  chamber s  
were  f i l l ed  wi th l x  TBE and the gel  was p r e - run  at 80 W to reach a 
t e m p e ra t u r e  o f  50°C and then the s ampl es  were  loaded.
2 .2 .5 .2  An n e a l i n g  of  pr imers
The PCR pr oduc t s  were  pur i f i ed  as de sc r i bed  in the  High  Pure  PCR 
Pr oduc t  Pu r i f i c a t i on  Kit® (Roche  Mo l ec u l a r  Bi ochemi ca l s ,  Germany) .  
The  a nnea l i ng  mi x t u r e  cons i s t ed  o f  7 pi (2 pg)  PCR DNA product ,
2 pi r eac t i on  buf f e r  and 0.5 pM pr imer .  The annea l i ng  mix tu r e  was 
d ena t u r ed  by hea t i ng  it at 99°C for  2-3 mins  and coo led  by placing 
the vial  i m m e d ia t e l y  on ice for  5 mins.  The  tube  was br ief ly  
c en t r i f u g e d  and chi l l ed  on ice unt i l  r equi red .
2 . 2 . 5 . 3  Labe l l i ng  reac t ion
To the i ce - co ld  annea l ed  DNA pr i mer  mi x t u r e  the f o l l owi ng  reagent s  
were  added  whi le  the tubes  were  kep t  on ice:
1. 2 pi o f  5x r eac t i on  buf f e r  (200 mM Tr i s - HCl  pH 7.5,  100 mM 
M g C l 2, 250 mM NaCl )
2. 1 pi o f  0.1 M d i t h i o th r e i to l  (DTT)
3. 2 pi o f  1:5 d i l u t ed  l abe l l i ng  mix (7.5 pM dGTP,  7.5 pM dCTP,
7.5 p M dTTP)
4. 0.5 pi  o f  32P- dATP (3000 Ci /mmol ,  10 pC i / p l )
5. 2 pi o f  s eq u e na se  enzyme  d i lu t ed  1:7 wi th enzyme  d i lu t ion  
buf fer  (10 mM Tr i s -HCl  (pH 7.5) ,  5 mM DTT)
The  r eac t i on  mix tu r e  was mixed  and incuba t ed  at room t empe ra t ure  
for  5 mins  to a l low the DNA to i n c o r po r a t e  the l abe l l ed  i sotope.
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2 . 2 . 5 . 4  T er mi n a t i o n  reac t ion
Four  tubes  were  l abe l l ed  G, A, T, C and 2.5 pi o f  the d ideoxy  
t e rmi na t i on  mi x t u r e  (80 pM dGTP,  80 pM dATP,  80 pM dTTP,  80 pM 
dCTP and 8 pM o f  the  a pp r op r i a t e  d ideoxy  n uc l eo t ide )  was added for  
each s eq u e nc in g  r eac t ion  and the tubes  were  p rehea t ed  for  1 min at 
37°C.  Af te r  5 min,  3.5 pi o f  the l abe l l i ng  mix tu r e  was t r ans fe r r ed  to 
each o f  the p r e he a t e d  t e rm i na t io n  t ubes  l abe l l ed  G, A, T or C, mixed 
and incuba t ed  at 37°C for  5 mins.
The  reac t i ons  were  t e r mi n a t e d  by add ing  4 pi  o f  s top so lu t ion  (95 % 
f o r mami de ,  20 mM EDTA,  0.05 % b r omo p he no l  b lue  and 
0.05 % xy lene  cyanol  FF)  and p l aced  on ice.  The  r eac t i ons  were 
br i e f ly  cen t r i fu g ed  in a mi c r o f ug e  at 13000xg  to co l l ec t  the  reac t ion  
mi x t u r e  at the  b o t t om o f  the  tube.  The  r eac t i on  mi x t u r es  were  
de na t u r ed  at 80°C for  5 mins  in a he a t i ng  block  i mme di a t e l y  be fore  
l oad i ng  3 pi o f  the  r e ac t i o n  mix tu r e  onto  the gel  in the  o rde r  G, A, T, 
C. Thr ee  l oad i ngs  o f  3 pi each were  ob t a i ned  f rom each t e rmi n a t i o n  
r eac t ion  and were  s epa r a t ed  by ap p r ox ima te ly  2 hour s ,  wi th the  run 
t ime for  the  f i r s t  l oad ing  be ing  6 hours .  The gel  was e l ec t r ophor es ed  
at a cons t an t  p owe r  (80 W) us ing  a P o we rP a c  3000 Power  Supply 
( B i o - Rad ,  USA).
The  glass  p la t es  were  sepa r a t ed  fo l l owi n g  e l ec t r op h o r e s i s  and the gel 
was t r a n s f e r r e d  to an old X-ray  f i lm and cover ed  wi th c l ing-wrap .  
This  was p l aced  in an a u t o r a d i o g r a p h  cas se t t e  and exposed  to a 
CURI X medica l  X- r ay  f i lm (35 cm x 43 cm, AGFA)  o ve r n i gh t  at 
-20°C.  The  f i lm was d e ve l op e d  wi th the  kind pe rmi s s i on  o f  the X-ray 
uni t  s t a f f  wi th in  the  J o h a n n e s b u r g  Genera l  Hospi t a l .
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2 .2 .5 .5  S u bc lone  DNA s eq uenc i ng
Plasmid  DNA (sec t ion  2 . 2 . 7 )  was a lka l ine  dena t u r ed  by adding  4 pi 
o f  2 M NaOH,  2 mM EDTA to 2 pg of  DNA and incuba t ed  for  5 mins  
at room t empe r a t u r e .  The r eac t i on  was n eu t r a l i s ed  by add ing  20 pi o f  
a 3 M sod i um ace ta te  (pH 5.0)  so lu t ion .  The plasmid DNA was 
p re c i p i t a t ed  wi th 150 pi i ce-co ld  a bso l u t e  e thanol  at -70°C for 
1 hour ,  cen t r i f uged  at 13 OOOxg in a m i c ro f ug e  at room t empe r a t u r e  
for  5 mins  and washed  wi th 400 pi 70 % ethanol .  The pe l l e t  was air 
dr ied  in a s t er i l e  f low hood ove rn i gh t  and r e su sp e nd ed  in 7 pi water .
The p l a smid  DNA was sequenced  us ing  the s equenc i ng  pro toco l  
( s ec t i on  2 .2 .7 )  excep t  for  the  a nnea l i ng  mi x t u r e  which cons i s t ed  of:
7 pi DNA,  2 pi 5x reac t ion  buf fe r  (200  mM Tr i s -HCl ,  pH 7.5,
100 mM M g C h ,  250 mM NaCl )  and 0.5 pM pr imer .  The annea l ing  
mi x t u r e  was hea t ed  to 65°C for  2 mins  and s lowly coo led  to < 35°C 
over  a 30 min per iod.  The mix tu r e  was p laced  on ice and used for  
s equ en c in g  wi th in  60 mins  as de sc r i b e d  in sec t ion  2.2.6.
2.2.6 Su bc l on i n g  of  PCR product s
PCR produc t s  were  ob t a i ned  us ing the spec i f i c  p r imer s  for  the PI3K 
gene.  The PCR p r oduc t s  were  then inse r t ed  into the p QE- 80L  
Hi s t i d i n e  Tag E x p r e s s i on  vec tor  (Qiagen ,  Germany) .
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Fi gure  2.1: A map o f  the pQE-80L Hi s - t ag  e xpres s i on  vector .  The
a bb re v i a t i on s  used  are as fo l l ows ;  T5 p r omo t e r  (PT5) ,  lac ope ra tor  
( l acO) ,  r i b o s o m e - b i n d i n g  si te (RBS) ,  s t ar t  codon  (ATG) ,  6xHis  tag 
s equence  ( 6 x Hi s ) ,  mul t i p l e  c lon ing  s i te  wi th  r e s t r i c t i o n  si tes 
i nd i ca t ed  (MCS) ,  s top codons  in all  t h r ee  r ead ing  f rames  (Stop 
Codons ) ,  Col E l  o r ig in  o f  r e p l i c a t ion  (Col  E l ) ,  ampic i l l i n  r e s i s t ance  
gene  (Amp) ,  l a c l q r ep re ss o r  gene  ( l a c l q).
2.2 .6 .1  P r e pa r a t i o n  of  compet ent  cel l s
E s c h e r ic h ia  co l i  D H 5 a  g lycero l  s tock  cel l s  were  s t r eaked  on a Lur ia-  
Ber t an i  agar  p l a t e  and g rown o ve r n i gh t  at 37°C.  A s ingle  co lony f rom 
the s t r eaked  pla te  was i nocu l a t ed  in 5 ml Lu r i a - Be r t a n i  med i um (10 g 
t r yp t one  pep t one ,  5 g yeas t  ex t rac t ,  5 g NaCl ,  1 g D- g l ucos e )  in 
15 ml cu l tu re  tubes  (Elkay,  U.S.A) .  The  cu l tu res  were i ncubat ed  
o ve r n i gh t  at 37°C wi th shaking.  F o l l owi n g  the ove rn i gh t  i ncubat ion ,  
the cu l tu res  were  mixed  and 1 ml o f  the cu l ture  t r ans fe r r ed  to 100 ml 
L u r i a - Be r t an i  med i a  p r e - h e a t e d  to 37°C.  The 100 ml cu l ture  was
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i ncuba t ed  at 37°C and shaken  at 250 rpm unt i l  the abso r ban c e  value 
o f  the cu l tu re  at 600 nm was 0.4.  The  E. co li  cel l s  were  a l l owed  to 
cool  to 0°C in ice water .  The  b a c t e r i a  was then spl i t  be tween  two 
50 ml p o l y p r o p y l e ne  tubes  and c o l l e c t ed  by cen t r i f uga t i on  at 3 0 00xg  
for  20 mins  at 4°C.  The s up e r n a t an t  was a sp i r a t ed  and the bac te r i a l  
cel l s  were  r e s u sp e nd ed  in 10 ml t r a n s f o r m a t i o n  buf fer  (60 mM C a C l2, 
10 mM Pipes  (pH 7),  15 % g l yce r o l )  and lef t  on ice for  2 0 - 3 0  mins.
The  cel l s  were  aga in  co l l ec t ed  by c e n t r i f u g a t io n  at 3 0 00 x g  for 
20 mins  at 4°C and the s up e r n a t an t  a sp i r a t ed .  The cel l  pe l l e t  was 
r e s u sp e nd ed  in 3 ml t r a n s fo r m a t i o n  buf fer  unt i l  a h o mo ge no us  
s u sp e ns i o n  was ob t a ined .  The co mp et en t  bac t e r i a l  cel l s  were  
a l i quo t ed  (200 pi )  into 1.5 ml s t e r i l e  E p p e n d o r f  tubes ,  f rozen  in 
l iqu id  n i t r ogen  and s tored  at - 7 0 ° C .
2 .2 .6 .2  Res t r i c t i on  diges ts
2 .2 .6 .2 .1  Pr ep a ra t i o n  of  vec t or  and PCR for  l i gat ion
The PCR p r o d uc t  was pur i f i ed  us ing the  High Pure  PCR Pr oduc t  
P u r i f i c a t ion  Kit® (Roche  B i ochemi ca l s ,  Germany) .  In the p re sence  o f  
a c hao t r op i c  sal t ,  nuc l e i c  acids  bind s pec i f i c a l l y  to p re - t r ea t ed  glass  
f ibres .  Nuc l e i c  ac ids  can thus  be s epa r a t ed  and pur i f i ed  f rom 
impur i t i e s  such as sal t s ,  u n i n c o r p o r a t e d  n uc l eo t ides ,  p r imer s  and 
p o l yme ra se s  p resen t  in the PCR r ea c t i on  mix ture  (Voge l s t e i n  & 
Gi l l e sp i e ,  1979).  Nuc le i c  acids  were  e lu t ed  in 100 pi  o f  a l x  TE 
buf f e r  and s tored  at -20°C.
The pur i f i ed  PCR p r o du c t  and pQE- 80 L  vec t o r  were  d iges t ed  
o ve r n i gh t  at 37°C wi th the  r e s t r i c t i on  enzymes  H in d  I I I  (Roche  
B i ochemi ca l ,  Ge r many)  and Bam H I  ( P romega ,  USA)  in reac t ion  
buf fer  B (10 mM Tr i s -HCl ,  5 mM M g C l 2, 100 mM NaCl  and 1 mM 
m e r c ap t oe th an o l ,  pH 8). Both  enzymes  are 100 % e f fec t ive  in this
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buffer .  The  r e s t r i c t i o n - d i g e s t  r e ac t i on  of  the PCR pr oduc t s  con ta i ned ,  
2 U Bam HI,  2 U H in d  II I ,  2 pi o f  lOx reac t ion  buf fer  B, 10 pi  o f  
PCR p ro du c t  and s uf f i c i en t  s t e r i l e  wa te r  to make up the vo lume  to 
20 pi. To d iges t  2 pg pQE- 80L vector ,  4 U H in d  II I ,  4 U Bam HI,
4 pi o f  lOx reac t ion  buf fe r  B and s t er i l e  wa ter  to a volume of  20 pi 
were  added.  The  reac t ions  were i ncuba t ed  at 37°C overnight .  The 
enzymes  and f r ag me n t  cut  f rom the p QE- 80L  vec to r  were r emoved 
us ing  the High Pure  PCR P u r i f i c a t i on  kit.  This  was f o l l owed  by 
d e ph o sp h o r y l a t i o n  of  the vec t o r  wi th c a l f  i n t e s t i na l  phos ph o ry l a se  
and the vec t o r  was again c l eaned  us ing  the High Pure  Pu r i f i c a t ion  kit  
to r emove  the enzyme.  The vec t o r  and PCR p roduc t s  were  then s tored 
at -20°C unt i l  r equ i red .  The r e s t r i c t i on  diges t s  (5 pi a l i quo t s )  were 
sepa r a t ed  on a 1 % (w/v)  agarose  gel  ( s ec t i on  2 .2 .4 )  a long  wi th a 
100 base pa i r  mo le cu la r  we igh t  ma rke r  to obta in  an accura t e  
i nd i ca t i on  of  the  mo le cu la r  weight .
2 .2 .6 .3  Ligat ion  reac t ion
The known c on ce n t r a t i on s  o f  each band in the 100 base pai r  mass 
l a dde r  were  used to es t i mate  the  c on ce n t r a t i on s  o f  the  PCR produc t s  
and exp re s s i on  vector s .  This  was done  by comp ar in g  the in tens i t y  o f  
bands  o f  PCR produc t s  and vector s  on the agarose  gel  with the 
i n t ens i t y  o f  the  bands  o f  the 100 base pai r  mass  ladder .  The Rapid 
DNA Li ga t i on  Ki t  (Roche  M o l ec u l a r  Bi ochemi ca l s ,  Ge rmany)  was 
used for  the l i ga t i on  reac t ions .  The l iga t i on  r eac t i on  was ca t a lysed  
us ing  the T4 DNA l igase  (Roche  Mo l ec u l a r  B i ochemi ca l s ,  Germany)  
in a 20 pi reac t ion.  The l iga t i on  r eac t i ons  were  ca r r i ed  out  at an 
i n se r t : v e c t o r  mola r  ra t io o f  3:1.  The quan t i t y  o f  i nser t  used was 
de t e r mi ned  as fo l l ows :
vector (ng) x size of insert (kb)
Insert (ng) = X ratio




The r e s t r i c t ed  ve c t o r  was also deph o sp h or y l a t ed  to p reven t  
r ec i r cu l a r i s a t i on .  To the known quan t i t y  o f  inser t ,  the  r e s t r i c t ed  
ve c t o r  was d i l u t ed  in DNA buf f e r  to a vo lume  o f  10 pi and l x  T4 
DNA l iga t i on  buf fe r  (30 mM Tr i s - HCl  (pH 7.8) ,  10 mM M g C l 2,
10 mM DTT,  1 mM ATP was added  to a f inal  vo lume of  20 p.1. The 
so l u t i on  was mi xed  t h o r ou g h l y  be fore  add ing  2 U of  the enzyme  T4 
l igase.  A ne ga t i ve  con t ro l  co n s i s t i n g  o f  a r e s t r i c t ed  vec tor  and 
n u c l ea s e - f r e e  wa te r  was added.  The  l iga t i on  reac t ions  were  i ncubat ed  
at room t e mp e ra t u r e  for  30 mins.
2 .2 .6 .4  Tra n s f o rm a t i o n
The t r a n s f o r m a t i o n  reac t ions  were ca r r i ed  out  acco rd i ng  to the 
me t hod  de sc r i bed  by Sambr ook  et al ,  (1989) .  The comp e t en t  cel ls  
( s ec t i on  2 . 2 . 6 . 1 )  were  t hawed on ice and 50 pi cel l s  were  added to 
each r eac t i on  (5 pi) ,  i nc l ud i ng  the nega t i ve  con t ro l  con ta i n ing  
l i ne a r i s ed  p l asmid  DNA.  T r a n s f o r m a t i o n  reac t ions  were  also 
p e r f o r med  wi th  the  pos i t i ve  cont ro l  (u n c u t  p l a smid  DNA)  to check 
t r a n s fo r m a t i o n  e f f i c i ency .  The s uspens i ons  were  mixed  gent ly  and 
i nc uba t ed  on ice for  30 mins.  The t r a n s fo r m a t i o n  reac t ions  in 1.5 ml 
E p p e n d o r f  tubes  were  then sub j ec t ed  to hea t  shock at 42°C for 
90 seconds  to f ac i l i t a t e  DNA uptake  by the  co mp et en t  bacte r i a .  The 
tubes  were  r e tu rned  to ice be fore  the  add i t i on  o f  p re -wa rmed  
Lu r i a - Be r t a n i  med i a  (450  pi )  w i t h o u t  an t ib io t i c s  and incuba t ed  with 
shak ing  for  one hour .  The t r a ns f o r ma t io n  mix tures  were  p l a t ed  on 
L u r i a - Be r t an i  ampi c i l l i n  s e l ec t i on  p la t es  by sp r ead i ng  150 pi and 
300 pi o f  the ba c t e r i a  over  the sur face  o f  r e s pec t i ve  p la tes  wi th a 
s t er i l e  g lass  rod.  The p la tes  were  i nc uba t ed  at 37°C overnight .  
Fo l l o wi n g  i nc ub a t i on  the n u mb e r  o f  co lon ies  were  coun ted  and 
s c r eened  for  inser t s  by p l a smid  i so l a t i on  and re s t r i c t i on  d iges t i on  or 
PCR.
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2.2 .7  Screeni ng  of  co lonies  by p lasmid i so l a t i on
The a lka l ine  lys is  me t hod  (Sambr ook  et al ,  1989) was used to i sola te  
p lasmids .  Single  bac t e r i a l  co lon i es  f rom the t r a n f o r ma t i on  plates  
were i nocu la t ed  into 5 ml L u r i a - Be r t a n i  med i a  c on t a i n i ng  100 pg/ml  
c a r ben ic i l l i n  in 15 ml cu l tu re  tubes .  The cu l ture  was incuba t ed  
o ve r n i gh t  at 37°C wi th s hak ing  at 200 rpm.  Glycero l  s tocks  were 
p repa red  by mi x ing  500 pi o f  the susp e nd e d  cu l tu re  wi th an equal  
vo lume  of  60 % (v/v)  g lycero l  in a 1.5 ml mi c ro f uge  tube  and s tored 
at -70°C.  The r e ma in in g  cu l tu re  was t r a ns fe r r e d  to a cent r i fuge  tube  
and cen t r i f uged  at 4 OOOxg for  15 mins  at 4°C. The sup e r na t a n t  was 
asp i r a t ed  and the pe l l e t  r e su sp e nd ed  in 300 pi lys is  bu f f e r  (50 mM 
glucose ,  25 mM Tr i s -Cl  (pH 8),  10 mM EDTA (pH 8)) fo l l owed by 
i nc uba t ion  for  10 mins  at room t empe ra t u re .  To this  s uspens i on  
600 pi o f  a f r esh ly  p repa red  so lu t i on  of  0.2 M Na OH and 1 % (w/v)  
SDS was added ,  mixed by gent l e  i n v e r s io n  and incuba t ed  on ice for 
10 mins.  Af t e r  i ncuba t ion ,  450 pi o f  i ce-co ld  5 M po t a s s i um aceta te  
so l u t i on  (pH 4.8)  was added,  mixed by gen t l e  i nve r s i on  and i ncubat ed  
for  10 mins  on ice.  The s uspens i on  was c en t r i f uge d  at 10 OOOxg for 
10 mins ,  the s up e r na t an t  t r ans fe r r ed  to a f resh tube  and RNase  added 
to a f inal  c on ce n t r a t i on  o f  20 pg/ml .  The so lu t i on  was then incuba t ed  
at 37°C for  1 hour .  The so lu t ion  was then ex t r ac t ed  wi th an equal  
vo lume  of  phenol  (pH 8) and vor t exed  for  one minute  before  
cen t r i fu g a t i o n  at 10 OOOxg for  10 mins at room t empera t u re .
The upper  phase  was t r a ns fe r r e d  to a f resh tube  and an equal  volume 
o f  ch lo r o f o r m was added.  The s u spe ns i on  was vor t exed  for  one 
minute  and cen t r i f uged  at 10 OOOxg for  5 mins.  The upper  aqueous  
phase  was t r a ns fe r r e d  to a f resh tube  and p r ec i p i t a t ed  by adding 
0.1 vo lume o f  3 M sod ium ace ta te  (pH 5.2)  and an equal  volume of  
i ce - co ld  i sopropano l .  The  pe l l e t  was co l l ec t ed  by cen t r i fuga t i on  at 
10 OOOxg for  20 mins  at 4°C and washed  wi th 1 ml o f  p rech i l l ed  70 % 
e thanol .  The  pe l l e t  was  air  dr ied  and r e s uspended  in 50 pi o f  s ter i l e
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water .  The  c on ce n t r a t i o n  o f  the p l asmid  DNA was de te r mi n e d  us ing a 
UV s p ec t r op h o to m e t e r .  The  i so l a t ed  p lasmids  were also sub jec t ed  to 
r e s t r i c t i on  ana lys i s  to ver i fy  the  p resence  o f  inser t s  or  sequenc ing .
2.2 .8  Prote in Expres s i on
2.2.8.1  Time scale  ana lys i s  of  prote in  expres s i on
L u r i a - Be r t a n i  med i a  (5 ml) con t a i n i ng  50 p.g/ml c a r ben i c i l l i n  was 
i nocu l a t ed  wi th a s ingle  co lony and i ncuba t ed  ove rn igh t  at 37°C with 
shaking.  Ca r ben ic i l l i n  was used in place  o f  ampi c i l l i n  as it is more 
s table.  From this  cu l t u r e  500 p.1 was i nocu l a t ed  in 20 ml p r e -warmed  
2xYT media  (17 g b a c t o - t r yp t one ,  10 g ba c t o - yea s t  ex t r ac t  and 5 g 
NaCl  to one l i t r e)  c on t a i n i ng  50 p.g/ml ca rben i c i l l i n  and incuba t ed  at 
37°C wi th v i gorous  s hak ing  unt i l  the  abso r bance  at 600 nm reached 
0.6.  Expr es s i on  was i nduced  by add ing  i s op ro p y l - P -d  
t h i o g a l a c t o p y r a no s e  ( IPTG)  ( I nv i t r oge n ,  USA) to a f inal  
c on ce n t r a t i o n  o f  1 mM. I mmed i a t e ly  be fo re  i nduc t i on  wi th IPTG,
1.5 ml cu l tu re  sample  was c en t r i f u g e d  at 10 OOOxg and r e suspended  
in 2 x SDS - PAGE sampl e  buf f e r  (0 .09  M Tr i s - HCL (pH 6.8)  20 % 
g lycer o l ,  2 % SDS,  0.02 % b r omophe no l  blue and 0.1 M DTT)  and 
t aken  for  ana lys i s  on SDS-PAGE.  Samples  were  t aken  j u s t  pr ior  to 
add ing  I PTG and then at hour l y  in t e rva l s  for  4 hours .  The samples  
were i mmed i a t e l y  c en t r i f uged ,  the s up e r n a t an t  d i s ca rded  and the 
pe l l e t s  were  r e su sp en ded  in 2x SDS - PAGE sample  bu f f e r  to lyse the 
cel l s  and f rozen  at -20°C.
2.2 .8 .2  Growth and ind uc t i on  of  E. co l i
A co l ony  was p i cked  f rom an agar  p la te  and was g rown ( sec t ion  
2 .2 .8 )  in 2xYT media  c on t a i n i ng  50 pg/p.1 carben ic i l l i n .  From this 
cu l tu re  1 ml was i nocu l a t ed  in 50 ml p r e war med  2xYT media  
con t a i n i ng  50 p g / p l  c a r ben ic i l l i n .  The cu l ture  was incuba t ed  at 37°C 
wi th v i gorous  shak ing  unt i l  the  abso r ban c e  at 600 nm reached  0.5.
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Ex p re s s i on  was then i nduced  by add ing  I PTG to a f inal  concen t r a t i on  
o f  1 mM and the cu l tu re  fu r the r  i ncuba t ed  at 37°C for  4 hours .  The 
b ac t e r i a  were  co l l e c t ed  by c en t r i f u g a t i o n  at 3 OOOxg at 4°C for 
20 mins.  The  s upe r na t an t  was d i s ca rded  and the pel le t  f rozen at 
-70°C unt i l  r eady  for  use.
2.2 .8 .3  Prote in  ex t rac t i on  and pur i f i ca t i on
The f rozen  pe l l e t s  were  t hawed  on ice and 5 ml lysis  buf f er  
c on t a i n i ng  a p r o t ea se  i nh i b i t o r  cock ta i l  was  added.  The pro t ease  
i nh ib i t o r  cockta i l  was  composed  o f  0.02 mg/ml  pancreas  ext ract ,
0 .002  mg/ml  c hy mo t r y p s i n ,  0 .0005 mg/ml  t h e rmo l ys in ,  0.02 mg/ml  
t ryps in ,  0.33 mg/ml  papa in  and p h e n y l m e t h an e s u l f o n y l  f l uor ide  
(PMSF)  to a final  c on cen t r a t i on  of  100 pg/ml .  The samples  were  then 
s on ica t ed  at 6x 10 seconds  at 40 % power  us ing a son i ca t o r  wi th a 
mic ro t ip  p robe  (Heat  s y s t ems -U l t r a so n i cs ,  Inc,  NY,  U.S.A) .  The 
lysa t e  was cen t r i f uged  at 10 OOOxg at 4°C for  20 mins.  The 
s up e r n a t a n t  was t r a ns fe r r e d  to a new tube  and 100 pi 50 % nickel -  
NTA ( n i c k e l - n i t r i l o t r i a c e t i c  acid)  r es ins  which  were  p r e -e qu i l i b r a t e d  
wi th lys is  buf f er  (50 mM N a H 2PC>4, 300 mM NaCl ,  10 mM imidazo le ,  
pH 8 to one l i t re)  were  added.  The His  tag s equence  binds  to the 
n i c ke l - NT A res ins ,  a f t e r  the  un b o u nd  pro t e ins  are washed  away the 
t a rge t  pro t e in  is r ecove r ed  by e lu t i on  wi th  imidazo le .  The sys tem 
enab les  p ro t e ins  to be pur i f i ed  u nde r  n o n - d e na t u r i n g  condi t i ons .  The 
s o lu t i on  was i nc uba t ed  wi th gen t l e  shak i ng  on ice for  60 mins to 
a l l ow the n i c ke l -N T A  res ins  to bind pro t e in  c on t a i n i ng  the h i s t i d ine  
tag and then c en t r i f uge d  as before .  The  sup e r na t a n t  was r emoved  and 
the res ins  washed  three  t imes  in 5 ml wash buf fer  (50 mM N a H 2PC>4, 
300 mM NaCl ,  20 mM imidazo le ,  pH 8 to one l i t re) .  Sample  o f  res ins  
(20 pi)  was added  to sample  buf f e r  and bo i l ed  for  5 mins.  The 
sampl es  were  then run on a 12 % SDS-PAGE ( sec t ion  2 .2 .8 .4) .  The 
sampl es  were  f u r t he r  e lu t ed  wi th the  e lu t i on  buf fer  (50 mM N a H 2P 0 4 , 
300 mM NaCl  and 250 mM imidazo le ,  pH 8 to one l i t re) .
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To 70 jul o f  sample ,  2 x S D S - P A G E  sample  buf f er  was added  and the 
sampl es  sepa ra t ed  on a 12 % SDS-PAGE.
2 .2 .8 .4  Sodium dodecyl  su l ph at e  p o l y a cr y la m i d e  gel  
e l ec t r op h ore s i s  analys i s
2 .2 .8 .4 .1  Pr ep a ra t i o n  and running  of  SDS - PAGE gels
In o rde r  to s epa ra t e  the  p ro t e ins ,  a d ena t u r ing  d i s con t inuous  SDS- 
PAGE sys t em was used ( Laemml i  el al ,  1970).  The 12 % reso lv ing  
gel  mi x t u r e  for  a 0.7 mm thick mini  gel  was p repa red  as in Table  2.1.  
Pr io r  to cas t i ng  the  gel 50 pi o f  10 % APS and 5 pi of  TEMED were 
added  to the  gel mi x t u r e  as p r epa r ed  in Table  2.1.  The gel mixture  
was pou r ed  into the a s sembl ed  mini  gel  p la t es  l eav i ng  suf f i c i en t  
space  for  the s tack ing  gel.
Table  2.1:  12 % Reso l v i ng  gel  mixt ure
Water 2.72 ml
30 % a c r y l a m i d e / 0 . 8 % bis- 
a c r y l ami de  so lu t i on
3.2 ml
Res o l v i ng  gel  bu f f e r  s tock 
(1.5 M Tr i s - HCl ,  pH 8.8)
2 ml
10 % SDS 0.08 ml
Tota l  vo lume 8.0 ml
The gel  was o ve r l ayed  wi th wa ter  and lef t  o ve r n i gh t  to po lymer i se .  
Af te r  p o l yme r i s a t i o n  the ove r l ay  was r e mo v e d  and the sur face  r insed 
wi th l x  r e so l v i ng  gel  buf f er  to r emove  u np o l yme r i s e d  acry lamide .  
The gel  was then  ove r l ayed  wi th 1 ml o f  1 x r e so lv ing  gel buf f er  to 
ove rc ome  d i f f us i on  ef fect s .  The  s t ack i ng  gel mix tu r e  was prepared  as 
in Table  2.2.
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Table  2.2:  S t ack i ng  gel  mixture
Ster i l e  water 3.05 ml
30 % a c r y l a m i d e / 0 . 8 % bis- 
a c r y l ami d e  so lu t i on
0.665 ml
Stack ing  gel buf f er  (0.5 M Tr is-  
HC1, pH 6.8)
1.25 ml
10 % SDS 0.050 ml
APS 0.025 ml
TEMED 0.0025 ml
Tota l  vo lume 4.99 ml
The s t ack i ng  gel  mi x t u r e  as p repa red  in Table  2.2 was poured  onto 
the p o ly me r i s e d  sepa r a t i ng  ( r eso l v i ng )  gel  and the comb inser ted 
i mmedia t e ly .  Af t e r  the s t ack i ng  gel  had  po l yme r i s e d  the comb was 
r emoved  and the gel sur face  was r i nsed  wi th l x  s t ack ing  gel  buffer .  
The  glass  p la t es  were  p l aced  in the  e l ec t r op h o r e s i s  chamber  
( B i o -Ra d)  which  was f i l l ed  wi th l x  e l ec t r o ph o r es i s  buf f er  (0.1 M 
Tr is  base ,  0.38 M g lyc ine ,  0.1 % SDS) ,  p r io r  to load ing  20 p.1 of  the 
p repa red  samples .  The gel  was then e l e c t r o ph o r e s e d  at a cons tan t  
vo l t age  o f  200 vol ts  for  30 mins unt i l  the  Mul t i - T ag  pro t e in  marker  
(mi x t u r e  o f  p ur i f i ed  pro te in  t agged  wi th  g l u t a t h i on e - S- t an s f e r a se ,  
i n f l uen z a  h e m a g g l u t i n i n  pro t e in ,  human  c -myc  gene  and poly-  
h i s t i d i n e - t a gg ed  p ro t e ins )  r eached  the b o t t om o f  gel.  Fo l l owi ng  
e l ec t r op ho r e s i s  the  gel  sandwich  was r emoved  f rom the 
e l ec t r ophor es i s .  The  glass  p la tes  were  s epa ra t ed  to re l ease  the  gel  
and the gel  was i mmed i a t e l y  e qu i l i b r a t ed  in To wb i n  t r ans fe r  buffer  
(25 mM Tris,  192 mM glyc ine  and 20 % methano l  to one l i t re)  in 
p r e pa ra t i on  for  pro t e in  t r ans fe r  (Towbi n  et al ,  1979).
2 . 2 .8 .5  West ern  blot  t rans fer
Weste rn  b lo t t i ng  is a me t hod  based on en zy me - l i nk ed  
i m m u no d e t e c t i o n  o f  ant igen spec i f i c  an t ibod ies .  De tec t i on  occurs  
when the  an t igens  s pec i f i c a l l y  i n t e r ac t  wi th  a p r imary  an t i -h i s t i d i ne
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a n t i body  which then in t e rac t s  wi th  an a n t i - IgG seconda ry  a n t i body  
con ju ga t ed  wi th h o r s e r ad i sh  p e r ox i dase ,  a co lour  dev e l o p men t  
enzyme  ( Ma t hews  & van Holde ,  1990).  The Trans-blot® SD semi dry 
e l ec t ro p h o r e t i c  t r a ns f e r  a s sembl y  ( B i o - r ad )  was used for  pro te in  
t r ans f e r  f rom an S DS - PAGE gel  to a po l y v in y l i d e ne  f luo r ide  (PVDF)  
membrane .
Fo l l owi n g  e l e c t r o p ho r e s i s  the gel  was e qu i l i b r a t ed  in 100 ml Towbin  
t r ans fe r  bu f f e r  for  30 mins ,  to r emove  e l ec t r o ph o r es i s  buf f er  sal ts 
and de t e rgen t s .  The  Towbin  t r ans fe r  bu f f e r  was used to p reven t  an 
i nc rease  in co n du c t i v i t y  and amount  o f  heat  gene r a t ed  dur ing  the 
t r ans fe r .  This  was also to op t imi se  pro te in  b ind ing  to the (PVDF)  
me mb ra ne  du r i ng  t r ans fe r .  The  h y d r o p h ob i c  PVDF membranes  were 
cut  to the d i mens i ons  o f  the gel  and br i e f ly  soaked  in me thano l  to 
wet  t hem and then in Towbin  t r ans f e r  bu f f e r  for  30 mins.  The 
me mb ra ne  was h a nd l ed  wi th fo rceps  to p reven t  c on t ami na t i on  wi th 
p ro t e ins  t h r o u g h o u t  the t ransfer .
Two thick f i l t e r  paper s  were cut  to the d i mens ions  of  the gel and 
soaked  in t r a ns f e r  buffer .  The  p r e - s oak e d  f i l t e r  paper  was p laced onto 
the p l a t i n um anode  o f  the Trans-blot® SD semi dry e l ec t r ophor e t i c  
t r ans fe r  a ssembly .  The equ i l i b r a t ed  PVDF me mbr a ne  was p laced on 
top o f  the f i l t e r  pape r  avoid ing  air  bubbles .  The equ i l i b ra t ed  
SDS-ge l s  were  p laced  on top of  the memb r a nes  and covered  with 
p re - s oak ed  f i l t e r  papers .  The  c a t hode  was then p l aced  onto the s tack,  
a long wi th the  safe ty  cover  and the p ro t e in  t r ans fe r  occur red  at a 
cons t an t  cu r r en t  o f  175 mA for  30 mins.
2 .2 .8 .6  Hor se rad i s h  perox i dase  de t ec t i on
The me mbr a ne  was sub se qu e n t l y  washed  and br i e f ly  r i nsed  in TBST 
buf fer  (20 mM Tr i s - HCl ,  pH 7.5,  500 mM NaCl  and 0.005 % Tween) .  
The PVDF me mb r an e  was i nc uba t ed  in b lock ing  so lu t ion  (5 % bovine  
serum a lbumin  p repa red  in TBST)  for  30 mins  and then soaked  in
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TBST wi th  1 % (w/v)  bovine  serum a lbumin  con t a i n i ng  the pr imary  
an t i -His  a n t i body  (B i o te ch n o l o g y ,  Inc,  San ta  Cr uz , USA)  wi th a final  
c on ce n t r a t i o n  o f  0.2 mg/ml  for  one hour .  The membr ane  was washed  
wi th TBST e ight  t imes  for  5 min per iods  to r emove  the unbound  
an t ibody .  The me mbr a ne  was t r ans fe r r ed  to the TBST buf fer  
c on t a i n i ng  the s ec on d a ry  an t i mouse  a n t i body  with con juga t ed  
h o r s e r ad i sh  p e ro x id a se  con j uga t e  ( B io t e ch no l og y ,  Inc,  Santa  Cruz,  
USA)  wi th a f inal  co n ce n t r a t i o n  of  0.1 mg/ml  and i ncuba t ed  for 
60 mins.  The me mbr a ne  was then washed  eight  t imes  in TBST buf fer  
for  5 mins  each t ime and then s ubmer ged  in ho r s e r ad i sh  co lour  
d e ve lo p me n t  so lu t i on  (18 mg 4 - c h l o r o - l - n a p h t h o l ,  6 ml me thanol ,
60 p.1 30 % hydr ogen  perox ide  and 24 ml l x  Tr i s - sa l i ne )  for  30 mins.  
The membr anes  were  b lo t t ed ,  air d r i ed  and obse rved  for  band 
deve l opmen t .
2.2 .8 .7  C h e m i l u m i n e s c e n t  de t ec t i on  us ing  the Lumi - l i ght  
western  b lo t t i ng  subs trate
The L u m i - L i gh t  Wes t e rn  Blo t t i ng  Subs t r a t e  Ki t  (Roche  Di agnos t i cs ,  
Man n he im,  Ge rmany)  was used for  the c h e mi l u m i n e s c e n t  de tec t ion.  
The membr anes  were  soaked  in 8 ml o f  l umi - l i gh t  subs t r a t e  so lu t ion  
for  30 mins.  The me mb r a nes  were  then r emoved  f rom the lumi - l i gh t  
subs t r a t e  so lu t i on  and p laced  p ro t e i n  s ide up on a t r a ns pa r en c y  f i lm.  
The  membr anes  were  b lo t t ed  to r emove  excess  l iqu id  and covered  
wi th  a l igh t  t r a n s p a r e nc y  f i lm.  The membr anes  were  then  p laced in an 
X- ray  cas se t t e  and exposed  onto  an X- ray  f i lm for  pe r iods  o f  3 mins,  
30 mins and 2 hours  r e spec t ive ly .
2.3 Trit iated hypoxanthine incorporat ion assay
Hy p o x a n th i n e ,  a n u c l eo t i d e  p r e c u r s o r  is r equ i r ed  for  DNA synthes i s .  
The  pa ras i t e  is no t  capab l e  o f  s yn t he s i s in g  h y p ox a n t h i ne  and thus 
re l i es  on the h uma n  hos t  for  supply.  H yp o xa n th i n e  is t aken  up f rom
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the h uma n  hos t  t h ro u g h  the n u c l eo s id e / n u c l e o b a s e  t r a n s p o r t e r  and 
i n c oo r po r a t ed  into the  p a r a s i t e ' s  nuc l e i c  acid (Par ker  et al ,  2000) .
The  up t ake  o f  r ad io l ab e l l ed  t r i t i a t ed  h y p ox a n t h i ne  was used as an 
i nd i c a t o r  o f  the sens i t i v i t y  o f  the pa ras i t e s  to po t ent i a l  an t i ma l a r i a l  
agents .  The  ma la r i a  pa ras i t e s  were  s ubcu l t u r ed  in mic ro t i t r e  p la tes  
a long wi th var ious  drug  c oncen t r a t i ons  for  a s ingle  (48 hours )  and 
double  cycle  (72 hours )  o f  DNA s yn t hes i s  (Des j a rd i ns  et al,  1979).
2.3.1 Pr epa r at i o n  of  drugs
Wo rt ma nn in ,  fo r sko l in ,  1 , 9 - d i de ox y f o r s ko l i n  (S igma,  USA)  were 
d i s so lved  in d ime thy l  s u l phox i de  (DMSO)  to 10 mM s tock solut ions .  
C on ce n t r a t i on s  wi thin  the range  o f  6.5 mM to 500 nM were prepared  
f rom the s tock so lu t ion .  L Y 294002  (Promega ,  USA) was d i s so lved  in 
DMSO to p repa r e  a 5 mM s tock so lu t ion .  The i nh i b i t o r  so lu t ions  were 
d i l u t ed  t en - fo ld  in the wel l s  o f  the mi c r o t i t r e  pla te ,  thus  the final  
c on ce n t r a t i on s  o f  i nh ib i to r s  were  in the  range  o f  650 pM to 50 nM. 
C h l o r oq u i ne  and qu in ine  were  both  d i s so lved  in s ter i l e  water  to s tock 
c on ce n t r a t i on s  o f  1 mM and 0.1 mM,  respec t ive ly .  The drugs  were 
a l i quo t ed  and s tored at -70°C.  For  each e xpe r imen t  d i l u t ions  were 
f r esh ly  p r epa r ed  in i nco mp le t e  me d i a  t ha t  was d e f i c i en t  o f  
h ypoxan t h i ne .
2.3.2 Pr ep a ra t i o n  of  the i n t r a - e ry t h r o c y t i c  P. f a l c i p a r u m  
cul ture
The p e rc en t ag e  p a ra s i t a e mi a  o f  the s yn ch r on i se d  P. f a l c i p a r u m  
cu l t u re  was de te r mi n e d  as in s ec t i on  2.1.6.  The cu l ture  was then 
washed  th ree  t imes  wi th PBS,  to r emove  the compl e t e  cu l tu re  media  
and waste  p roduc t s  which  may i n t e r f e re  wi th e xp e r imen t a l  resul t s .
The cu l tu re  was ad jus t ed  to a 0.5 % p a ra s i t a e mi a  and a 1 % 
haematoc r i t .
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2.3 .3  Pr epa r at i o n  of  mi cro t i t re  plates
Fla t  bo t t omed  mi c ro t i t r e  pla tes  wi th 96 wel l s ,  a r r anged  in an e ight  
row by 12 co lumn mat r ix  were  used in the exper iment s .
Of  the  p r epa r ed  drug  d i lu t ions ,  25 pi was added to t r i p l i ca t e  or 
qu ad r up l i ca t e  we l l s  and 25 pi o f  h y p o x a n t h i n e  f ree med i a  was added 
to the  con t ro l  wel l s  ( r ow H).  Two h undr ed  mic ro l i t r e s  o f  a 
s u spe ns i on  o f  u n in f ec t ed  red b lood cel l s  (1 % haema t oc r i t )  were  
added  to the four  cont rol  wel l s ,  cons t i t u t i n g  the red blood cell  
cont rol s .  Two h undr ed  mic ro l i t r e s  o f  the  ad jus t ed  P. fa lc ip a ru m  
s uspens i on  was added  to the r ema i n i ng  e ight  wel l s  which cons t i t u t ed  
the pa ras i t e  drug  free cont ro l  wel ls .  The  pla te  was then t r ans f e r r ed  to 
a s t er i l e  g lass  d e s i c c a to r  wi th candles  and 20 ml o f  s ter i l e  water  
added.  Candles  were  lit  to p rov ide  an a nae rob i c  a t mosphere  sui ted for  
opt imal  pa r a s i t e  growth.  When the f l ame  was e x t i ngu i s hed  the glass  
d es i cca t o r  was i nc uba t ed  at 37°C for  24 hours  ( Des j a rd i n  et al,
1979).
2.3 .4  Pr ep a ra t i o n  of  radi oac t i ve  i so t ope  and labe l l i ng  of  
paras i te s
Et hanol  was evap o r a t e d  f rom the 3 [ H] - hypoxan t h i ne  i sotope  
(17 .9  Ci /mmol ,  5 mCi)  ( A me rs ham P h a r ma c i a  B io t echno l ogy ,  UK) 
and h y p o x a n t h i n e - f r e e  cu l tu re  med i um was added to p repa re  a 
0.03 pCi /ml  s o lu t i on  p r io r  to adding  25 pi i so t ope  to each well .  The 
pla tes  were  i nc uba t ed  for  a fu r the r  24 hour s  at 37°C in a s ter i le  
cand le  j a r  a f t e r  which the pa r a s i t e  DNA was p r ec i p i t a t ed  ( sec t i on  
2 .3 .5)  for  the  s ingle  cycle  exper imen t .  An i den t i ca l  set  o f  pla tes  were 
f u r the r  i ncuba t ed  for  ano t he r  24 hour  pe r iod  to de t e r mi ne  the paras i t e  
g rowt h  a f ter  a doub le  cycle  o f  DNA synthes i s .
2.3.5 P re c i p i t a t i o n  of  paras i te  DNA
After  the r e s pec t i ve  i ncuba t ion  per iods ,  a s emi -au t omat ed  cell  
h a r ve s t e r  ( T i t e r t e k s Cel l  Ha rv es t e r ,  F low L abor a t o r y ,  Norway)  was
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used to p r ec i p i t a t e  the pa ras i t e  DNA f rom each p la te  onto glass  f ibre  
f i l t e r  paper .  Wate r  lysed the pa ras i t e s  and the pa ras i t e  DNA was 
depos i t ed  onto glass  f ibre  f i l t e r  paper s  (Wal lac ,  F in l and) ,  which were 
lef t  to air dry and then t r a ns fe r r e d  to sample  bags f i l led wi th 10 ml 
Betaplate® s c i n t i l l a n t i on  f luid (Wal l ac ,  F in l and) .  The sample  bags 
were  t r a ns fe r r e d  to the  Wal lac® Betapla te® sc i n t i l l a t i on  counter  
(Wa l l ac  1205)  and coun ted  for  1 min/wel l .
2.3.6 Data e va l uat i on
The ca l cu l a t ed  pe r cen t age  va lues  were  used  to genera t e  a s igmoida l  
dose  r e sponse  curve  us ing the n o n - r e g r e s s i o n  da ta  analys i s  curve  
f i t t i ng  p ro g ramme ,  Enzf i t t er® (Biosof t ,  UK)  and Graph Pad Prism® 
(Graph  Pad Sof tware ,  Inc,  USA).  The drug  concen t r a t i on  which 
inh i b i t ed  50 % paras i t e  g rowth  ( I C 50 va lue )  was de t e r mi ned  f rom the 
s igmoid  dose r e sponse  curve.
The f o l l owi ng  equa t i on  was used to de te r mi ne  the  pe rc en t a ge  paras i t e  
growth:
% Paras i t e  = drug (cpm)  - mRBC cont ro l  (cpm)_____ x 1 00
growth  mPARA cont ro l  ( cpm)  -  mRBC cont ro l  1
where  :mRBC = mean red blood cell  cont rol
mPARA = mean pa ra s i t e  cont ro l
cpm = counts  per  minute
2.3.7 S t at i s t i ca l  analys i s
The IC50 values  o f  the drugs  were exp re s sed  as means  ± s t andard  
dev i a t ion  and the s t a t i s t i ca l  ana lys i s  c ompar i son  be tween the drugs
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was done  us ing the S t u d e n t ’s t - t es t ,  where  a p va lue  less than 0.01 
was cons i de r ed  s ign i f i can t .
2.3 .8  Co n f i r ma t i o n  of  hyp o xa n t h i n e  assay  data
Ef fec t s  o f  the  se l ec t ed  compounds  on the s ingle  and doub le  cycle  o f  
pa ras i t e  g rowth  were  i nves t iga t ed  by means  o f  G i emsa  s t a ined  thin 
b lood  s l ides  ( s ec t i on  2.1 .6) .  Di f f e r en t i a l  pa ras i t e  count s  and paras i t e  
ap pea ra nce s  were  de t e r mi ned  for  se l ec t  h igh concen t r a t i ons  
(0 .005 p.M-500 pM)  and compar ed  to an un t r ea t ed  pa ras i t e  cont rol .
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3.0 R E S U L T S
3.1 I d e n t i f i c a t i o n  o f  p h o s p h a t i d y l i n o s i t o l  3 - k i n a s e  in 
P. f a l c i p a r u m
The  t b l a s t n  p r o g r a m  at  t he  N C B I  w as  u s e d  to  c o m p a r e  t he  a m i n o  ac id  
s e q u e n c e  o f  P I 3 K  f r o m  o t h e r  o r g a n i s m s  t o  t he  d y n a m i c a l l y  t r a n s l a t e d  
n u c l e o t i d e  s e q u e n c e s  p r e s e n t  in t h e  P. f a l c i p a r u m  g e n o m e  d a t a b a s e .
A P. f a l c i p a r u m  s e q u e n c e  w h i c h  had  s i g n i f i c a n t  a l i g n m e n t  to  P I 3K in 
S a c c h a r o m y c e s  c e r e v i s a e ,  D r o s o p h i l a  m e l a n o g a s t e r  a nd  A r a h i d o p s i s  
l h a l i a n a  w a s  s e l e c t e d .  T h i s  c o n t i g  c o n t a i n i n g  t h e  s e q u e n c e  w a s  
s u b m i t t e d  t o  an o p e n  r e a d i n g  f r a m e  s e a r c h  at  t he  N C B I  w e b s i t e  
( h t t p : / / w w w . n c b i . n i m . n i h . g o v / g o r f / o r f i g . c g i ). T h e  b l a s t p  p r o g r a m  wa s  
u s e d  to  a l i g n  t h e  v a r i o u s  O R F s  a g a i n s t  p r o t e i n  s e q u e n c e  d a t a  o f  the  
G E N B A N K .  F i g u r e  3.1 b e l o w  is a c o m p l e t e  O R F  as  d e p i c t e d  in 
P l a s m o D B  and  t h e  s e q u e n c e  u s e d  in t h i s  s t u d y  a l so  f o u n d  at  N C B I  is 
s h o w n  in b l a c k  and  is l o c a t e d  at  t he  C - t e r m i n u s  o f  t he  P F 0 7 6 5 w  g e ne  
s e q u e n c e .
1 a t g a a a a t t a g a t a t g a c a a g t g c t c c a g t a c a a a a g a c c t a a a c  
M K I R Y D K C S S T K D L N  
4 6 t a c t t t t t t c a t t t a a a a t t a g g t t t t t t t g t t t g t t a t a a a a a t  
Y F F H L K L G F F V C Y K N  
9 1  c a c a a t g a t a a a t a t t c c t t t a a a a a t a a a a t c t t a c a a a a a a a t  
H N D K Y S F K N K I L Q  K N 
1 3 6  g a c a c t a t a t t a t t t t t t a a g a a a a a a a a g a a a t t c a t g t a t c t c  
D I  L F F K K K K K F M Y L
1 8  1 a g a a a a a a a a a a a a a a a a a a a a a a a a a a a a a t a c t c a t t c a g a t t  
R K K K K K K K K K I L I Q I  
2 2 6  a t a c a a g a a t a t a a t a a a t a t a a t g a a t a t t t t a a a t a t a a t t c a  
I  Q E Y N K Y M E Y F K Y N S
2 7  1 a a t t t a g a a g g t a a t c a a g g a t t c a a t a a a a a a c c a g a a a a a a a t  
N L E G N Q G F N K K P E K  H 
3 1 6  a a a a a c a c a a a a g g a a a t g t a t a t a c t g a t c a t a c a a a t c a a a a t  
K N T K G N V Y T D H T N Q  N 
3 6 1  g c a a a a t c a a a a a t a t a t a a t t a t g a t a t g a a t g a t g a t t c t t a t  
A K S K I  Y N Y D M N D D S Y  
4 0 6  t c t a a t t a t g t g a a c a a c a a t a a t g t t t t t a g a a t a t c a t c t t t t  













9 4  6
9 9 1
1 0 3  6
10 8 1
1 1 2  6
1 1 7 1
12  1 6
12 61
13 0 6
1 3 5  1
1 3  9 6
1 4 4  1
14 8 6
1 5 3  1
1 5 7  6
1 6 2  1
16 6 6
t t g a t a t t a a a t a a t g a a t t t t t t g g a t a t c c c c t t c a a t t t g t t  
L I  L N N E F F G Y P L Q F  V 
t g t g a a a c a g a a g g g a g a a g t a g g a a c c a t g a a c a t t a t c c g g a c  
C E T E G R S R  M H E H Y P D 
g t a c a t g g g g a t a a t a t t a a g t a t a a c a a a t g t g a t g a t a a t a a g
V H G D N I  K Y N K C D D  N I<
t a t a a c a a a t g t g a t g a t a a t a a g t a t g a t a a a t g t g a t g a t a a t
Y N K C D D N K Y D K C D D  N
a a g t a t a a c a a a t g t g a t g a t a a t a a g t a t g a t a c a t g t g a t g a t  
K Y N K C D D N K Y D T C D D  
a a t a a g t a t g a t a c a t g t g a t g a t a a t a a g t a t g a t a c a t g t g a t  
N K Y D T C D D N K Y D T C D  
g a t a a t a a g t a t a a c a a a t a t g a t g a t g a t a a g t a t g a t a c a t g t  
D N K Y N K Y D D D K Y D T C
g a t g a t a a t a a g t a t a a c a a a t a t g a t g a t .  g a t a a g t a t a a c a a a  
D D N K Y N K Y D D D K Y N K
Y D D D K Y N K Y D D D K
a  a  a  a  g  t  a  g  a  a  a  a  a  a  g  a  a  a  a  a  a  c  1 1 a a  t  a  a  t a  t  a
K S R K K K K L . N N L Y K
t  a  t  g  a  t  g  a  t  g  a  t  a  a  g t  a  t  a  a  c. a  a  a  t  a  t  g  a  t  g  a  t  g  a  t  a  a  g  t  a  t  g  a  a
Y E 
. a  a  c  c  a  t  a  
T I
1 1  a  a  c  a  a  a  a  a  a  a  a  a  a  a  g  a  a  a  a  a  a  a  a  t  g  a  a  c  t  c  t  a  a  1 1 1 .  a  t  g  t  g  t  a  
L T K K K R K K M  N S M L C V' 
a t a a a t a a a a t a t a c a a g t a t c c t a t a a a a t a t t g t g a a t t a a a t  
I N K I Y K Y P I K Y C E L N  
t c c a a a g c g t t t g t a t t t t t t a t t a t t a a a a a t g t a g g t g t t c a t
S K A F V F F I  I  K N V G V H
a a a a t a a c a t a t t a t t c a t a t a a t a a a t t a t t t t c g a a a g a t g g t  
K I T Y Y S Y N K L F S K D G  
g t t t t a a a t c a a g g a a t t c a a a t a t g c a a a c t t t a t c a t g t g a a c  
V L N Q G 1 Q I  C K L Y H V N  
a a a a a t a a a a a a a t t a a a c a a a t t a t t t t t g a a g c c t t g a a a a a t  
K N K K I K Q I  I F E A L K  II 
a a a a t a a c c t t t t c a t a t g a t a a c a a t c c a a a c a a t a t c a a g a a a  
K I T F S Y D N N P  N N I  K K
i t a t c a t g a t c t c
F L K K N C A Y H D L  
. t a t t t c a a g g g t c a c a a a c a a a g g g a a a a a t q t  
I  K L F Y F K G H K Q R E K C  
a a c a a a a a a t t a a a t a t g g a a a a a a c c t t t g g g g t g c a c a a a t c c  
N K K L N M E K T F G V H K S
S R Y N Y K T Y K K K K K I  D
a t g t g t a a a a a t t a t t g t g a t g a t a t a c t t g a t a c a t a t a a t a g t
M C K N Y C D D I L D T Y N S
a a a t a t t a c a a g g g t g a a t t a t c c g g g c a g c a t a a a c a t a t c a a g
K Y Y K G E L S  G Q H K H I  K
a t .  g a c g g g g g a a c a a a a a g a a g a g c a t .  c a t a t a a a a t a t a c a c a t
M T G E Q K E E H H I K  Y T H
t t g a a t t t t a a t c a t g g g a a a g a t g a a a c a t t t t a t a a a g a a t t a
L N F N H G K D E T F Y K E L
t a t a a a t g t a a t t a t a t t g a a a a a t a t a t a t c g t c t g t a a a t t a t
Y K C N Y I  E K Y I  S S V N Y
t t t t t a t t g g a g a g a a g a c g a a t g t t t a a c a a a t a t a a a c a a c a a
F L L E R R R M F N K Y K Q Q
g a g t t g t g t g t g a a c a a a a a t g a g g a g a a t a a t a a a a a t a a a a a t
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E L C V N K N E E N N K N K N 
g a t g a t g a t a a t a a a a a t g a t g a t g a t a a c a a a a a t g a t g a t g a t  
D D D N K N D D D N K N D D D  
a a t a a t a a a a a t g a t g a t g a t a a t a a a a a t g a t g a t g a t g a t a a t  
N N K N D D D N  K N D D D D N 
a  a  a  a  a  t  g  a  t  g  a  t. g  a  t  a  a  t  a  a  a  a  a  t  g  a  t  g  a  t  g  a  t  g  a  t  a  a  t  a  a  a  a  a  t  
K N D D D N K .  N D D D D N K N  
g a t g a t g a t g a t a a t a a t a a a a a t a a t a t t c a a t g t g a t a a c c a t  
D D D D N N K N N I  Q C D N H 
t  c  a  g  a  t  a  a  t  a  1 1 1  a  t  a  t  g  t  g  t  g  g  t  a  c  c. t. a  t  g  g  t  a  a  t  a  t  g  g  a  a  a  a  c  
S D N I Y M C G T Y G N M E N  
t a t a a t g t t c c t c a t a g t a c g a a t a a t a c a a a t c t c c a a t c c a t a  
Y N V P H S T N N T N L Q S I  
a  a  g  a  a  a  a  g  a  a  1 1  a  1 1 a  a  c  a. t  g  a  a  c  a  t  a  1 1  a  g  a  c  a  a  t  a  t  a  a  g  g  t  g  t; 
K K R I I N M N I L D N I R C  
a  a  t  a  a  a  a  c  1 1 a  c  a  a  a  t  a  c  a  1 1 g  a  t  a  a  a  a  a  t  a  a  a  1 1 c  a  a a t g t t t t  
N K T Y K Y 1 D K N K F  K C F
a c a t a t t a t t c a t g t a a a a a t t a t a a t g t a t g c a a a a a a a t t a t a  
T Y Y S C K N Y N V C K K I  I  
g a a  a a a t a t a a a c t t t a t a a a t t t t t a a a a a a a a a a a a a a t t g a a  
E K. Y K L Y K F L K K K K I  E
g g a t a c a t g a t t t t g a a t t t c c t t a a t t t t a a t a a a g a a t t a a t a  
G Y M I  L N F L N F M K E L I
t a t t a t a a t g a a c a t a a a a a a g a t a t g t c t a c a t t a c a t g a t a a t  
Y Y N E H K K D M S T L H D N  
1 1  a  1 1 1  g  a  t  g  t  a  a  1 1 1  c  c  a  a  t  a  a  t  c  a  a  a  a  t  g  a  a  a  a  t  g  t. g  a  a  a  t  a  t  
L F  D V  I  S N N Q N E N V K . Y
a a t c a t a t t t g t a a t a a t a a t a a g t a t g a t t g g t t t t t t a a t t c c  
N H I C N N N K Y D W F F N S  
t t t g a t t a t g t a g g t a a t c t a g a g g a a t c c a t c a c a t g t t t c a a t  
F D Y V G N L E E S I T C F N  
a a t c a c a a a a a a a a a g a a a a t a t g a a a a a t a t a a a a a a t a t a a a a  
N H K K K E N M K N I  K N I  K
a a a a a a a a a a a a a a a a a t t t g t t t t a c a a t g a a c a a c a t a a t a t a  
K K K K K N L F Y N E Q H  N I  
a a a a a t a a t a a a a a t g a t t a c c a t t t t g a t a a g t a t c c t t c t t c t  
K N N K N D Y H F D K Y P S  S 
t t a t a .  t a g t c a t t t a a c a a a t a a a a a a a t g g t a a a c a a t a c a g a g  
I, Y S H L T N K K M  V N N T E 
g t a a a t a a t a t a a a a g a t g a a a a t t c c c t t c a g a t g t a t a t t a t t  
V N N I  K D E M  S L Q M Y I  I  
a a t a a a g a t g t t a c a a a a a a t a a g g a t g g t a a c t t a c t a t t a a a t  
N K D V T K N K D G N L L L  N 
t c a t a t t a t a a t t c t a a a t t g g g t a a a t c a a t a a a t a c a t g t t c t  
S Y Y N S K L G K S I N  T C S
a a g g a a a t a t a t a a a g a g g a a c a t a a a a a t g t t t a t a t a t a t a a t  
K E I  Y K E E H K N V Y I  Y N
a  a  a  a  a  a  a  1 1  a  c  a  a  a  a  a  t  g  a  a t  a  t. a  a  a  a  a  t  g  a  a  g  a  c  g  g  a  a  c  a  a  a  a  a  
K K I T K M N I  K M K T E Q K  
t a t a t c t g c g t c g a t t c g a a a a g g a a t a c a a g a a c a t a t a a t a g t  
Y I C V D S K R N T R T Y N S  
a a a a a c a t a c g a a c a t a t a a t a g t a a a a a o a t a c g a a c a t a t a a t  
K N 1 R T Y N S K N I R T Y N  
a g t a a a a a c a t a c g a a c g t a t a a t a g g a a a a a c a t a c g a a c g t a t  
S K N I  R T Y N R K N I  R T Y
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2 9 2  6 a a t a g g a a a a a c a t a c g a a c g t a t a a t a g g a a a a a c a t a c g a a c g  
N R K N  I  R T Y N R K N I  R T  
t a t a a t a g g a a a a a c a t a a g a t g t a a t a a c a g a a a a a a a t t c c a t  
Y N R K N I R  C N N R K K F H
c t a a a t a g a a a t a a a a a a a a a a a t g g t t g t g t a a a a a a a t a c a a a  
L N R N K K K N  G C V K K Y K
t t a t a t g a t g a a a g g a a t a c c t t g g t a t a t a a g a a c a a a a t a g g g
T I i V  Y K N K I  G 
t t t g a a g g a a g a a a t t g g a a a a a g t a c a a a a  
K E E I G K S T K  
a a g t t g a a c g a t a t a t t t g a a c a t a t a a g t a a c t a t a c a a a t c g t  
K L N D I  F E H I  S N Y T N R
a t t a g t a a g a a t a t a a a t a t a a c a a a t a a a a a t a g a t a t g a t g a t  
1 S K N I N I T N K N R Y D D  
t a t c c t t t t g a t t t t t t g t c a a a a g a t a a a a t t g a a t a t a t c t c t  
Y P F D F L S K D K I E Y I S  
a t g t t a t c a c c a a c t a t a a a c g a g a t t a a a a c a t t a a a t a c t a t t  
M L S P T I N E  I K T L N T I
L Y D E R N
a g t a a c c a t
S M H F F L
c t t a c c a t t c c a c t t a t t a a a a t g a a t g a g t a t g a a a a a a a t t g t
L T I P L I K M N E Y E K N C
a t a t g g a g a t t c a g a t t t c a a t t a t t a a a t a g a a a a g a g a c c t t a
I  W R F R F Q L L N R R E T L  
g g a a a a t t c c t a a a a t c t a t t a a t t g g a a t a a t a a a g a a g a a g a a  
G K F L K S  I N W N N K E E E  
g a a g a a g c c a t a a t t t t a t t a a a t a a g t g g g c a a a a c c a g g t a t a  
E E A I  I  L L N K W A K P G I  
g a g a a t t g t a t a g a a t t a t t t t a t t c a c a t c t a c a t c a t t a t g t t  
E N C I E L F Y S H L H H Y V  
a t t a a a a a a t a t a t t a t a g a t a t t a t a a a g a a t a g t a a a a a a q a a  
I K K Y I I D I I K N S K K E  
g a a a t c a a a t t a t a t c t a t t t c a a t t g g t c c a a a g t t t a a g a a c t  
E I K L Y L F Q L V Q S L R T
1 1 1  a  a  1 1 a  t  c  a  a  c  a  t  a  t  a  g  a  t. a  a  t  c  t  a  1 1 1  a  1 1 a  a  t  a  c  1 1 1 a  a  t  a  
F N Y Q H I D N L  F I N T L I  
c  a  a  a  a a  t  g  t  a  1 1  a  a  a  t  c  a  a  a  a  a  a  a  c. t  a  t  c  c  a  t  a  t  a  1 1 1 1 1 a  1 1; g  g  
Q K C I K S K K L S I Y F Y W  
t t t t t a t t a a g t g a a g c g a a a g a t a a a a t t a a a g g c a a a t t g t a t  
F L L S E A K D K X K G K L  Y
I I  a  c  a  t  a  t  a  c  a  t  a  a  a  1 1  a  1 1 .1. a  1 .1  a  a  t  a  a  at 1 1  a  a  t  g  a  c  1 1 c  t  a  a  t
L H I  H K L F I N K L M T S N
a t t a g a  a  a  a  a  a  t  a  a  a  a 1 1  a t c c t  ^ci 8. cl 8. 0. cl t  C cl cl cl cl C
I  R K N K I  I L D I L K N Q N
c  g  1 1 1  c  c  g  t  a  a  t  c  a  a  1 1 a  1 1  a  t  a  t  c  t  a  a  c  a a  a  a  a  1 1  g  c  c  a  a g  a  a  t  
R F R N Q L L Y L T K I  A  K ’ N
a a a a c a g a c a g a a t a c a a a a t a a a a c c a g a a a a t t a a g a a a c t t t
K T D R 1 Q N K T R K L R N F
c  t  a  1 1 t  t c  t  a  a  1 1  a t g g a t a t a t a a a t a t c  a  a  a  g  a  c
L F Y Y R T N Y G Y I  N I k  b
t t t a t a a a a a a t a a t a t t t t t a t a t c t g a t c a t a a t g t c t a t g a t
F I  K N N I  F I  S D H N V Y D
t t t t t g g a t a t a t g t a a a a t g a a a a g g g a a a a t t c g c t g g a t a c t
F L D 1 C K M K R E N S  L O T
c c t a t g a g g g g t g a t a a c a t t g g t c a a c c t a g t t a c c t g g g a a t g
P M R G D N I G Q P S Y L G M
g t c c c t g g t a t g g g t a a a t c c a c t g a c g a t a g t a a a a a t g t t t a c
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V P G M G K S T D D 3 K N V Y
g g  t  g  a  t  g  a  t  a  a  t  a  a  a  a  a  t  g  t 1 1  a  t  g  g  t  g  a  t  g  a  t  a  a  t  a  a  a  a  a  t  g  1 1
G D D N K N V Y G D D N K N V
t a t g g t g a c g a t a g t a a a a a t a t t t a t t g t g a c g a t a a t a a a a a t  
Y G D D S K N I Y C D D N K  N 
g  1 1 1 .  a  t  g  g  t  g  a  t  g  a  t  a  a  t  a  a  a  a  a  t  a  1 1 .1  a  t  g  g  t  g  a  c  g  a  t  a g  t  a  a  a  
V Y G D D N K N I Y G D  D S K 
a a t a t t t a t g g t g a c g a t a a t a a a a a t a t t t t t a g t g a t g a t a a t ,  
N I  Y G D D N K H I  F  S D D N
a a a a a c c t t t a t a g t g a c a a t a a t a a t a a t a a a c a c a t a a g a t a t  
K N I, Y S D N N N N K H I  R Y
a a t a a g t a c g t a a a a a a t a t a t c c t a t g a a c a c t t t a a t g a a t a t  
N K Y V R N 1 S Y E H F N E Y  
c c t t a c g a t a a t a a a a a g a g t a g a a a t a t a t a t a c a t g t a a t a a a  
P Y D N K K S R N I Y T C  N K 
g  a  t  a  t  a  t  g  t  a  a  1 1 c  t  a  1 1 1 a  1 1  a  1 1 . 1  a  g  a  t  a  a  c  g  a  a  c  1 1  a  c  a  a  t  a  
D I C N S I Y Y L D N E L T I  
a a t t a t g a t a t a a a a g a t g a t t t a t a t t t t t t t c a a t a t a a a a g a  
M Y D I  K D D L Y F  F  Q Y K R
a g t t c a g a t g a a a a a t t a t t a a a t a c a  g a t t t a a g t a a t g a t t c t  
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K K N R K K Y N E I Y Q L S I  
a a a a a g t a t a t c t a t a a a g c a g g t g a t g a t t t a a g a c a a g a t c a t  
K K Y I Y K A G D D L R Q D H
L V I Q I  I  Y V M D N I W K R  
t a t g g t t t g g a t t t a a a a a t g a c a c t a t a t a g a g t a t t a g c g t t a  
Y G L D L K M T  L Y R V L A L  
t c g a c a g a t g a t g g t t t t a t t g a a t t t g t g g a t t a t g c a g a a t c t
D D V DF I
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a t t a g c t t g t t a g a t g c a a t g  
L R Y H S Q L I  I S L L D A M  
t g t g a t g c a g g a t t a a a g g a t a t g a a a a t g a g t c c a g a g t t a t g t  
C D A G L K D M K M S P E L C  
g t c t t a a a a g t a c a a g a a a a a t t t a g a c t t g a t t t a a a t g a t g a a  
V L K V Q E K F R L D L N D E  
g c a g c a g a a a t t t a t t t t c t t a g t g t t a t c a a t g c a t c c g t t a a a  
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a n n o t a t e d  in P l a s m o D B .  T h e  O R F  i d e n t i f i e d  in A p r i l  2001 and w h i c h  is 
t he  s u b j e c t  o f  t h i s  s t u d y  is s h o w n  in b l a c k .  T h e  s e q u e n c e s  u s ed  f o r  the  
d e s i g n  o f  t h e  p r i m e r s  a re  u n d e r l i n e d  and  c o l o u r e d  b lue .
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3 . 1 . 1  T he  b l a s t p  r e s u l t s  o f  t he  o p e n  r e a d i n g  f r a m e
T h e  b l a s t p  p r o g r a m  w a s  u s e d  to  c o m p a r e  t h e  O R F  o f  t he  C - t e r m i n u s  
u s e d  in t h i s  s t u d y  a g a i n s t  t h e  G e n b a n k .  The  d e s c r i p t i o n s  and  E v a l u e s  
o f  t h e  t o p  t e n  s e q u e n c e s  p r o d u c i n g  s i g n i f i c a n t  a l i g n m e n t  o b t a i n e d  are  
s h o w n  b e l o w ;
s p 1P 5 4 6 7 6 1P3K 4 P H O S P H A T ID Y L IN O SIT O L  3 -K IN A S E  V P S 3 4 - l i k e
g b |A A B 7 1 9 7 1 . 1 | (A C 0 0 2 2 9 2 )  P h o s p h a t i d y l i n o s i t o l  3 - k i n a s e
( A r a b i d o p s i s  t h a l i a n a )
P H O SPH A T ID Y L IN O SIT O L  3 -K IN A S E
(P I 3 - K I N A S E )
r e f | N P  0 7 5 2 4 7 .1 1  p h o s p h a t i d y l i n o s i t o l  3 - k i n a s e  
( R a t t u s  n o r v e g i c u s )
p i r 1 | T 0 8 4 2 0  1 - p h o s p h a t i d y l i n o s i t o l  3 - k i n a s e
r e f  1XP 0 0 8 7 8 8 . 3  | p h o s p h o i n o s i t i d e - 3 - k i n a s e ,  c l a s s  3 
(Hom o s a p i e n s )
s p |P 4 2 3 4 7 |P 3 K 1  SOYBN PH O SPH A T ID Y L IN O S IT O L  3 -K IN A S E  
( r o o t  n o d u l e )
s p |P 4 2 3 4 8 |P 3 K 2  SOYBN P H O S P H A T ID Y L IN O SIT O L  3 -K IN A S E  
( r o o t  n o d u l e )
p i r [ 1 S 5 7 2 1 9  p h o s p h a t i d y l i n o s i t o l  3 - k i n a s e  -  h u m a n
r e f [NP 0 0 2 6 3 8 .1 1  p h o s p h o i n o s i t i d e - 3 - k i n a s e ,  c l a s s  3 ;  V p s 3 4
S c o r e  E v a l u e  
4 e - 7  0
3 e - 6 9
3 e - 6 9
3 e - 6 8
3 e - 6 8
3 e - 6 8
3 e - 6 8
8 e - 6 8
2 e - 6 7
2 5 7  2 e - 6 7
The  t o p  a l i g n m e n t  o f  P. f a l c i p a r u m  O R F  w i t h  t h e  m o s t  s i g n i f i c a n t  
a l i g n m e n t  ( l o w  E v a l u e s )  in t h e  b l a s t p  s e q u e n c e  o f  A p r i l  2001 is s h o w n  
b e l o w .  T h e  q u e r y  s e q u e n c e  r e f e r s  t o  t he  P. f a l c i p a r u m  O RF  s e q u e n c e ,  
w h i l s t  t he  s u b j e c t  r e f e r s  to  t he  G e n b a n k .  T h e  p o s i t i v e  s ign  (+)  b e t w e e n  
t he  q u e r y  and  s u b j e c t  s e q u e n c e  i n d i c a t e s  s p e c i f i c  a m i n o  a c i d  r e s i d u e s  
t h a t  b e l o n g  t o  t he  s a m e  c l a s s  and  h a v e  a s i m i l a r  3 - D  s t r u c t u r e .
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s p I P 5 4 6 7 6 1P 3K 4 D IC D I P H O S P H A T ID Y L IN O SIT O L  3 -K IN A S E  V P S 3 4 -L IK E  
( P I 3 -K IN A S E )
p i r |  |A 5 9 0 0 3  p h o s p h o i n o s i t i d e  3 - k i n a s e  -  s l i m e  m o l d  ( D i c t y o s t e l i u m  
d i s c o i d e u m )
q b |A A A 8 5 7 2 6 .1 1  ( U 2 3 4 8 0 )  p h o s p h a t i d y l i n o s i t o l  3 - k i n a s e  [ D i c t y o s t e l i u m
d i s c o i d e u m ]
L e n g t h  =  8 1 6 ,  S c o r e  =  2 6 6  b i t s  ( 6 8 0 ) ,  E x p e c t  =  4 e - 7 0
I d e n t i t i e s  =  1 2 6 / 2 5 5  ( 4 9 % ) ,  P o s i t i v e s  =  1 7 5 / 2 5 5  (68% )
Q u e ry :  33 2  IYKAGDDLRQDHLVIQIIYVMDNIWKRYGLDLKMTLYRVLALSTDDGFIEFVDYAESISS 391 
I+ K  DDLRQD L + IQ + I +MD + K+ LDLK+T Y+VLA + +DG +E V+ +E+++S 
S b j c t : 5 6 1  IFKTNDDLRQDQL11QLISLMDRLLKKENLDLKLTPYKVLATAEEDGIVEMVNPSEAMAS 620
Q u e ry :  39 2  IKKNYKGEIRQYFIDNSTCSSSPLGFDTEILQNFISSCAGYSVITYILGIGDRHLDNLMV 451 
+ Y G +I ++F ++ + SP G E++ F+ SCAGY VITYILGIGDRHLDNL++
S b j c t :  621  VLSKYDGDILKFFKTHNPDADSPYGIAPEVMDTFVKSCAGYCVITYILGIGDRHLDNLLL 680
Q u e ry :  452  TKDGRFFHIDFGYIFGEDPKPFSPPMKLCKEMIEAMGGAHSIGYEQFLKKCCLAYKYLRY 511  
T +G+ FHIDFGYI G+DPK PPMKLCKEM+ MGG +S YE+F + CC AY LR 
S b j c t :  681  TPNGKLFHIDFGYILGKDPKILPPPMKLCKEMVLGMGGENSKHYEKFKQLCCEAYNILRK 740
Q u e ry :  5 1 2  HSQLIISLLDAMCDAGLKDMKMSPELCVLKVQEKFRLDLNDEAAEIYFLSVINASVKTLF 571  
S L I+ + L  M DA + + E +LKVQEK +L+L D+ A L ++N SV LF
S b j c t :  7 4 1  SSHLILNLFALMVDASIPSISDDKEKSILKVQEKLQLELTDQEASNSLLQLLNDSVTALF 800
Q u e ry :  572  PWVDKLHEWALNWK 58 6  
PV+++ H+W WK 
S b j c t :  801  PVIIEMAHKWLQYWK 815
S c o r e  = 3 3 .9  b i t s  ( 7 6 ) ,  E x p e c t  = 3 .9
I d e n t i t i e s  = 1 5 /5 9  ( 25%) ,  P o s i t i v e s  = 3 5 /5 9  ( 58%) ,  G ap s  = 1 4 /5 9  (23%)
Q u e ry :  53  SINFVQKQKIKKIKT----------------------------PLILPIDPNIELLSFLPEQSYVLRSSLYPI 97
++N +++KI+K++ P+ L P++P+IE + +  +PE+S + +S+ P+
S b j c t :  488  AMNITREKKIEKLRIMLAEGEYKDLSDFQPIRLPVNPDIEIIGIVPEKSNIYKSAKSPL 5 4 6
T h e  a m i n o  t e r m i n u s  o f  t h e  P f P I 3 K  d o e s  no t  s h ow  s i g n i f i c a n t  s i m i l a r i t y  
to o t h e r  P I 3 K  in o t h e r  o r g a n i s m s .
3.2 P r i m e r  des ig n  for  P I3 K  a m p l i f i c a t i o n  by PCR
P r i m e r s  s p e c i f i c  f o r  P f P I 3 K  w e r e  d e s i g n e d  u s i n g  t he  s e q u e n c e  
i n f o r m a t i o n  o b t a i n e d  in t he  O R F  ( s e c t i o n  3 . 1) .  To  f a c i l i t a t e  d i r e c t i o n a l  
c l o n i n g  i n t o  an  e x p r e s s i o n  v e c t o r  a d d i t i o n a l  n u c l e o t i d e s  f o r  t he  B a m  HI  
r e s t r i c t i o n  s i t e  and  t h e  H i n d  I I I  r e s t r i c t i o n  s i t e  w e r e  a d d e d  to  t he  s e n s e
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and  a n t i s e n s e  p r i m e r s  r e s p e c t i v e l y .  T h e  p r i m e r  s e q u e n c e s  d e s i g n e d  w e r e  
as f o l l o w s :  B a m  H I  r e s t r i c t i o n  s i t e  d e n o t e d  in b l u e  u n d e r l i n e d  p r i n t  and 
H i n d  I I I  r e s t r i c t i o n  s i t e  by r ed  u n d e r l i n e d  p r i n t .
P r i m e r  f or  t he  s e n s e  s t r a n d :
T m= 5 9.1 °C
A m i n o  a c i d  s e q u e n c e :  I H Y I D D
Bam H I
P r i m e r  s e q u e n c e :  s ' c a t  c a c  g g a  t c c  a t t  c a t  t a t  a t t  g a t  g a t
P r i m e r  f o r  t h e  a n t i s e n s e  s t r a n d :
T m= 6 0 . 5°C
A m i n o  a c i d
s e q u e n c e :  E W A L N W K
Hind III
C o d i n g  s e q u e n c e :  5 '  g a g  t g g  g c c  t t a  a a t  t g g  a a a  a a g  c t t  a a t  t a g 3 '
Hind III
C o m p l e m e n t a r y :  3 ' c t c  a c c  c g g  a t t  t t a  a c c  t t t  t t c  g a a  t t a  a t c  5 '  
S e q u e n c e
Hind III
P r i m e r  s e q u e n c e :  5 ' c t a  a t t  a a g  c t t  t t t  c c a  a t t  t t a  g g c  c c a  c t c  3 '  
P r i m e r  p o s i t i o n s  in p Q E - 8 0 L :
5 ' -PRO M OTER R E G IO N -X h o l-O P E R A T O R  1-TA ACAA TTA T AATAGATTCA 
S e n s e  p r i m e r
5 '- C G  GATAACAATT T C A C A C A G -3 '
ATTGTGAGCG GATAACAATT TCACACAGAA T T C A T T -R B S ~ M E T -A R G -G L Y -S E R -6 x H IS  T A G -B am  
H1 - S p h l - S  a c l - K p n l - S m a 1 - S a 1 1 - P s  t l - H i n d i  1 1 -A A T T A G C T G A  GCTTGGACTC CTGTTGATAG 
ATCCAGTAAT GACCTCAGAA C - 3 '
3 ' -G G TC A TT ACTGGAGTCT T G - 5 ' 
a n t i s e n s e  p r i m e r
s
T C T  3 '
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3 . 2 . 1  O p t i m i s a t i o n  o f  P C R  u s i n g  t he  PCR M a s t e r  E n z y m e  S ys te m®
T h e  P C R  r e a c t i o n  w a s  o p t i m i s e d  by m o d i f y i n g  e x p e r i m e n t a l  v a r i a b l e s  
t h a t  i n f l u e n c e  s p e c i f i c i t y  and  y i e l d  o f  t he  d e s i r e d  p r o d u c t .  T h e r e f o r e  
a n n e a l i n g  t e m p e r a t u r e ,  p r i m e r  c o n c e n t r a t i o n s  and D N A  c o n c e n t r a t i o n s  
w e r e  i n v e s t i g a t e d  t o  a c h i e v e  o p t i m u m  c o n d i t i o n s  fo r  t he  P C R  r e a c t i o n s .  
T h e  D N A  u s e d  f o r  t he  P C R  r e a c t i o n s  w a s  i s o l a t e d  f r o m  t he  3D7  s t r a in  
o f  P. f a l c i p a r u m .
2 642  bp 
1 500
MWM 1 2 3 4 5
1 812 bp
F i g u r e  3 .2 :  P C R  o f  P I 3 K  at d i f f e r e n t  a n n e a l i n g  t e m p e r a t u r e s .  Th e
P C R  p r o d u c t s  o b t a i n e d  u s i n g  p r i m e r s  d e s i g n e d  fo r  P f P I 3 K  o v e r  a r a n g e  
o f  a n n e a l i n g  t e m p e r a t u r e s  a re  r e p r e s e n t e d  as f o l l o w s :
1 = 5 8°C,  2 = 6 1 °C,  3 = 62°C, 4 = 63°C, 5 = 6 4° C .
T h e  p r o m i n e n t  b a n d  o b t a i n e d  at  t he  d i f f e r e n t  a n n e a l i n g  t e m p e r a t u r e  
( 5 8 - 6 2 ° C )  w a s  1 812 bp,  w h i c h  w a s  m o r e  t h a n  t h e  e x p e c t e d  b a s e  p a i r  
l e n g t h  (1 758 bp )  s i n c e  t he  r e s t r i c t i o n  s i t e s  and  a d d i t i o n a l  n u c l e o t i d e s  
wi l l  be  i n c l u d e d .  D o u b l e  b a n d s  at  1 812  bp w e r e  n o t e d  at  t he  l o w e r  
a n n e a l i n g  t e m p e r a t u r e s  ( 5 8 - 6 2 ° C ) .  M i n o r  b a n d s  o f  900  bp and 4 0 0  bp
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w e r e  a l so  o b s e r v e d  in t he  r e a c t i o n s .  T h e  m o s t  s p e c i f i c  a n n e a l i n g  
t e m p e r a t u r e  w a s  s h o w n  to  be 6 4 ° C  h o w e v e r  t he  P C R  p r o d u c t  d e c r e a s e d  
s i g n i f i c a n t l y  as  64°C is h i g h e r  t h a n  t h e  Tm f o r  t he  p r i m e r s .
MWM 1 2  3
1 812 bp
F i g u r e  3 . 3 :  O p t i m i s a t i o n  o f  p r i m e r  an d  D NA  c o n c e n t r a t i o n  P C R
p r o d u c t s  w e r e  o b t a i n e d  w h e n  v a r y i n g  t h e  p r i m e r  and  D N A  c o n c e n t r a t i o n  
w i t h  an a n n e a l i n g  t e m p e r a t u r e  o f  6 4 ° C  and  u s i n g  t h e  P C R  M a s t e r  Kit®. 
The  l a n e s  w e r e  r e p r e s e n t e d  as  f o l l o w s :
1 = 0.5 p g / 2 5  p i  D N A  c o n c e n t r a t i o n /  0 .5  p M  p r i m e r  c o n c e n t r a t i o n ,
2 = 0.5 p g / 2 5  p i  D N A  c o n c e n t r a t i o n /  0.1 p M  p r i m e r  c o n c e n t r a t i o n ,
3 = 1 p g / 2 5  p i  D N A  c o n c e n t r a t i o n /  0.1 p M  p r i m e r  c o n c e n t r a t i o n .
L o w e r  p r i m e r  (0.1 p M )  and  h i gh  D N A  ( l p g )  c o n c e n t r a t i o n s  p r o d u c e d  a 
m o r e  p r o m i n e n t  b a n d  at  1 812  bp (3) .  M i n o r  b a n d s  w e r e  a l so  p r o d u c e d  
( 6 0 0  bp ,  30 0  bp )  w h e n  a p r i m e r  c o n c e n t r a t i o n  o f  0.5 p M  w as  used .
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3 . 2 . 2  P C R  u s i n g  t h e  E x p a n d  H i g h  F i d e l i t y  E n z y m e  Sy s te m®
T h e  E x p a n d  H i g h  F i d e l i t y  P C R  s ys t em® c o m p o s e d  o f  a t h e r m o s t a b l e  
Taq D N A p o l y m e r a s e  and  a p r o o f  r e a d i n g  p o l y m e r a s e ,  P w o  D N A  
p o l y m e r a s e  w a s  u s e d  a f t e r  o p t i m i s i n g  t he  c o n d i t i o n s  f o r  t e m p l a t e  and  
p r i m e r s .  T h e  e n z y m e  s y s t e m  is d e s i g n e d  to g i v e  P C R  p r o d u c t s  w i t h  h i gh  
y i e l d s  and  s p e c i f i c i t y .  F i g u r e  3 .4  d i s p l a y s  t h e  P C R  p r o d u c t s  o b t a i n e d  
f r o m  t h e  t w o  e n z y m e s  u sed .
1 2  MWM 3 4
F i g u r e  3 . 4:  C o m p a r i s o n  o f  P C R  p r o d u c t s  o b t a i n e d  u s i n g  the  PCR  
M a s t e r  E n z y m e  s ys t e m® an d  the  E x p a n d  H i g h  F i d e l i t y  E n z y m e
s ys t e m®.  T h e  l a n e s  w e r e  r e p r e s e n t e d  as  f o l l o w s :
1 & 2 = P C R  M a s t e r  p r o d u c t  
3 & 4 = E x p a n d  H i g h  f i d e l i t y  s y s t e m  p r o d u c t
T h e  P C R  M a s t e r  E n z y m e  Sys t em® p r o d u c e d  a d i s t i n c t  d o u b l e  b a n d  at 
t he  e x p e c t e d  l e n g t h  o f  1 812  bp ( l a n e s  1 and  2) ,  w h i l e  t he  P C R  
r e a c t i o n s  u s i n g  t h e  E x p a n d  H i g h  F i d e l i t y  E n z y m e  sys t em® p r o d u c e d  a
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s i n g l e  p r o m i n e n t  b a n d  at  t he  e x p e c t e d  l e n g t h  o f  1 812  bp l a n e s  3 and  
4) .  D o u b l e  b a n d s  w e r e  o b s e r v e d  w h e n  u s i n g  t he  P C R  M a s t e r  kit® d ue  to 
t h e  l a ck  o f  f i d e l i t y  o f  t he  e n z y m e  s y s t e m .
3 . 2 . 3  S e q u e n c i n g  o f  t he  P f P I 3 K  P C R  p r o d u c t
T h e  P f P I 3 K  P C R  p r o d u c t  o b t a i n e d  u s i n g  E x p a n d  H i g h  F i d e l i t y  E n z y m e  
sys t em® w a s  s e q u e n c e d  f r o m  b o t h  e n d s  o f  t he  O RF  t o  v e r i f y  t he  
n u c l e o t i d e  s e q u e n c e  ( F i g u r e  3 .5) .
-
G A T C  G A T C  G A T C
F i g u r e  3 . 5 :  D N A  s e q u e n c e  o f  P C R  p r o d u c t .  A u t o r a d i o g r a m  o f  
s e q u e n c e d  P C R  p r o d u c t s  are  s h o w n .  T h e  p r i m e r s  u s e d  w e r e  d e s i g n e d  
f r o m  t h e  s e n s e  and  a n t i s e n s e  s t r a n d s  o f  t he  O RF  o f  c o n t i g  P 4 2 3 3 6 .  The  
r e a c t i o n s  w e r e  l o a d e d  in t h e  o r d e r  o f  G,  A,  T,  C.
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The  n u c l e o t i d e  s e q u e n c e  o b t a i n e d  w a s  u s e d  in t he  b l a s t n  s e a r c h  o f  t he  
P l a s m o D B  ( h t t p / / :  w w w . p l a s m o d b . o r g ) to d e t e r m i n e  t h e  i d e n t i t y  o f  t he  
s e q u e n c e .  T h e  s e q u e n c e  o b t a i n e d  o f  P f P I 3 K  u s i n g  p r i m e r s  fo r  t he  s e n s e  
s t r a nd :
5 ' TTACAATTTA ATCATAATTT AGATTTTTTT TTAAATGCTA CTTATAGTGA TGAAGATAAT 
AATTATGAAA TATTAGATGA CTCTATAAAT TTTGTTCAGA AACAAAAAAT TAAAAAAATA 
AAAACACCTT TAATTTTACT ATAGATCCTA ATATTGAATT ATTAATCTTT CTTACCTGAA 
GAATCATAT C T A 3 '
T h e  p a i r w i s e  a l i g n m e n t  w h i c h  had  t h e  m o s t  s i g n i f i c a n t  s i m i l a r i t y  
( l o w e s t  E v a l u e )  o f  t he  s e q u e n c e  o b t a i n e d  u s i n g  t h e  p r i m e r  f o r  t he  
s e n s e  s t r a n d  is s h o w n  b e lo w :
> g i / 9 7 7 3 9 9 7 7  P .  f a l c i p a r u m  3 D 7  G E N O M I C  p f a l _ c h r 5  
L e n g t h  =  1 , 3 4 3 , 5 5 2
P l u s  S t r a n d  H S P s :
S c o r e  =  9 6 0  ( 1 5 0 . 1  b i t s ) .  E x p e c t  =  6 . 0 e - 3 8 ,  P =  6 . 0 e - 3 8
I d e n t i t i e s  = 1 9 0 / 1 9 2  ( 9 8 % ) ,  P o s i t i v e s  =  1 9 0 / 1 9 2  ( 9 8 % ) ,
S t r a n d  =  P l u s  /  P l u s
Q u e r y :  1 TTACAATTTAATCATAATTTAGATTTTTTTTTAAATGCTACTTATAGTGATGAAGATAAT 60
I I M I I I I II II I I I I II  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
S b j c t : 6 3 3 6 9 5  TTACAA.TTTAATGATAATTTAGATTTTTTTTTAAATGCTACTTATAGTGATGAAGATAAT 63 3 7 5 4
Q u e ry :  61 AATTATGAAATATTAGATGACTCTATAAATTTTGTTCAGAAACAAAAAATTAAAAAAATA 120
I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I II  I I I I I I I II I I I I I I I I I I I I I I I I I
S b j c t :  6 3 3 7 5 5  AATTATGAAATATTAGATGACTCTATAAATTTTGTTCAGAAACAAAAAATTAAAAAAATA 63 3 8 1 4
Q u e ry :  121  AAAACACCTTTAATTTTACCTATAGATCCTAATATTGAATTATTATCTTTCTTACCTGAA 180
I I II I I I I I I I I I I I I II II II I I II I I I I I I I I I II I I I I I I I I II I I I I I I I I I I I I I
S b j c t :  6 3 3 8 1 5  AAAACACCTTTAATTTTACCTATAGATCCTAATATTGAATTATTATCTTTCTTACCTGAA 633874
Q u e ry :  181  GAATCATATCTA 192
I I I I I I I I II
S b j c t :  6 3 3 8 7 5  CAATCATATGTA 6 3 3 8 8 6
T h e  s e n s e  s e q u e n c e  o b t a i n e d  fo r  t he  P f P I 3 K  w i t h  p r i m e r  f o r  t he  
a n t i s e n s e  s t r a nd :
5 'T A C C A T T C T C  AATTAATTAT TACCTTGTTA GATGCAATGT GTGATGCAGG ATTAAAGGAT 
ATGAAAATGA GTCCAGACTT ATGTGTCTTA AAAGTACAAG AAAAATTTAG ACTTGATTTA 
AAT CAT GAAG CAGCAGAA 3 '
69
T h e  p a i r w i s e  a l i g n m e n t  w i t h  t h e  m o s t  s i g n i f i c a n t  s i m i l a r i t y  ( l o w e s t  E 
v a l u e )  u s i n g  t h e  p r i m e r  f o r  t he  a n t i s e n s e  s t r a n d  w i t h  c o n t i g  P 4 2 3 3 6  is 
s h o w n  b e l o w :
> g i I  2 3 5 0 4 5 7 0 [ e m b |A L 9 2 9 3 5 2 . 1 1 P F A 9 2 9 3 5 2  p l a s m o d i u m  f a l c i p a r u m  s t r a i n  3 D 7 , 
c h r o m o s o m e  5 ,  s e g m e n t  2 / 4  
L e n g t h  =  3 1 3 0 5 0
S c o r e  =  2 5 8  b i t s  ( 1 3 0 ) ,  E x p e c t  =  2 e - 6 6
I d e n t i t i e s  =  1 3 6 / 1 3 8  ( 98%)
S t r a n d  =  P l u s  /  P
Q u e ry : 1
S b j c t : 2 8 8 1 5 0
Q u e ry : 61
S b j c t : 2 8 8 2 1 0
Q u e ry : 121
S b j c t : 2 8 8 2 7 0
t a c c a t t c t c a a t t a a t t a t t a c c t t g t t a g a t g c a a t g t g t g a t g c a g g a t t a a a g g a t  60 
I I I I!  I I I I! I I I II I I I I  I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
t a c c a t t c t c a a t t a a t t a t t a g c t t g t t a g a t g c a a t g t g t g a t g c a g g a t t a a a g g a t  2 8 8 2 0 9
a t g a a a a t g a g t c c a g a c t t a t g t g t c t t a a a a g t a c a a g a a a a a t t t a g a c t t g a t t t a  120
I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I II I I I I I I I I I I I I II I I I I I I I I I I I 
a t g a a a a t g a g t c c a g a g t t a t g t g t c t t a a a a g t a c a a g a a a a a t t t a g a c t t g a t t t a  2 8 8 2 6 9
a a t g a t g a a g c a g c a g a a  138 
I I I I  I I I I I I II I I I I I I 
a a t g a t g a a g c a g c a g a a  2 8 8 2 8 7
T h e  b l a s t n  r e s u l t s  o f  t h e  m a n u a l  s e q u e n c i n g  d a t a  c o n f i r m e d  the  
s e q u e n c e  t o  be  p a r t  o f  t h e  O RF  i d e n t i f i e d  in c o n t i g  P 4 2 3 3 6 .  The  
s e q u e n c e  is p a r t  o f  t h e  C - t e r m i n a l  end  o f  t h e  P f P I 3 K  s e q u e n c e .  The  
s e q u e n c e  d a t a  o b t a i n e d  is n o t  100 % i d e n t i c a l  t o  t he  P l a s m o D B  
s e q u e n c e ,  t h i s  ma y  r e s u l t  in t he  m i s i n c o r p o r a t i o n  o f  a m i n o  a c i d s  in 
p r o t e i n  e x p r e s s i o n  r e s u l t i n g  in a d i f f e r e n t  a m i n o  a c i d  b e i n g  e x p r e s s e d .
3.3 C l o n i n g  o f  P f P I 3 K  p r o d u c ts  into an e x p r e s s i o n  ve c to r
T h e  P f P I 3 K  P C R  p r o d u c t s  w e r e  c l o n e d  i n t o  t he  p Q E - 8 0 L  e x p r e s s i o n  
v e c t o r  in a d i r e c t i o n a l  m a n n e r .  T h e  c o l o n y  c o u n t s  o b t a i n e d  are  s h o w n  
b e l o w  in T a b l e  3.1 .
T h e  h i g h  c o u n t s  o b t a i n e d  f o r  t he  p l a s m i d  p o s i t i v e  c o n t r o l  i n d i c a t e d  t ha t  
t he  t r a n s f o r m a t i o n  o f  t h e  c o m p e t e n t  D H 5 a  c e l l s  w i t h  t he
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p Q E - 8 0 L  v e c t o r  w a s  s u c c e s s f u l .  T h e  p l a s m i d  n e g a t i v e  c o n t r o l  had  no 
c o l o n i e s  i n d i c a t i n g  t h a t  t h e  r e s t r i c t i o n  d i g e s t e d  v e c t o r  d id no t  
r e c i r c u l a r i s e  ( T a b l e  3 . 1 ) .
T a b l e  3 . 1:  T he  c o l o n y  c o u n t s  o b t a i n e d  f r om  t he  t r a n s f o r m a t i o n  o f  
c o m p e t e n t  D H 5 a  E s c h e r i c h i a  c o l i  c e l l s .
P C R  p r o d u c t  i n s e r t  
( s a m p l e s )




P l a s m i d  n e g a t i v e  c o n t r o l 0
P l a s m i d  p o s i t i v e  c o n t r o l 1586
T h r e e  d i f f e r e n t  H i g h  F i d e l i t y  P C R  r e a c t i o n s  w e r e  c l o n e d  t o  c h e c k  fo r  
m u t a t i o n s  and  m i s i n c o r p o r a t i o n  o f  n u c l e o t i d e s .  P l a s m i d s  w e r e  i s o l a t e d  
f r o m  t h e  t r a n s f o r m e d  c l o n e s  and  s c r e e n e d  by  r e s t r i c t i o n  d i g e s t i o n  and  
P C R  t o  v e r i f y  t h e  p r e s e n c e  o f  i n s e r t .  P l a s m i d s  f r o m  e i g h t  c l o n e s  f r o m  
e a c h  P C R  r e a c t i o n  w e r e  s u b j e c t e d  to  r e s t r i c t i o n  d i g e s t  w i t h  B a m  H I  and 
H i n d  I I I .  T h e  p r o d u c t s  w e r e  s e p a r a t e d  on  a 1 % a g a r o s e  ge l  and  the  
i n s e r t s  w e r e  s h o w n  t o  be o f  t h e  c o r r e c t  s i ze  o f  1 812  bp ( F i g u r e  3 .6) .
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2 6 4 2  bp 
1 500 bp
i n s e r t
p l a s m i d
1 2 3 MWM 4 5 6 7 8
F i g u r e  3 . 6:  R e s t r i c t i o n  a n a l y s i s  o f  p l a s m i d s  o b t a i n e d  f r o m  
t r a n s f o r m e d  b a c t e r i a .  T h e  p r o d u c t s  o f  t he  r e s t r i c t i o n  d i g e s t  on t he  
p l a s m i d s  c o n t a i n i n g  t h e  P13K  i n s e r t  a r e  s h o w n .
1 & 2 = C l o n e s  f r o m  P C R  A;
3, 4 & 5 = C l o n e s  f r o m  P C R  B;
6, 7 & 8 = C l o n e s  f r o m  P C R  C.
T h e  p l a s m i d s  i s o l a t e d  f r o m  c l o n e s  w h i c h  w e r e  o b t a i n e d  f r o m  t h r e e  
d i f f e r e n t  P C R  r e a c t i o n s  A, B and  C h ad  i n s e r t s  o f  t h e  c o r r e c t  s i ze  o f  
1 812  bp.  T h e  c o l o n i e s  w e r e  f u r t h e r  s c r e e n e d  by P C R  t o  d e t e r m i n e  t he  
t r a n s f o r m a t i o n  e f f i c i e n c y  o f  t he  t h r e e  d i f f e r e n t  P C R  p r o d u c t  i n s e r t s  
( A - C ) .  H i g h  t r a n s f o r m a t i o n  e f f i c i e n c y  w a s  o b s e r v e d  f o r  al l  t h r e e  P C R  
r e a c t i o n s ,  w h e r e  al l  t h e  p l a s m i d s  s c r e e n e d  had  i n s e r t  as  s h o w n  in 
F i g u r e  3 .7 .  N e g a t i v e  c o n t r o l  P C R  r e a c t i o n s  w e r e  a l s o  p e r f o r m e d  and  did 










MWM 1 2 3 4 5 6 7 8 9
1 812 bp
F i g u r e  3 .7 :  A g a r o s e  ge l  e l e c t r o p h o r e s i s  o f  P I 3 K  c l o n e s  s c r e e n e d  by  
P CR.  T h e  p r o d u c t s  o f  P C R  s c r e e n s  on  t he  t r a n s f o r m e d  c l o n e s  o f  the  
t h r e e  P C R  r e a c t i o n s ,  A ( l a n e s  1-9) ,  B ( l a n e s  1-9)  a nd  C ( l a n e s  1-9)  
c o n t a i n i n g  P f P I 3 K  i n s e r t s  a re  s h own .
Al l  t h e  p l a s m i d s  c o n t a i n e d  an i n s e r t  w i t h  a c o r r e c t  s i ze  o f  
1 812  bp.  S c r e e n i n g  by  P C R  p r o d u c e d  a d d i t i o n a l  b a n d s  ( 8 0 0  bp )  bu t  
p l a s m i d  i s o l a t e d  a nd  d i g e s t e d  d id  no t  f o r m  t h i s  band .
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3 . 3 . 1  S e q u e n c i n g  o f  t he  P f P I 3 K  i n s e r t s
T h e  P f P I 3 K  i n s e r t s  in s o m e  o f  t h e  i s o l a t e d  p l a s m i d s  w e r e  s e q u e n c e d  at 
b o t h  e n d s  o f  t h e  i n s e r t s  f o r  v e r i f i c a t i o n .  To  v e r i f y  t he  s e q u e n c e s ,  t he  
o b t a i n e d  s e q u e n c e s  w e r e  s u b j e c t e d  to  a b l a s t n  s e a r c h  at  t he  m a l a r i a  
g e n o m e  d a t a b a s e .  T h e  s e q u e n c e  p r o d u c t s  w i t h  t h e  m o s t  s i g n i f i c a n t  
a l i g n m e n t  a r e  s h o w n .
T h e  s e q u e n c e  o f  P f P I 3 K  i n s e r t s  o b t a i n e d  w i t h  t h e  p r i m e r  f o r  t he  s e n s e  
s t r a n d  by m a n u a l  s e q u e n c i n g :
5 '  AAAATTGAAC GAAATAGAGA TAACTCTTTC TTGTCTAATT TTTACAATTT AATGATAAT 
TAGATTTTTT TTTAAATCCT ACTTATAGTG ATGAAGATAA TAATTATGAA ATATTAGATG 
ACTCTATAAA TTTTGTTGAG AAACAAAAAA TTAAAAAATA A A A A 3'
T h e  p a i r w i s e  a l i g n m e n t  w i t h  t he  m o s t  s i g n i f i c a n t  s i m i l a r i t y  ( l o w e s t  E 
v a l u e )  o b t a i n e d  u s i n g  t h e  s e n s e  s t r a n d  w i t h  t he  c o n t i g  P 4 2 3 3 6  is s h o w n  
b e lo w :
> 9 7 7 3 9 9 7 7  P .  f a l c i p a r u m  3 D 7  G E N O M I C  p f a l _ c h r 5  
L e n g t h  =  1 , 3 4 3 , 5 5 2  P l u s  S t r a n d  H S P s :  S c o r e  = 7 6 4  ( 1 2 0 . 7
b i t s ) ,  E x p e c t  = 4 . 3 e - 2 9 ,  P =  4 . 3 e - 2 9  I d e n t i t i e s  =  1 6 3 / 1 6 5  
( 9 8 % ) ,  P o s i t i v e s  =  1 6 3 / 1 6 5  ( 9 8 % ) ,  S t r a n d  =  P l u s  /  P l u s
Q u e r y :  1 AAAATTGAACGAAATAGAGATAACTCTTTCTTGTCTAATTTTTTACAATTTAATGATAAT 5 9
I I I I I I I I I I I I I  I I! I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
s b j c t :  6 3 3 6 5 3  AAAATTGAACGAAATAGAGATAACTCTTTCTTTTCTAATTTTTTACAATTTAATGATAAT 6 3 3 7 1 2
Q u e r y :  6 0  TTAGATTTTTTTTTAAATCCTACTTATAGTGATGAAGATAATAATTATGAAATATTAGAT 1 1 8
I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
6 3 3 7 1 3  TTAGATTTTTTTTTAAATGCTACTTATAGTGATGAAGATAATAATTATGAAATATTAGAT 6 3 3 7 7 2
Q u e r y :  1 1 9  GACTCTATAAATTTTGTTGAGAAACAAAAAATTAAAAAATTAAAAA 1 6 4
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t :  6 3 3 7 7 3  GACTCTATAAATTTTGTTCAGAAACAAAAAATTAAAAAAATAAAAA 6 3 3 8 1 8
The  s e n s e  s e q u e n c e  o f  t he  P f P I 3 K  i n s e r t  o b t a i n e d  w i t h  p r i m e r  fo r  t he  
a n t i s e n s e  s t r a nd :
5 '  GCATATAAAT ATTTAACATA CGATTCTCAA TTAATTATTA CCTTGTTAGA TGCAATGTGA 
TCCAGGATTA AAGGATATGA AAATGAGTCC AGAGTTTTGT CTTAAAAGTA CAAGAAAAAT 
TTACACTT 3 '
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T h e  p a i r w i s e  a l i g n m e n t s  o f  t h e  m o s t  s i g n i f i c a n t  s i m i l a r i t y  o b t a i n e d  
u s i n g  p r i m e r  f o r  t he  a n t i s e n s e  s t r a n d  w i t h  c o n t i g  P 4 2 3 3 6  is s h o w n  
b e l o w :
> q i 12 3 5 0 4 5 7 0 1 e m b |A L 9 2 9 3 5 2 ■1 IP F A 9 2 9 3 5 2  P l a s m o d i u m  f a l c i p a r u m  s t r a i n  3 D 7 , 
c h r o m o s o m e  5 ,  s e g m e n t  2 / 4  
L e n g t h  =  3 1 3 0 5 0
S c o r e  =  1 8 6  b i t s  ( 9 4 ) ,  E x p e c t  =  5 e - 4 5
I d e n t i t i e s  =  1 2 9 / 1 3 2  ( 9 6 % ) ,  G a p s  =  1 / 1 3 2  ( 0%)
S t r a n d  =  P l u s  /  P l u s
Q u e r y :  1 g c a t a t a a a t a t t t a a g a t a c c a t t c t c a a t t a a t t a t t a g c t t g t t a g a t g c a a t g t g t  5 8
I II  I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t :  2 8 8 1 3 2  g c a t a t a a a t a t t t a a g a t a c c a t t c t c a a t t a a t t a t t a g c t t g t t a g a t g c a a t g t g t  2 8 8 1 9 1
Q u e r y :  5 9  g a t c c a g g a t t a a a g g a t a t g a a a a t g a g t c c a g a g t t t t g t g t c t t a a a a g t a c a a g a a  1 1 6
I I I  I I I I I I I I I I II I I I II I II I II I I I II I I I II I I I I II I I II I I I I I I I I I I I I 
S b j c t :  2 8 8 1 9 2  g a t g c a g g a t t a a a g g a t a t g a a a a t g a g t c c a g a g t t a t g t g t c t t a a a a g t a c a a g a a  2 8 8 2 5 1
Q u e r y :  1 1 7  a a a t t t a c a c t t  1 2 8  
I I I II I I I I I I
S b j c t :  2 8 8 2 5 2  a a a t t t a g a c t t  2 8 8 2 6 3
T h e  s e q u e n c e  w a s  96 % i d e n t i c a l  to  t h a t  o f  t h e  P l a s m o D B .  
D i s c r e p a n c i e s  w e r e  d u e  to  m i s i n c o r p o r a t i o n  o f  n u c l e o t i d e s  d u r i n g  
a m p l i f i c a t i o n  in PCR.
T h e  i n s e r t  w as  a l s o  s e q u e n c e d  by a u t o m a t e d  s e q u e n c i n g .  T h e  s e q u e n c e  
p r o d u c e d  f r o m  t he  a u t o m a t e d  s e q u e n c e r  u s i n g  v e c t o r  p r i m e r  f r o m  t he  
s e n s e  s t r a n d  e x t e n d e d  f u r t h e r  i n t o  t h e  OR F.
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GTTCATAATA TTAAAAAAAT GAACAAGCAT AAAAGGGATG ATTACATGAT TAATGAAAAG 
GTCCTTCCAT GTGTTAGTAA TTCGTGTTTG GGCGATAAAC TGATCCCGTC GCATGATAAA 
ATGAGGTCGT CGCATGATTA AATGATGCCG TCACATGATA AAATCATGCC A TCG CA TG 3'
T h e  p a i r w i s e  a l i g n m e n t  w i t h  t he  m o s t  s i g n i f i c a n t  s i m i l a r i t y  is s h o w n  
b e l o w :
> 9 7 7 3 9 9 7 7  P .  f a l c i p a r u m  3D 7 GENOMIC p f a l _ c h r 5  
L e n g t h  = 1 , 3 4 3 , 5 5 2
P l u s  S t r a n d  H S P s :  S c o r e  =  3 8 1 8  ( 5 7 8 . 9  b i t s ) ,  E x p e c t  =  4 . 9 e - 1 6 7 ,
P =  4 . 9 e - 1 6 7 ,  I d e n t i t i e s  =  7 7 0 / 7 7 8  ( 9 8 % ) ,  P o s i t i v e s  =  7 7 0 / 7 7 8  ( 9 8 % ) ,  S t r a n d  
=  P l u s  /  P l u s
Q u e r y :  1 TTCTTGTCTAATTTTTTACAATTTAATGATAATTTAGATTTTTTTTTAAATCCTACTTAT 6 0
I I I I I I I I I II I I I I I I I I II I I I I I I I I II I I I I I II I I I I I I I I I I I I II I I I I I I 
S b j c t : 6 3 3 6 8 0  TTCTTTTCTAATTTTTTACAATTTAATGATAATTTAGATTTTTTTTTAAATGCTACTTAT 6 3 3 7 3 9
Q u e r y :  6 1  AGTGATGAAGATAATAATTATGAAATATTAGATGACTCTATAAATTTTGTTCAGAAACAA 1 2 0
I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I II I I I I I I 
S b j c t :  6 3 3 7 4 0  AGTGATGAAGATAATAATTATGAAATATTAGATGACTCTATAAATTTTGTTCAGAAACAA 6 3 3 7 9 9
Q u e r y :  1 2 1  AAAATTAAAAAAATTAAAACACCTTTAATTTTACCTATAGATCCTAATATTGAATTATTA 1 8 0
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t :  6 3 3 8 0 0  AAAATTAAAAAAATAAAAACACCTTTAATTTTACCTATAGATCCTAATATTGAATTATTA 6 3 3 8 5 9
Q u e r y :  1 8 1  TCTTTCTTACCTGAACAATCATATGTATTACGTTCTTCTTTATATCCTATACTTATTGCT 2 4 0
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t :  6 3 3 8 6 0  TCTTTCTTACCTGAACAATCATATGTATTACGTTCTTCTTTATATCCTATAGTTATTGCT 6 3 3 9 1 9
Q u e r y :  2 4 1  TGTTTAGTTCGAAAAAAAATTAAATTATATAATGAAAATTATAATAATTTAATTATTAAT 3 0 0
I I I I I I I I I I I I I I I I I I I I I I II II I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I
S b j c t :  6 3 3 9 2 0  TGTTTAGTTCGAAAAAAAATTAAATTATATAATGAAAATTATAATAATTTAATTATTAAT 6 3 3 9 7 9
Q u e r y :  3 0 1  AATCATACCTTTTATAAAAATGACCAAAATAAGGATAATATCATAAACAATTTGTCATAT 3 6 0
I I I I I II I I I I I I I I I II II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t :  6 3 3 9 8 0  AATCATACCTTTTATAAAAATGACCAAAATAAGGATAATATCATAAACAATTTGTCATAT 6 3 4 0 3 9
Q u e r y :  3 6 1  GATAAGTCATATCATTCATATTATAACTCGCAATTTATTAAAACTTTACAAAATTCTTTT 4 2 0
I I I I I I I I I I I I II I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I
S b j c t :  6 3 4 0 4 0  GATAAGTCATATCATTCATATTATAACTCGCAATTTATTAAAACTTTACAAAATTCTTTT 6 3 4 0 9 9
Q u e r y :  4 2 1  GTAAGTACAACAAGTCTTAATTATCATTATAATTTTTTGAAATGTTCAAATAATAATATT 4 8 0
I I I I I I I I I II I I I I I I I I I I I I I I I I I I II I I I II I I I I I I I I I I I I I I I II I I I I I I
S b j c t :  6 3 4 1 0 0  GAAAGTACAACAAGTCTTAATTATCATTATAATTTTTTGAAATGTTCAAATAATAATATT 6 3 4 1 5 9
Q u e r y :  4 8 1  TTTTATAAAAACAAAAAAATTGAAAGAATTAAACCAAACACATCAATTCAAAAAGCCTTT 5 4 0
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t :  6 3 4 1 6 0  TTTTATAAAAACAAAAAAATTGAAAGAATTAAACCAAACACATCAATTCAAAAAGCCTTT 6 3 4 2 1 9
Q u e r y :  5 4 1  CCGTCCAATGAAAATATATTAAATAGAAATCAACATGTGTATTATAGTAATAACCAAATT 6 0 0
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t :  6 3 4 2 2 0  CCGTCCAATGAAAATATATTAAATAGAAATCAACATGTGTATTATAGTAATAACCAAATT 6 3 4 2 7 9
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Q u e ry : 6 0 1  GTTCATAATATTAAAAAAATGAACAAGCATAAAAGGGATGATTACATGATTAATGAAAAG 6 6 0  
I I I I I I I I I I II I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I II II I II I I I I I I I II I 
S b j c t :  6 3 4 2 8 0  GTTCATAATATTAAAAAAATGAACAAGCATAAAAGGGATGATTACATGATTAATGAAAAG 6 3 4 3 3 9
Q u e r y :  6 6 1  GTCCTTCCATGTGTTAGTAATTCGTGTTTGGGCGATAAACTGATCCCGTCGCATGATAAA 7 2 0
I I I I I I II II II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t :  6 3 4 3 4 0  GTCCTTCCATGTGTTAGTAATTCGTGTTTGGGCGATAAACTGATGCCGTCGCATGATAAA 6 3 4 3 9 9
Q u e r y :  7 2 1  ATGAGGTCGTCGCATGATTAAATGATGCCGTCACATGATAAAATCATGCCATCGCATG 7 7 8
I I I I II I I I I II I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t :  6 3 4 4 0 0  ATGAGGTCGTCGCATGATAAAATGATGCCGTCACATGATAAAATGATGCCATCGCATG 6 3 4 4 5 7
T h e  s e q u e n c e s  o b t a i n e d  o f  p a r t  o f  t h e  P f P I 3 K  i n s e r t  by s e q u e n c i n g  and  
t h o s e  o f  t he  O R F  i d e n t i f i e d  in c o n t i g  P 4 2 3 3 6  s h o w e d  9 6 - 9 8  % i d e n t i t y .  
H o w e v e r  a d d i t i o n a l  e r r o r s  d ue  t o  p o l y m o r p h i s m  m a y  h a v e  b e e n  p r e s e n t  
in t h e  o v e r a l l  s e q u e n c e  a nd  i d e n t i t y  m a y  be  l o w e r .  T h e  p a r t  o f  t he  
i n s e r t  s e q u e n c e d  w h i c h  had  p r e v i o u s l y  b e e n  c l o n e d  in a p Q E - 8 0 L  v e c t o r  
w h i c h  h a s  an  N - t e r m i n a l  H i s  t ag ,  w a s  t h u s  v e r i f i e d  to  be pa r t  o f  t he  
O R F  f o r  P f P 1 3 K .
T h e  s e q u e n c e  p r o d u c e d  u s i n g  an a u t o m a t e d  s e q u e n c e r  u s i n g  t he  
p Q E - 8 0 L  v e c t o r  a n t i s e n s e  p r i m e r  is as  f o l l o w s :
5 '  T T T C C A A T T T  A A G G C C C A C T C A T G C A A T T A  T C C A C A A C A A  C A G G A A A TA A  C G T T T T A A C G  
G A T G C A T T G A  T A A C A C T A A G  A A A A T A A A T T  T C T G C T G C T T  CA T CA T T T A A  A T C A A G T C T A  
A A T T T T T C T T  G T A C T T T T A A  G A CA CATA AC T C T G G A C T C A  T T T T C A T A T C  C T T T A A T C C T  
G C A T C A C A C A  T T G C A T C T A A  C A A G C T A A T A  A T T A A T T G A G  A A T G G T A T C T  T A A A T A T T T A  
T A T G C T A G A C  A A C A T T T T T T  T A A G A A T T G T  T C A T A A C C T A  T A C T A T G A G C  T C C T C C C A T A  
G C T T C A A T C A  T T T C T T T A C A  T A A T T T C A T A  G GTG G AG AAA A T G G T T T T G G  A T C C 3 '
T h e  p a i r w i s e  a l i g n m e n t  w i t h  t h e  m o s t  s i m i l a r  h o m o l o g y  is s h o w n  
b e lo w :
> 9 7 7 3 9 9 7 7  P .  f a l c i p a r u m  3D 7 GENOMIC p f a l _ c h r 5  L e n g t h  =  1 , 3 4 3 , 5 5 2
M i n u s  S t r a n d  H S P s :  S c o r e  =  1 7 6 0  ( 2 7 0 . 1  b i t s ) ,  E x p e c t  =  4 . 4 e - 7 4 ,
P =  4 . 4 e - 7 4  I d e n t i t i e s  =  3 5 4 / 3 5 5  ( 9 9 % ) ,  P o s i t i v e s  =  3 5 4 / 3 5 5  ( 9 9 %) ,
S t r a n d  =  M i n u s  /  P l u s
Q u e r y :  3 5 4  GGATCCAAAACCATTTTCTCCACCTATGAAATTATGTAAAGAAATGATTGAAGCTATGGG 2 9 5  
I I I I II I I I  I I I I I I I I I I I I II  I I I I I II I I I II I I I I I I I I I I I I I  I II I I I I I I I I I 
S b j c t :  6 3 5 0 2 3  GGATCCAAAACCATTTTCTCCACCTATGAAATTATGTAAAGAAATGATTGAAGCTATGGG 6 3 5 0 8 2
Q u e r y :  2 9 4  AGGAGCTCATAGTATAGGTTATGAACAATTCTTAAAAAAATGTTGTCTAGCATATAAATA 2 3 5  
I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I II II I 
S b j c t :  6 3 5 0 8 3  AGGAGCTCATAGTATAGGTTATGAACAATTCTTAAAAAAATGTTGTCTAGCATATAAATA 6 3 5 1 4 2
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Q u e r y :  2 3 4  TTTAAGATACCATTCTCAATTAATTATTAGCTTGTTAGATGCAATGTGTGATGCAGGATT 1 7 5  
I I I I I I I I I I I I I I I I I II I 1 I I I I I I I 111 I I I I I I I I I I II I I I I I I I I I I I I I I II I 
S b j c t :  6 3 5 1 4 3  TTTAAGATACCATTCTCAATTAATTATTAGCTTGTTAGATGCAATGTGTGATGCAGGATT 6 3 5 2 0 2
Q u e r y :  1 7 4  AAAGGATATGAAAATGAGTCCAGAGTTATGTGTCTTAAAAGTACAAGAAAAATTTAGACT 1 1 5
I I 111 I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I! M I I I I I I I
S b j c t :  6 3 5 2 0 3  AAAGGATATGAAAATGAGTCCAGAGTTATGTGTCTTAAAAGTACAAGAAAAATTTAGACT 6 3 5 2 6 2
Q u e r y :  1 1 4  TGATTTAAATGATGAAGCAGCAGAAATTTATTTTCTTAGTGTTATCAATGCATCCGTTAA 5 5
II II I I I I I I I I I I I I II I I I I I I I I II I I I I I I I I I I I I I II II I I II I I I I I I I I I I I 
S b j c t :  6 3 5 2 6 3  TGATTTAAATGATGAAGCAGCAGAAATTTATTTTCTTAGTGTTATCAATGCATCCGTTAA 6 3 5 3 2 2
Q u e r y :  5 4  AACGTTATTTCCTGTTGTTGTGGATAATTTGCATGAGTGGGCCTTAAATTGGAAA 1
I I I I I I I I I I I I I I I I  I I I I I I I I II I I I I I I I I I I I I I I I II II I I I I II I I I 
S b j c t :  6 3 5 3 2 3  AACGTTATTTCCTGTTGTTGTGGATAAATTGCATGAGTGGGCCTTAAATTGGAAA 6 3 5 3 7 7
T h e  s e q u e n c e s  o b t a i n e d  o f  t he  C - t e r m i n a l  p a r t  o f  t h e  P f P I 3 K  i n s e r t  
u s i n g  an a u t o m a t e d  s e q u e n c e r  s h o w e d  98 % - 9 9  % i d e n t i t y  t o  the  
c o m p l e t e  P F E 0 7 6 5 w  s e q u e n c e  g e n e  f o u n d  in t h e  P l a s m o D B  
( h t t p / / w w w : p l a s m o d b . o r g ) .  F u r t h e r m o r e  t he  s e q u e n c e s  o b t a i n e d  by 
a u t o m a t e d  s e q u e n c e  h ad  l e s s  d i s c r e p a n c i e s  c o m p a r e d  t o  t he  m a n u a l  
s e q u e n c e s .  H o w e v e r  o ne  c o n s i s t e n t  e r r o r  n o t e d  in b o t h  t h e  m a n u a l  and  
a u t o m a t e d  s e q u e n c e s  m a y  be  d ue  t o  p o l y m o r p h i s m ,  w h i l e  t h e  o t h e r  
e r r o r s  in t h e  m a n u a l  s e q u e n c e  m a y  b e  d ue  to  e x p e r i m e n t a l  e r r o r .  The  N-  
t e r m i n u s  e x t r e m i t y  and  726  bp f r a g m e n t  m i d d l e  o f  t he  O R F  h a ve  no t  
b e e n  v e r i f i e d  d ue  to  t i m e  c o n s t r a i n t s .
I n s p e c t i o n  o f  t h e  a u t o m a t e d  s e q u e n c e  d a t a  in r e l a t i o n  t o  t he  a m i n o  ac id  
s e q u e n c e  o f  t h e  P F E 0 7 6 w  O R F  s h o w s  d i s c r e p a n c i e s  i n d i c a t e d  in b l u e  
and  r ed  in t h e  p a i r w i s e  a l i g n m e n t .  T h e  d i s c r e p a n c i e s  s h o w n  in b l u e  may  
h a v e  m i n i m a l  e f f e c t  on t he  o v e r a l l  a m i n o  a c i d  s e q u e n c e  in c o m p a r i s o n  
to  t he  O R F  e n c o d i n g  t h e  P F E 0 7 6 w  g e n e .  T h e  d i s c r e p a n c i e s  s h o w n  in r ed  
i n d i c a t e  t h a t  t he  c h a n g e s  in t he  n u c l e o t i d e s  m a y  l e ad  to c h a n g e s  in t he  
o v e r a l l  p r o t e i n  c o n f i g u r a t i o n .
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T r y p t o p h a n  r e p l a c e d  l y s i n e  22 on t he  a u t o m a t e d  s e q u e n c e  o b t a i n e d  
u s i n g  s e n s e  v e c t o r  p r i m e r s .  T r y p t o p h a n  is an a m i n o  ac i d  wi t h  n o n p o l a r  
s ide  c h a i n s  w h i l s t  l y s i n e  has  c h a r g e d  p o l a r  s ide  c h a i n s .  H i s t i d i n e  74 a 
b a s i c  a m i n o  a c i d  a l so  r e p l a c e d  a s p a r t i c  a c i d  w h i c h  is a c i d i c .  
A s p a r a g i n e  578  w h i c h  is an a m i n o  a c i d  w i t h  u n c h a r g e d  p o l a r  s ide  
c h a i n s  r e p l a c e d  l y s i n e  w h i c h  ha s  p o l a r  s i d e  c h a i n s  on t he  a u t o m a t e d  
s e q u e n c e  o b t a i n e d  u s i n g  a n t i s e n s e  v e c t o r  p r i m e r s .
T h e s e  c h a n g e s  in a m i n o  a c i d s  a r e  l i k e l y  to c a u s e  c h a n g e s  in t he  
s e c o n d a r y  and  t e r t i a r y  s t r u c t u r e  o f  t he  p r o t e i n  and  wi l l  i n f l u e n c e  the  
f u n c t i o n  o f  t he  p r o t e i n .  T h e  N - t e r m i n u s  p a r t  o f  t he  s e q u e n c e  e n c o d i n g  
t he  O R F  o f  P F E 0 7 6 5 w  was  no t  v e r i f i e d  t h e r e f o r e  t he  c o m p l e t e  
i n s p e c t i o n  o f  t he  s e q u e n c e  c o d i n g  P F E 0 7 6 5 w  is n o t  s h o w n  b e l o w .
T h e  C - t e r m i n a l  p a r t  o f  t he  O RF  e n c o d i n g  P F E 0 7 6 5 w  s e q u e n c e  is s h o w n  
b e l o w .
T h e  a m i n o  a c i d s  t h a t  w e r e  c h a n g e d  d u e  to  t he  d i s c r e p a n c i e s  s h o w n  in 
t he  n u c l e o t i d e  s e q u e n c e  r e l a t i v e  to t he  P F 0 7 6 5 w  ORF g e n e  s e q u e n c e  are  
s h o w n  b e l o w  in b l ue .  T h e  a m i n o  a c i d s  t h a t  m a y  c a u s e  a d v e r s e  c h a n g e s  
to t h e  s t r u c t u r e  o f  t he  p r o t e i n  a re  s h o w n  in r ed  b e l o w .
1  M IH Y ID D S K N V K IE R N R D N S  2 0  F F S N F L Q F N D N L D F F L N A T Y  4 0
4 1  S D E D N N Y E IL D D S IN F V Q K Q  6 0  K I K K I K T P L I L P I D P N I E L L  8 0
8 1  S F L P E Q S Y V L R S S L Y P I V I A  1 0 0  C L V R K K IK L Y N E N Y N N L IIN  1 2 0
1 2 1  N H T F Y K N D Q N K D N IIN N L S Y  1 4 0  D K S Y H S Y Y N S Q F IK T L Q N S F  1 6 0
1 6 1  E S T T S L N Y H Y N F L K C S N N N I 1 8 0  F Y K N K K IE R IK P N T S IQ K A F  2 0 0
2 0 1  P S N E N IL N R N Q H V Y Y S N N Q I 2 2 0  V H N IK K M N K H K R D D Y M IN E K  2 4 0
2 4 1  V L P C V SN S C L G D K L M P S H D K  2 6 0  M RSSHDKM M PSHDKM M PSHD 2 8 0
2 8 1  K L M S P H Y T L M SS H D K P V A P S 3 0 0  G V SSL G E K K SK D E K K N R K K Y  3 2 0
3 2 1  N E IY Q L S IK K Y IY K A G D D L R  3 4 0  Q D H L V IQ IIY V M D N IW K R Y G  3 6 0
3 6 1  L D L K M T L Y R V L A L S T D D G F I 3 8 0  E F V D Y A E S I S S IK K N Y K G E I  4 0 0
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4 0 1  R Q Y F ID N S T C S S S P L G F D T E  
4 4 1  IG D R H L D N L M V T K D G R F F H I  
4 8 1  K E M IE A M G G A H SIG Y E Q  FLK  
5 2 1  DAMCDAGLKDMKMS P E L C V L  
5 6 1  S V IN A S V K T L F P V W D K L H E
I L Q N F I S S C A G Y S V I T Y I L G  4 4 0  
D F G Y IF G E D P K P F S P P M K L C  4 8 0  
K C C L A Y K Y L R Y H S Q L IIS L L  5 2 0  
K V Q E K F R L D L N D E A A E IY F L  5 6 0  







3.4 Protein express ion of  PfPI3K
Clones  f r om three  sepa ra t e  PCR reac t i ons  were  screened  for 
exp re ss io n  by i n du c t i o n  o f  cu l tures  wi th  IPTG.  The pro te in  expressed  
was i so l a t ed  by n i c ke l - a f f i n i t y  c h r om a t og r a p hy  f rom I PTG- i nduc ed  
P f P I 3K  clones  in the  pQE- 80 L  vec t o r  wi th an N- t e rmi na l  His  tag and 
p robed  us ing  the an t i -Hi s  monoc l ona l  an t ibody.  The  Hi s - t agged  
pro t e ins  were  i den t i f i ed  wi th a h o r s e r ad i s h  pe ro x i da se  con juga t e  
s econda r y  an t i body  and lumi - l i gh t  wes t e r n  b l o t t i ng  subs t ra te .
3.4.1 E xpr es s i on  of  c loned ORF
A pi lo t  exp re s s i on  o f  the  c lones  p ro d u c ed  no s ign i f i c an t  bands  and a 
l a rge r  sca le  exp r e ss io n  s tudy p r o d uc ed  bands  o f  the expec t ed  s ize 
(68 KDa)  (F i gure  3.8 & 3.9).  The  wes t e rn  blot  ana lys i s  showed the 
p re s ence  o f  e xp r e s s ed  pro t e in  wi th  a s ize  o f  68 KDa.  The presence  o f  
o ther  minor  bands  may be due to deg r a da t i o n  p r oduc t s  o f  prote ins  
(F igure  3.8a) .  Ne ga t i ve  and pos i t i ve  con t ro l s  f r om IPTG induced  
cel l s  wi th  an e xp r e s s i on  ve c t o r  wi t h o u t  the  i nser t  and express ion  
vec t o r  c o n t a i n i ng  the inser t  were  also i nc l uded  to eva lua t e  the 
s pec i f i c i t y  o f  the de t ec t ed  bands  (da t a  not  shown) .
Co oma ss ie  ge l s  o f  prote in  ex t r ac t s  be f o r e  (da ta  not  shown)  and af ter  
p u r i f i c a t i o n  were  a l so ana l ysed  (F igure  3 .8b) .  The numerous  
add i t i ona l  bands  may be d e gr ad a t i o n  p r oduc t s  o f  pro t e in  and 
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Figure  3.8a:  West ern  blot  analys i s  o f  PfPI3K.
A = Smal l  sca le  e xpe r imen t s  o f  e xp r e s s ed  P f PI 3 K clones  in the 
absence  o f  1PTG induc t ion .  A Mul t i - T ag  pro te in  marke r  is 
i nd i ca t ed  on the ex t r eme  right .
B = Large  sca le  ex p er i men t s  o f  e xp r e s s ed  P f PI 3 K clones  in the 
p re sence  o f  IPTG induct ion .
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Fi gure  3 .8b:  Commas s i e  s ta ined gel  of  e xpres sed  Pf PI 3K clones  
af t er  p u r i f i c a t i o n .
F i gure  3.9:  St andard curve  for  the d e t e rm i n a t i o n  of  the mo l e cu l a r  
wei ght s  o f  Hi s - t a gg ed  prote ins  in the wes t ern  blot  analys i s .  The
symbol  ^  r epresen t s  the  r e l a t i ve  d i s t ance  mi gr a t ed  by the expressed  
P f PI 3 K pro t e in  (68 Kda  = 0.2 Rf) aga ins t  its mo l e cu l a r  we igh t  logio.  
The  curve  was gene r a t ed  by p l o t t i ng  the  r e l a t i ve  d i s t ance  migra t ed  by 
pro t e in  (Rf) aga i ns t  the logio o f  its mo l e c u l a r  weight .
3.4 .2  Expres s i on  o f  p h os p ha t i d y l i n o s i to l  3 - k i nas e  in the mal ar i a  
paras i t e
The mi c r oa r r ay  data  ob t a ined  by Le Roch ,  et a l ( 2003)  shows  that  the  
P F E 07 6 5w  gene is exp re s sed  in t r o phozo i t e s ,  s ch i zon t s  and 
g amet ocy t e s .  Mass  s pe c t r o m e t ry - b a s e d  ev idence  at P l a smoDB also 
shows  tha t  the  pro t e in  encoded  by P F E0 7 65 w  is p re sen t  in 
sporozo i t es .
3.5 Sequence analysis  o f  P. fa lc ip a ru m  PI3K
The pe rc en t ag e  iden t i t y  be tween  the c om p a r ed  s equences  refers  to the 
n um b e r  o f  amino acids  r es idues  t ha t  are iden t i ca l  in the a l ignment .  
The pa i r wi se  a l i gnme nt  ob t a ined  a f ter  comp ar in g  the Pf PI3K ORF 
(1 758 bp) aga ins t  PI 3K sequences  in o the r  o rgan i sms  demons t ra t ed  
s imi l a r i t y  be tween  the ca t a ly t i c  domains .  The pa i rwi se  a l i gnmen t  is 
shown in F igur e  3 .10 obt a ined  f rom the Clus t a l  W a l i gnment  p r ogr am 
at EBI ( h t t p : / / w w w . e b i . a c . u k ). The pa i rwi se  b las tp  p r ogr am was used 
to compar e  the  amino acid sequence  o f  the  a mi n o - t e rm i n u s  o f  P fPI3K 
wi th t ha t  o f  the  p l ecks t r i n  homo lo g y  doma i ns  t ha t  are p resen t  in the 
a mi n o - t e rm i n i  o f  o the r  o rgani sms .  No s ig n i f i c an t  s imi l a r i t y  was 
found  be tween  the s equences  thus  i n d i ca t i ng  that  P f P I 3 K  does not  
have  a p l ecks t r i n  h om o l og y  domain.
Tabl e  3.2:  P e rce nt a g e  i dent i ty  o f  ORF in cont i g  P42336 (PfPI3K)  
with  PI 3K in other  organi sms .
PI3K in var i ous  organi sms %  Ident i ty  of  Pf PI3K to 
other  organi sms
A r a b id o p s i s  tha l iana 27
D ro s o p h i la  m e la n o g a s te r 34
H om o sap iens 30
S a c ch a ro m yc e s  c e re v i s ia e 42
R a t tu s  m uscu lus 20
D ic to s t e l iu m  d is co id eu m 22
R oo t  nodu le 31
H uman 32
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The overa l l  i den t i t y  o f  all  the  spec ies  is lower  compar ed  to the 
va lues  for  the  C- t e r mi na l  only.  T h e r e f o r e  t hough  all the spec ies  such 
as Homo sap i ens  show a 50 % s imi l a r i t y  to the Pf PI3K cata ly t i c  
domain ,  the overa l l  gene  s imi l a r i t y  is l ower  (Table  3.2).
3.5.1 Cat a l y t i c  domain  analys i s
The ca t a l y t i c  domains  o f  PI 3K d i f f e r  s i gn i f i c an t l y  f rom those  
de sc r i bed  by Hanks  and Quinn (1991) .  This  is due to the fact  that  
PI3Ks  have  been shown to p h o s ph o r y l a t e  both p ro te ins  and l ipids ,  
wh i l s t  s e r i n e / t h r e on i n e  k inases  p h o s p h o r y l a t e  p ro t e ins  (Wy ma nn  & 
Pi ro la ,  1998) .  The Pf P I 3K ca t a l y t i c  domain  con ta ins  the  C- t e rmina l  
which  cons i s t s  o f  the  ac t i va t i on  and ca t a l y t i c  loops  tha t  are impor t an t  
in the  d e t e r m i na t i on  o f  s ubs t r a t e  s pec i f i c i t y  (F i gure  3 .10) .  One of  the 
h igh ly  con se rv e d  f ea tu res  o f  the n u c l e o t i d e  b ind ing  s i te  is a 
conse rved  lys ine  r e s idue  i mpor t an t  for  ATP bind ing  and coord i na t i on  
shown in F i gur e  3 .10 ( V a nh ae s eb r o ec k  et al,  2001) .  The C- t e rmina l  
lobe  has four  cr i t i ca l  r e s idues  tha t  are c r i t i ca l  for  ATP b inding ,  three  
l ys ine  r e s idues  and an a rg in ine  r e s i due  (F igure  3 .10)
( Va nh ae s eb r o e c k  et al ,  2001) .  The ca t a ly t i c  si te r e s pons i b l e  for  
i n i t i a t i ng  p h o s p ho r y l a t i o n  infe r r ed  f rom h o m o l og y  to o ther  PI3Ks  is 
de f ined  by the consens us  s equence  G I G DR H LD N  in PfPI3K.  The 
c onsensus  s eque nc e  G I G D R H L D N  is loca t ed  be tween  amino acids  440 
and 448 in P f PI 3 K (F igure  3.10) .
D . m e l a n o g a s t e r  
H .  s a p i e n s  
A .  t h a l i a n a  
V p s 3 4  




-------------- MIh y xDDSKNVKIERNRDNSFFSNFLQFNDNLDFFL 36
D .  m e l a n o g a s t e r  
H .  s a p i e n s  
A .  t h a l i a n a  
V p s 3 4  
P f P I 3 K




D .  m e l a n o g a s t e r  
H .  s a p i e n s  
A .  t h a l i a n a  
V p s 3 4  






D. melanogaster LTFREIEVIN-EREKRMSDYMFLMIEFPAIWDDMYNYAWYFEPEGDVK 244




D. melanogaster YKLPAKPKLVSVPDSEIQMENLVERKHHRLARSERSGISDRDAKPTASIR 294




D. melanogaster DQLHTIVYRYPPTYVLSSEEQDLVWKFRFYLSSHKKALTKFLKCINWKLE 344
H. sapiens DQLNIIVS-YPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLP 342
A. thaliana  SEKRALTKFLRCVEWSDV 18
Vps34 LKGNSDILKQPPNTKVTSKEALLIWRFRYYLTNNKKALTKFLRCVEWSES 335











D. melanogaster EDLLLYLLQLVQALKYEDPRHIVHLHGCIFPERDWRSILDDNGSLLDQS 441
H. sapiens EDLLMYLLQLVQALKYEN----------------------FDDIKNGLEPT 418
A. thaliana EELQCYLLQLVQALRFER--------------------------------- 83








KKDSQSSVSENVSNSGINS-------- AEIDSSQI ITS------------ 4 48
---------------------------------SDR-----------------86
-------------------------------FDGNPS----------------409
D. melanogaster SVALPNPSAPATPGSSSLPCDSNSNALMLAEGISFGSVPANLCTFLIQRA 541
H. sapiens —  PLPSVSSPPPASKTKEVPDGEN--------------LEQDLCTFLISRA 4 83
A. thaliana  SCLSQFLVQRA 97
Vps34  DSPLISFLFERS 421












D. melanogaster FNLRGIFYNLRKQRRFIDELVKLVKLVAKEPGNRNKKTEKFQKLLAEQDM 641
H. sapiens KSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNE- 581
A. thaliana  YQLWQSLVRQTELTAQLCSITREVRNVRGNTQKKIEKLRQLLGGLLS 194









ELTYFE— EPIRSPLTPNVLIKGIVAGESSLFKSALHPLRLTFRTPEEGG 242 
— KDLSDFQPIRLPVNPDIEIIGIVPEKSNIYKSAKSPLGLKLRTTKGE- 556 







KYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKH 67 9 






























KLSKEMVEAMGGIS SE HHHEFRKQCYTAYLHLFJRHANVMLNLFSLMVDAT 889 
KLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDAN 827 
KLCKEMVEAMGGAESQYYTRFKSYCCEAYNILRKSSNLILNLFHLMAGST 4 4 0 
KLCKEMVTjGMGGENSKHYEKFKQLCCEAYNILRKSSHLI LNLFALMVDAS 7 5 6 





















Fi gure  3 .10:  The amino acid s eq uence  a l i g n me n t  of  
domai n  of  PI3K in d i f f erent  organi sms .  The Clus ta l
the cata lyt i c
W progr am at
EBI (h t t p : / / w w w . e b i . a c . u k ) was used to gene r a t e  s equence  a l i gnment s
c ompar ing  amino acid sequences  o f  P I 3K in o the r  o rgan i sms  wi th that
o f  PfPI3K.  The  ca t a ly t i c  core  ( homol ogy  r eg ion  1) shows  h ighly  
c onse r ved  amino acid r es idues  ( shown in blue) .  The  res idues  cr i t i ca l
for  ATP bind ing  ( l ys i ne  and a rg in ine  r e s idues )  are shaded in green.  
The  s igna t u r e  r es idues  such as the ATP b i nd i ng  si tes  are c o l oured  in 
red,  whi le  the  p r o l i n e - r i ch  region is co l ou re d  in pink.  The 
a bb re v i a t i on s  used are as fo l lows:  D. melanogaster- .  D ro so p h i la  
m e la n o g a s te r  (c lass  II) ;  H. sapiens'.  H om o sa p ien s  (c lasss  I);
A. thaliana' . A r a b id o p s i s  thaliana-, V p s 3 4 : S a c ch a ro m yc e s  cere v i s ia e  
(yeas t )  ( c l ass  II I )  and PfPI3K:  P la sm o d iu m  fa lc ip a ru m  
p h o sp h a t i d y l i n o s i t o l  3-kinase.
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The fo l l owi n g  mot i f s  were  i den t i f i ed  us ing  a m o t i f  f i nde r  at the  EBI 
webs i t e  (h t tp / / :  www.  eb i . ac .uk) .  F igur e  3.11 i l l us t r a t e s  the  d i f f e r en t  
mot i f s  found  in the amino acid s equence  o f  the ORF.
1 M IH Y ID D S K N V K IE R N R D N S F F SN F L Q F N D N L D F F L N A T Y S D E D N N Y E IL D D SIN FVQ K Q 60
6 1 K I K K I K T P L I L P I D P N I E L L S F L P E Q S Y V L R S S L Y P I V I A C L V R K K IK L Y N E N Y N N L IIN 1 2 0
1 2 1 NHT FYKNDQN K D N IIN N L S Y D K SY H SY Y N S Q F IK T L Q N S F E S T T S L N Y H Y N F L K C S N N N I 1 8 0
1 8 1 F Y K N K K IE R I K P N T S IQ K A F P S N E N IL N R N Q H V Y Y SN N Q I VHNIKKM NKH KRDD YM IN EK 2 4 0
2 4 1 V L P C V S N S C L GDKLM PSHDK MRS SHDKMMP SHDKMMPSHD KLM SPH YTLM S S H D K P VA P S 300
3 0 1 G V S S L G E K K S KD EKKN R KKY N E IY Q L S IK K Y IY K A G D D L R Q D H L V IQ I IY VMDNIW KRYG 360
3 6 1 L D L K M T L Y R V L A L S T D D G F I E F V D Y A E S IS S IK K N Y K G E I R Q Y F ID N S T C S S S P L G F D T E 4 20
4 2 1 IL Q N F IS S C A G Y S V I T Y I L G IG DRH LD N LM V T K D G R F F H I D F G Y IF G E D P K P FSP P M K L C 480
4 8 1 KEM IEA M GG A H S IG Y E Q F L K K C C L A Y K Y L R Y H S Q L I I S L L DAMCDAGLKD M K M SP ELC V1 540
5 4 1 K V Q E K F R L D L N D E A A E IY F L S V IN A S V K T L F P V W D K 1 H E WA1NWK 58 6
Figure  3 .11:  Amino  acid mot i f s  in PI3K.  The amino acid s equence  
o f  P I 3K s howi ng  the ATP b ind ing  mot i f s  ( red) .  A p r o l i ne - r i ch  m o t i f  
(p ink)  and the l euc i ne  z i p pe r - l i k e  m o t i f  (b lue )  are shown.
3.6 The effects o f  selected compounds on P. fa lc iparu m
3.6.1 An t i m a l a r ia l  e f fect s  o f  the p h o s p h at i d y l i n o s i t o l  3 - k i nase  
inh i b i t ors  and f or sko l i n  and 1 , 9 - d i de o xy f o r sk o l i n
The I C 5o va lues  for  ch l o r o q u in e ,  qu in ine ,  wor t mann i n ,  LY294002 ,  
f o r sko l i n  and 1 , 9 -d id e ox yf o r sk o l i n  ove r  a s ingle  and double  cycle  
were  d e t e r mi ne d  f rom s igmoid  dose  r e sp on se  curves  as shown in 
F i gu r e  3.12.  Inh ib i t i on  assays  were  r epea t ed  at l eas t  f ive  t imes  for  
each agen t  t es t ed .  F igur e  3.12 r ep re sen t s  the  I C 50 va lues  obta ined  
f rom f ive exper iment s .  The  s t anda rd  d ev i a t ion  is for  the five 
exper iment s .
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log concentration (jiM)
Figure 3.12: Sigmoid dose response curves of selected compounds and antimalarial 
agents over a single (top) and double (bottom) cycle of DNA synthesis representative 
of five experiments. Chl o r oqu i ne  ( ♦ ) ,  qu in ine  ( ), LY294002  ( ♦ ) ,
1, 9 - d i de ox yf o r s ko l i n  ( T ) ,  wor t mann i n  ( ) , f o r sko l in  ( ■ ) ,  (1)
s t anda r d  devia t ion.
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The I C 5o va lues  ob t a i ned  for  wor t mann i n  over  a s ingle  
(110  ± 4.90 pM)  cycle  and double  (66 .12  ± 8.93 pM)  cycle  are  h i ghe r  
than the  d o c um en t ed  resul t s  o f  wo r t ma n n i n  on whole  cel l s  such as 
h uma n  n e u t r oph i l s  (10 pM)  (Powis  et a l ,  1994).  The I C 50 values  
ob t a i ned  for  L Y2 94 00 2  over  a s ingle  (32 .14  ± 2.80 pM)  cycle and 
double  (27 .45  ± 5.68 pM)  cycle  are c omp ar ab l e  to the I C 50 va lues  
ob t a ined  on cu l tu red  rabbi t  cel l  l ines  (20 pM)  (Vlahos  et al ,  1994).  
The ob t a ined  I C 50 va lues  for  f o r sko l i n  over  a s ingle  
(169 . 76  ± 2.41 pM)  and double  (80 .80  ± 7.84 pM)  cycle  are h igher  
co mp ar ed  to the  I C 50 va lues  ob t a ined  on smoot h  musc l e  cel l  l ines 
( 50 - 100  pM)  ( S eamons  & Daly,  1986) .  Ch l o r o q u i n e  and quin ine  
r emain  a t h o u s a n d - f o l d  more  po t en t  than the pro t e in  k inase  i nh ib i to r s  
i nve s t iga t e d  ( wor t mann i n  and LY294002 .  The PI 3K spec i f i c  
i nh i b i t o r s  wo r t ma nn in  and L Y 2 94 0 0 2  had s ign i f i can t  d i f f e r ences  wi th 
r ega rd  to the i r  e f fec t s  on P. f a l c i p a r u m  over  a s ingle  ( p<0 . 0002)  and 
doub l e  ( p < 0 . 0 0 8)  cycle.  L Y2 9 40 0 2  was shown to be the mos t  potent  
o f  the  p r o t e i n  k inase  i nh ib i to r s  i nves t iga t ed  (F igure  3.13) .
The a deny l a t e  cyc l a se  ac t i va tor ,  f o r sko l i n  and its iner t  ana logue  
1 >9-dideoxyfor sko l in  were  also s ig n i f i c an t l y  d i f f e r en t  over  a s ingle  
( p < 0 . 0001)  and doub l e  (p<0 .0 0 8 8 )  cycle  o f  DNA synthes i s .
1, 9 - d i d e o xy f o r sk o l i n  has  a more  po t en t  i nh i b i t o r y  e f fec t  on 




Figure  3 .13:  Co mpa r i s on  of  IC5o values  over  a s ingle  ( ) and
doubl e  ( ) cycle  o f  DNA synthes i s .  The values  i nd i ca t e  the mean
± s t anda rd  dev ia t i on  o f  at leas t  t h r ee  e xp e r i men t s
3.6 .2  M or p h o lo g ic a l  e f fect s  o f  the se l ec ted  comp o u nd s  on 
P. f a l c i p a r u m  3D7 s train
The morp h o l o g ica l  e f fec t s  o f  three  c on ce n t r a t i on s  o f  t hese  se lec ted  
c omp ou n ds  were  c ompar ed  to the d rug  f ree  pa ras i t e s .  At the high 
drug  c on ce n t r a t i on  the t ro ph o z o i t e s  a pp ea re d  to be more  vacuo l a t ed  
than the  un t r ea t ed  con t ro l  t r o p ho z o i t e s  ( F i gure  3 .14) .  Whi l s t  the 
pa ras i t e s  in the  r ing s tage  appea red  s ma l l e r  c ompar ed  to the cont rol  
pa ras i t e s  (not  shown) .  The  red b lood cell  me mb r a n e  appeared  to 
remain  un a l t e r ed  compar ed  to the con t ro l  red blood cel l s  but  more 
re f ined  me thods  such as e l ec t ron  m i c ro s co py  would need to be done 
to ver i fy  thi s  obse r va t ion .  At the h igh  drug  concen t r a t i on  the 
t r ophoz o i t e s  a ppea red  to be sma l l e r  than the un t r ea t ed  cont rol  
t r o ph o zo i t e s  ( F i gure  3 .15) .  Whi l s t  the  pa ras i t e s  in the r ing s tage 
a ppea red  smal l e r  c ompar ed  to the  cont ro l  pa ras i t e s  (not  shown) .  The
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pe rc en t a ge  r ings ,  t ro ph o zo i t e s  and s ch i zon t s  d e cr ea sed  as 
c on ce n t r a t i on s  inc reased .
Figure  3 .14:  Ef fects  of  se l ected comp o u nd s  on the t roph ozo i t e  
s tage  o f  P la sm o d iu m  f a l c i p a r u m  compared  to an untreated control  
( under  lOOOx oil  immers ions ) .  A: con t ro l ,  B: 1, 9 - d i de oxyf o r sko l i n ,  
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Fi gure  3 .15:  The e f fect s  of  se l ected c om p o u n ds  on the growth of  
P. f a l c i p a r u m .
LY2 9 40 0 2  was the more  e f f ec t ive  p ro t e i n  k inase  i nh i b i t o r  aga ins t  the 
r ing s tage  o f  P. f a l c i p a r u m  compar ed  to wor t mann i n ,  and also had a 
lower  I C 50 va lues  (F i gure  3.13 & 3.15) .  H ow ev e r  both P13K 
inh ib i to r s  do not  show a s ign i f i c an t  e f f ec t  aga i ns t  the s ch i zon t  and 
t r o p h oz o i t e  s tages  o f  P. f a l c i p a r u m . 1, 9 - d i de ox y f o r sk o l i n  has a lower  
I C 50 va lue  c ompar ed  to fo r sko l in  and showed  to be more ef fec t ive  
aga ins t  the  r ing s tages  o f  P. f a l c i p a r u m  (F i gure  3.13 & 3.15) .
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4.0 DISCUSSION
4.1 I de nt i f i ca t i o n  of  a p ho sp ha t i d y l i no s i t o l  3 - k i nase  h o m o lo g u e  
in P. f a l c i p a r u m
An open r ead ing  f r ame  encoding  a pu t a t i ve  PI3K homo l o g u e  was used 
to des ign spec i f i c  p r i mer s  to ampl i fy  t he  sense  s t rand o f  the  DNA 
cod ing  for  the  ORF (F igure  3.1) .  The  PCR Mas te r  kit® was used to 
o p t i mi ze  some o f  the  PCR pa r amet e r s  such as annea l ing  t empe r a t u r e ,  
p r imer  and DNA concen t r a t i on .  The  op t i mum annea l ing  t e mp e ra t u r e  
was found  to be 64°C,  where  a s i ng l e  band of  the  expec t ed  s ize  of  
1 812 bp was obt a ined ,  wi th  no other  bands  due to non- spec i f i c  
b i nd i ng  be ing  gener a t ed .  At the  lower  a nn ea l i ng  t empe ra t u r e s  
(58-62°C)  minor  bands  (900 bp & 400 bp)  were  obse rved  ( shown in 
F i gu r e  3.3) .  This  may have  been due to n on - s pe c i f i c  b ind ing  of  
p r imers  at lower  annea l i ng  t e mpe ra t u r e s .  The  op t i mum pr imer  
(0.1 pM)  and DNA c on cen t r a t i on  (1 p g / 30  pi )  gene r a t ed  a PCR 
produc t  o f  the  expec t ed  s ize  o f  1 812 bp at an annea l i ng  t e mp e ra t u r e  
o f  64°C (F igure  3.3).
The 1 812 bp PCR p r oduc t  ge ne r a t e d  when us ing  the  Expand  High 
F i de l i t y  kit®, was pa r t i a l l y  s equenced  f r om both  ends o f  the  ORF to 
de te r mi ne  the  sequence  (F i gure  3.5) .  Ana lys i s  of  the DNA sequence  
of  t he  PCR produc t  wi th  the  Blas tn  p r o g ramme  at P l a smoDB showed 
98-99  % i den t i t y  to the  same par t  o f  the  sequence  of  P fPI3K 
(P F0765w)  l oca t ed  on c h r o mo so me  5. H ow e v e r  the  overa l l  s equence  
may have  a lower  iden t i t y  in c om p ar i so n  to the  ORF of  P F 0 7 6 5 w 
seque nc e  due to p o lymor ph i sm.  The  changes  in the  amino acid 
s eque nc e  may lead to overa l l  changes  in the  s econdary  and t e r t i a ry  
s t r uc t u r e  o f  the  protein.
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The P f P I 3K  PCR p roduc t s  f rom th r ee  PCR reac t ions  were c loned  into 
the  p QE80L e xp r e s s i on  vector .  The  t r a n s f o r m e d  c lones  were  screened  
by r e s t r i c t i on  d i ges t i on  and PCR ( F i gu r e  3.6 & 3.7) .  Pr oduc t s  
ob t a ined  by r e s t r i c t i on  d iges t i on  o f  p l a smids  show an inser t  o f  the 
expec t ed  s ize  o f  1 812 bp when s epa ra t e d  on a 1 % aga r ose  gel.  When 
c lones  were  s c r eened  by PCR a minor  band of  800 bp was also seen in 
add i t i on  to the  1 812 bp band when the  PCR Mas t e r  kit® was used.  
Thi s  may be due to unspec i f i c  b i nd i ng  o f  p r imers  to a r eg ion  of  
c o m p l e me n t a r i t y  to the  sense and a n t i s e n s e  p r imers  wi th in  the  ORF 
sequence .  When the  P f P I3 K  inser t s  of  the  p QE - 8 0 L  p l a smid  were 
sequenced  by a u t oma t ed  s equ e nc in g  us ing  vec t o r  pr imers ,  a longer  
s eq ue nc e  was ob t a ined  and ana lysed  to e s t ab l i sh  the  iden t i t y  essent i a l  
for  p ro t e in  express ion .  The P f PI 3 K inser t  was s equenced  wi th vector  
p r imer s  and was found to be in f rame.
A smal l  (5 ml)  t ime sca le  pro t e in  e xp r e s s i on  s tudy o f  the pu t a t i ve  
P f P I 3 K  gene  produced  no de t ec t ab l e  p roduc t  by wes t e rn  blot  ana lys i s  
us ing  an t i -His  monoc lona l  an t ibody  (F i gure  3.8a) .  A la rger  sca le  
pro t e in  expres s ion  e xpe r imen t  o f  the  p u t a t i ve  Pf PI3K gene  produced  
three  bands  o f  the  s izes 68.5 KDa,  45 KDa  and 35 KDa (F igure  3.8b).  
The band of  68.5 KDa is most  l ike ly to be t he  exp re s sed  pro t e in  and 
the smal l e r  bands  (45 KDa  & 35 KDa)  are p r obab l y  t runca t ed  
t r a ns l a t i o n  p roduc t s  or p r o t e o l y t i c  d e gr a da t i on  p roduc t s  o f  the 
pro t e in  (F igure  3 .8b) .  F u r the r  i n v e s t i ga t i on s  are r equ i r ed  to op t imi se  
the  e xpre s s i on  o f  P f P I 3K  and to ver i fy  the  iden t i t y  of  the  68.5 KDa 
band.
4.1.1 Se quence  analys i s  of  the predi c ted  gene  in Pl asmoDB  
c ont a in i ng  the ca ta l y t i c  domain
Blas t  ana lys i s  of  the  ORF con t a i n i ng  the  ca t a ly t i c  domain produced  
s i gn i f i c an t  a l i gnmen t  to the  V p s 3 4 - l i k e  pho s ph a t i dy l i no s i t o l  3 -k i na se  
( F i gure  3.2) .  The  Vp s3 4 - l i k e  P I 3K is i mp l i ca t ed  in the  sor t ing  of  
vacuo l a r  pro te ins  in yeas t  cel l s  and in mammal i an  cel ls
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(S t ack  & Emr,  1994).  In P. f a l c i p a r u m  the  Pf PI3K may have  a s imi l a r  
func t i on  as to t ha t  of  t he  Vps34- l i ke  PI3K.  F u r t h e r mo r e  the PfP13K 
may be i nvo l ved  in t he  dev e l o p men t  and f unc t i on i ng  of  the  food 
vacuo l e  in P. f a l c i p a r u m , thus P f P I 3K  may be an impor t an t  po t en t i a l  
drug t a rge t  in malar ia .  The  P f PI 3 K open r ead ing  f r ame  conta ins  the  
s equences  DRHLDN and DFG conse rved  in the  ca t a ly t i c  loop of  most  
pro te in  k inases  (F i gure  3.10) .  Like  other  PI3Ks ,  Pf PI3K does not  
con ta i n  the  g l yc i ne  r ich GxGxxG sequence  m o t i f  which  is p resent  in 
s e r i n e / t h r e on i n e  kinases .
KK
D .  m e l a n o g a s t e r  FNLRGIFYNLRKQRRFIDELVKLVKLVAKEPGNRNKKTEKFQKLLAEQDM 64 
H .  s a p i e n s  KSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNE- 581
A .  t h a l i a n a  ---YQLWQSLVRQTELTAQLCSITREVRNVRGNTQKKIEKLRQLLGGLLS 194
V p s 3 4  ------AQRVNAQNKFISRLSLLSVELKAMNITREKKIEKLRIMLAEGEY 509
P C P I 3 K  RDDYMINEKVLPCVSNSCLGDKLMPSHDKMRSSHDKMMPSHDKMMPSHDK 281
R K K
D .  m e l a n o g a s t e r  SCAGYCVITYLLGVGDRHLDNLLLTTNGKLFHIDFGYILGRDPKPMPPPM 839 
H .  s a p i e n s  SCAGYCVITYILGVGDRHLDtTLLLTKTGKLFHIDFGYILGRDPKPLPPPM 777 
A. t h a l i a n a  SCAGYSVITYILGIGDRHLDNLLLTDDGKLFHVDFAFILGRDPKPFPPPM 390 
V p s 3 4  SCAGYCVITYILGIGDRHLDNLLLTPNGKLFHIDFGYILGKDPKILPPPM 706 
P f P I 3 K  SCAGYSVITYILGIGDRHLDNLMVTKDGKFFHIDFGYIFGEDPKPFSPPM 477
Figure  4.1:  Sequence  of  the ca ta ly t i c  domai n  in PfPI3K.  Al ignment  
o f  the  P f P I 3 K  wi th other  PI3Ks  in o the r  o rgan i sms  shows  the  four  
c h ar ac t e r i s t i c  l ys ine  r es idues  i nvo l ved  in p h o s ph o r y l a t i o n  of  PI3Ks  
shown in green.  P f PI 3 K has a me th i on i ne  in p l ace  o f  l ys ine  in the  
pos i t i on  c o l oured  in tu rquoi se .  The  amino acid  r es idues  cha r ac t e r i s t i c  
o f  t he  ca t a l y t i c  loop are shown in red.  The p r o l i ne - r i ch  reg ion  is 
shown in pink.  The  lys ine  r e s i due  c r i t i ca l  for  p ro t e in  k inase  ac t iv i ty  
is shown in blue.
4.1 .2  Se qu en ce  ana lys i s  of  the p h o s p h at i d y l i n o s i t o l  3 -k inase  
predic ted in Pl asmoDB
Other  reg ions  i den t i f i ed  in the  c ompl e te  P F E 0 7 6 w  gene  inc ludes  the 
he l i ca l  domain  and a ca t a l y t i c  core  domain  (Fruman et al ,  1998).  A 
p r o l i n e - r i ch  reg ion  and a l euc i ne  z i pp e r - l i ke  r eg ion  have  also been 
ident i f i ed .
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4.1 .2 .1  The c ata l y t i c  domain
The C- t e rmi na l  o f  Pf PI3K conta ins  one of  the h igh ly  conse rved  
fea tures  o f  the  ca t a ly t i c  domain ,  na me l y  a conse rved  lys ine  r es idue  
wi th in  the  ATP b ind ing  si te which  is c h a r ac t e r i s t i c  o f  most  prote in  
k inases  (F i gure  4.1) .  The  lys ine  r e s idue  ad j acen t  to the GDRHLDN 
and DFG region  is c r i t i ca l  for  pro t e in  k inase  ac t i v i t y  in all p ro t e in  
k inases .  Ob s t r u c t i o n  of  this r e s idue  by the PI 3K inh i b i t o r  
wor t ma nn i n ,  was shown to impa i r  p h o s p ho r y l a t i o n  (Va nh ae se br o c k  et 
a l , 2001) .  The C- t e rmina l  r eg ion  in the ORF o f  P f P I 3K  conta ins  the 
ATP b ind ing  and ac t i va t i on  s i tes  which  de t e r mi ne  subs t r a t e  
spec i f i c i t y .  F o u r  r es idues  are c r i t i ca l  in the ac t i v a t i o n  o f  the 
ca t a l y t i c  loop,  three  l ys ine  r e s i dues  and an a rg in ine  r e s idue  
(F igure  4 .1)
In P f P I 3K  the l ys ine  r e s idue  in pos i t i on  808 is r ep l aced  by a 
me th io n i ne  re s i due  and s ince  lys ine  has  char ged  polar  side chains  
whi l s t  me th io n i ne  has non polar  s ide cha ins  this  may lead changes  in 
the  s t r uc t u r e  o f  the p ro t e in  (F igure  4.1) .  Thus  the ATP c oord i na t i on  
and t r ans f e r  o f  p hos pha t e s  to the l ipid  head g roups  in P I 3Ks  is 
d i f f e r en t  f rom the ca t a lys i s  d i sp l ayed  by o t he r  PI3Ks  (F igure  4.1) .  
The  ca t a ly t i c  loop is r e sp o ns i b l e  for  d e p r o t on a t in g  the subs t r a t e  
t he reby  g e ne r a t i n g  the n uc l eo p h i l e  t ha t  a s soc i a t e s  wi th the y- 
pho sp h a t e  o f  ATP ( Va nh ae s eb r o c k  et al ,  2001) .  The ca t a ly t i c  loop is 
de f ined  by the c onsensus  s equence  G I G D R H L D N  ( Wat e r f i e l d  et al,  
1997) .  This  consens us  sequence  is p r e s en t  in PfPI3Ks .
4 .1 .2 .2  The he l i ca l  domain
The domain  ad j acen t  to the N - t e rm i n u s  o f  the ca t a ly t i c  domain  in the 
compl e t e  P f P I 3K  gene s equence  in the  P l a smoDB is the  he l i ca l  
domain  (not  shown)  which  acts as the s t ruc tu ra l  spine on which o ther  
domains  are anchor ed  ( Va nh a e s e b r o c k  et al ,  2001) .  The domain 
cons i s t s  o f  f ive  par t s  o f  an t ipa ra l l e l  h e l i c es  t ha t  are a r ranged  in a 
pa t tern.  The a r r a ng em en t  sugges t s  a pos s i b i l i t y  that  the  he l i ca l
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domain  is i nvo l ved  in p r o t e i n - p r o t e i n  i n t e r ac t ions  ( Va nh a e s e b r o c k  et 
al,  2001).
4.1 .3  A dd i t i o n a l  s t ruc tura l  mot i f s  in Pf PI3K
Two add i t i ona l  s t ruc tu ra l  mot i f s  were  i den t i f i ed  in the  1 758 bp ORF 
that  are s imi l a r  to t hose  i den t i f i ed  in o ther  PI3Ks .  The f i r s t  
i den t i f i ed  r eg ion  is a p r o l i ne - r i ch  reg ion  which is i mp o r t an t  in the 
med ia t i on  o f  p r o t e i n - p r o t e i n  a s soc i a t i ons  (F igure  3.10) .  The  pro l ine-  
r ich r eg ion  was shown to form a l e f t -h a nd e d  he l i ca l  domain  in PI3Ks  
found  in D ro s o p h i la  (Va nh ae seb r ock  et a l ,  1997).  The  second mot i f  
i den t i f i ed  in t he  pu t a t i ve  PfPI3K is a r eg ion  s imi l a r  to the  basic  
l euc i ne  z ip p e r - l i ke  domain.  The  l euc i ne  z i pp e r - l i ke  m o t i f  has the 
t yp i ca l  l e uc i ne /v a l i n e / i s o l e u c i n e  a r r a ng em en t  o f  r es idues  (F igure  
4.2) .  The  bas ic  l euc i ne  z i pp er - l i k e  m o t i f  may form he l i ca l  s t ruc tures  
that  can f o r m a co i l ed  d imer i c  p ro t e in  z ipper  complex.  In 
t r a n s c r i p t i o n  fac tors  the  l eucine  z i ppe r  m o t i f  f unc t i ons  in DNA 
bind ing  and t r a ns c r ip t i on  f ac to r  d i mer i s a t i on .  It has been sugges t ed  
that  the  l euc i ne  z i ppe r  may func t i on  as a b ind ing  domain  for the 
p l ecks t r i n  h o m o l og y  domain  in PI 3K and may thus  have  a s imi la r  




V p s34  
PfPI3K
EYAAIFKHGDDLRQDQLILQMITLMDKLLRRENLDLKLTPYKVLATSSKH 7 4 1  
KYPVIFKHGDDLRQDQLILQIISLM DKLLRKENLDLKLTPYKVLATSTKH 679 
SCKLIFKKGDDLRQDQLWQMVWLMDRLLKLENLDLCLTPYKVIATGHDE 292 
EYGVIFKTNDDLRQDQLIIQLISLM DRLLKKENLDLKLTPYKVLATAEED 606 
-------YIYKAGDDLRQDHLVIQIIYVM DNIWKRYGLDLKM TLYRVLA1STDD 377
Figure  4 .2:  The l euc ine  z i p p e r - l i k e  mot i f .  The l euc i ne  z ippe r - l i ke  
mot i f s  a re  i nd i ca t ed  in b lue  in t he  above  Clus t a l  a l ignment .
The p re sen c e  o f  a p l ecks t r i n  h omol ogy  domain  in the  comple t e  gene 
s eque nc e  p red i c t ed  in the  P l a smoDB was i nves t iga t ed  us ing  the mot i f  
f inder  at t he  EBI webs i t e  (h t t p : / / w w w . e b i . a c . u k ) and no typ i ca l  match 
was found.  The  p l ecks t r i n  homo lo g y  domain  is found in many 
s i gna l l i ng  pro te ins  tha t  med ia t e  p r o t e in - l i p i d  i n te rac t ions .
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In t he  case  o f  most  do w ns t r e a m  e f fec t or s  of  P I 3K such as PDK and 
pro te in  k i na se  B the p l ecks t r i n  homo l og y  domain  is r equ i r ed  for  its 
r e c r u i t me n t  to the  p l a sma  membrane .
The  r e c r u i t m e n t  occur s  t h r ough  b i nd i ng  of  phos pho i nos i t i des  
p r oduced  by the  ac t i va t ed  PI3Ks  (Hi l l  & He mmi ngs ,  2002) .  A PDK 
h o m o l o g u e  which  p rov ides  a mi s s i ng  l ink be t ween  PI 3K and its 
d o wn s t r e a m e f fec t or s  in the  PI 3K s i gn a l i ng  pa t hways  has not  been 
p red i c t ed  in the  P l a smoDB.  F u r the r  i nv es t i ga t i on s  can c lar i fy  the 
spec i f i c  means  of  PI3K s i gna l ing  in the  a bsence  of  PDK and a 
p l ecks t r i n  homo l og y  domain  or i den t i fy  o ther  p ro te ins  which may 
ful f i l l  the  f unc t ion  of  PDK.
4.2 A n t i ma l a r ia l  propert i es  o f  s e l ec ted  comp o u nd s
The t r i a t ed  h y p ox a n t h i n e  i n c o r po r a t i o n  assay was used as a di rect  
measu r e  o f  the  an t i ma l a r i a l  ac t i v i t y  o f  the  se l ec t ed  compounds ,  
wo r tma nn i n ,  LY294002 ,  fo r sko l in  and 1, 9 - d i deoxyf o r skon .  
Wo r t ma nn i n  and L Y 294002  were  less po t en t  than  ch l o r oqu i ne  and 
qu in ine  in i nh i b i t i ng  P. f a l c i p a r u m  growth.  They inh ib i t ed  
P. f a l c i p a r u m  in the  mi c r omol a r  ( 20- 200  p.M) r ange  compar ed  to 
c h l o r o q u i n e  and qu in ine  which inh i b i t ed  in the  low na no mo l a r  
(9 -100  nM) range  (F igure  3.13) .  L Y2 9 40 0 2  was more  e f f ec t i ve  than 
wo r t ma nn i n  over  a s ingle  and double  cyc l e  o f  DNA synthes i s .
The  a de ny l a t e  cyc l a se  ac t i va to r  f o r sko l i n  i nh ib i t ed  P. f a l c i p a r u m  
g rowt h  wi th a r e l a t i ve ly  high IC50 compar ed  to its iner t  ana logue
1, 9 - d id e ox y f o r s ko l i n ,  over  a s i ng l e  and d oub l e  cycle  o f  DNA 
synthes i s  (F i gure  3.13) .
4.2.1 An t i m a l a r ia l  e f fect s  o f  w or t ma nn i n
High conce n t r a t i on s  o f  wo r t ma nn i n  were  r equ i r ed  to inh ib i t  whole  
cel l  ac t i v i t y  in compar i son  wor t mann i n  i nh i b i t ed  i so la t ed  PI3K
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enzymes  wi th  I C 50 va lues  in the  nan o mo la r  r anges  ( shown in Table  
4.1)  (S t ack  & Emr,  1994;  Wal ke r  et al ,  2000) .  Thi s  may be due to the  
i nc r eased  ava i l ab i l i t y  of  the  drug to the  ac t i ve  s i t e  on i s o l a t ed  
enzymes  compar ed  to whole  cel l s .  Wo r t ma nn in  was not  as e f f ec t ive  
on P. fa l c ip a r u m  as compar ed  to S. p o m b e  and S. c e rev i sa e  yeas t  
cel l s  ( T ab l e  4.1)
Table  4.1:  The i nh i b i t ory  e f f ec t s  o f  w o r tm a n n i n  on di f f erent  
e nz yme  sys tems .
O r g a n i s m
I s o l a t e d  e n z y m e  
( I C 5 0 )
W h o l e  c e l l  ( I C 5 0 )
V p s 3 4 - l i ke  S. 
c erev i sa e  yeas t  cel l s
20-50 p M 1
Human  p l a t e l e t  cel ls 2-5 n M 2 —
Human  l eukocy t es 10-20 n M 3 —
S c h i z o s a c c h a r o m y c e s  
pom  be
— 20 p M 3
P. f a l c i p a r u m  
S ingle  cycle  
Double  cycle
— 110.40 ± 4.90 pM 
66.12 ± 8.93 pM
1: Stack  & Emer ,  1994;  2 : Wal ke r  et a l ,  2000;  3: Powis  et al,  1994
Blas t  ana lys i s  o f  the  ORF have  su g ges te d  that  the  PI 3K h omo l og ue  in 
P. f a l c i p a r u m  is s imi l a r  to the  V ps 34 - l i k e  PI 3K found in yeas t  cel ls 
(F i gure  3 .10) .  The  c lose  s hape  c o m p l e m en t a r i t y  be tween  the PI3K 
ac t i ve  s i te and wor t mann i n  enables  wo r t ma nn i n  to i r r eve r s ib ly  inhib i t  
mos t  i so l a t ed  P13Ks at nan o mo la r  c on ce n t r a t i on s  (10-50 nM)
( V a nh ae se br oc k  et al ,  1997).  Al though  the  ca t a l y t i c  domain of  
P fPI3K is s imi l a r  to the  class  III  V p s 3 4 - l i k e  PI 3K it d i f f er s  to those  
found in o ther  P I 3K in class  I and II. One of  the  l ys ine  res idues  in 
the  r eg ion  for  ATP b i nd i ng  in P f P I 3 K  is r ep l aced  by a me th ion ine
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r e s idue  ( F i gu r e  4.1) .  Me t h i o n i ne  has su l fu r  con ta i n ing  s ide chains  
and less h y d r o p h i l i c  compar ed  to l ys ine  which  is a bas ic  amino acid 
and s t rong l y  polar .  It  is pos s i b l e  tha t  thi s  may cause  a change  in the  
3D c o nf i g ur a t i o n  o f  the  ac t i ve  si te,  r e s u l t i ng  in a dec r ease  in the  
i nh i b i t o r y  e f fec t  o f  wor t mann i n  on the enzyme.
Studies  have  shown t ha t  most  p ro t e in  k inase  i nh i b i t o r s  show 
d i s c r ep an c i e s  when appl i ed  to cu l t u red  cel l s ,  due to t he i r  l imi ted 
s e l ec t i v i t y .  T h e r e f o r e  it r emains  u n c l ea r  whe ther  the  resu l t s  ob ta ined  
on cu l tu red  cel l  l ines  were  the  c on s e q u e n ce  of  low spec i f i c i t y  in the 
i nh i b i t i on  o f  PI3K,  or pos s i b l e  i nh i b i t i on  of  o ther  r e l a t ed  kinases  
(Ste in ,  2001) .  Fu r the r mor e ,  in P. f a l c i p a r u m  the  drugs  have  to cross 
severa l  membranes  be fo re  r each i ng  the  t a rge t  enzyme.
In t ox i c i t y  s tudies  car r i ed  out  on rats ,  wo r t ma nn i n  was shown to be 
t oxic  at 7 mg/kg  body weight ,  where  gas t r i c  and myocard ia l  
h ae mo r r h a ge s  were  noted ,  a long  wi th nec r os i s  of  the  sp leen ,  lymph 
nodes  and ga s t r o  in t es t i na l  t r ac t  a s soc i a t ed  l ympho i d  t i s sue  (Gunthe r  
et al ,  1989).  A s ing l e  dose  o f  1 mg/kg  body weigh t  r e su l t ed  in Rhesus  
monkeys  h av i ng  weakness ,  dec r eased  mot i l i t y ,  i ncoo rd i na t ed  
b eh av io u r  and a no r e x i a  ( Wi e s i nge r  et al ,  1974).  Wor t mann i n  (1 pM)  
has also been r epor t ed  to i nc r eas e  p l a t e l e t  a gg r ega t i on  and sero tonin  
r e l ease  ( Ha sh i mot o  et a l ,  1992).  This  could  have  c l in ical  impl i ca t i ons  
such as p o t en t i a t i ng  the  pa t ho l ogy  o f  malar ia .  In vitro  exposur e  of  
wo r t ma nn i n  to neu t r oph i l s  or ma cr ophage s  r esu l t s  in the  inh ib i t i on  of  
r e sp i r a to r y  burs t s  dur ing  p hagocy t os i s  and exocy tos i s  (Baggol in i  et  
al,  1987).  In ma l a r i a  infec ted  pa t i en t s  this  may d ec r ea se  the  capac i ty  
o f  the  s ys t em to c lear  P. f a l c i p a r u m - i n f ec t ed  e ry th rocy tes  and 
merozo i t e s .  From the tox i c i t y  da ta  and high concen t r a t i ons  r equ i r ed  
to ach i eve  a t he ra peu t i c  ef fect ,  wo r t ma nn i n  should  not  be used for 
t h e r a peu t i c  purposes .  However ,  less  t ox i c  ana logues  may be a 
wor t hwh i l e  fu ture  dev e l o pmen t  for  i nves t iga t i on .
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4.2 .2  An t i m a l a r ia l  e f fect s  o f  LY294002
The s pec i f i c  P I 3K i nh ib i to r  LY294002  was shown to be t he  most  
e f f ec t ive  o f  all  t he  compounds  i nv es t i ga t ed  aga ins t  t he  P. f a l c i p a r u m  
3D7 s t ra in  (F i gure  3. 13). The  I C 50 ob t a ined  for  P. f a l c i p r u m  is 
c o m p ar a b l e  to t hose  o f  r abb i t  smoot h  cel l s  and yeas t  cel l s  
(Tab l e  4.2) .
Table  4.2:  The i nh i b i t ory  e f fect s  o f  LY294002  on var ious  
or ga n i s ms  and i so la ted  enzymes .
Organi sm Isolated enzyme  ( I C 5 0 ) Wh o l e  cel l s  ( I C 5 0 )
V ps 34 - l i k e
S. c erev i sa e  yeas t  
cel ls
50 p M 1
Human
n eu t r oph i l s
10 n M 2 20 p M 2
R abb i t  smooth  
musc l e  cel ls
— 32 p M 2
P. fa l c ip a r u m  
S ing l e  cycle  
D ou b l e  cycle
—
32.14 ± 2.8 pM 
27.45 ± 5.68 pM
1: Stack & Emr,  1994;  & 2 : Vl ahos  et a l ,  199^
L Y2 94 00 2  is a l so more  e f f ec t ive  on i s o l a t ed  enzyme  PI3Ks  compar ed  
to its e f fec t s  on who le  cel ls  ( Tab l e  4 .2)  (S tack  & Emr,  1994; Vlahos  
et al ,  1994).  The  I C 50 va lues  on the  e f fec t s  of  LY294002  on the 
pa ras i t e  are s imi l a r  to o ther  l iv ing  cel l s  (Tab l e  4.2) .  Though  no 
e xp er i men t a l  ev i dence  ind i ca t es  whe t he r  P I 3K k inase  ac t i v i ty  is 
p re sen t  in u n i n f e c t ed  e ry t h rocy t e s  the  i nh i b i t i on  of  the hos t  cel l  PI3K 
may co n t r i b u te  to the  ef fect s  o f  t he  i nh i b i t o r  on pa ras i t e  growth.  
L Y2 94 00 2  has al so been ex t ens i ve l y  app l i ed  to cu l tu red  cel l s  i norde r  
to i nv e s t i ga t e  the  b i o log i ca l  e f fec t s  o f  PI3K act iva t ion .  Studies  have
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shown that  L Y2 94 00 2  acts as a c om p e t i t i v e  i nh ib i to r  o f  ATP at the  
ca t a ly t i c  s i te  o f  P I 3K  (Stein ,  2001) .  The  main d e te r mi nan t  o f  PI3K 
inh i b i t i on  by LY29 4 0 02  is the  bulky 8-phenyl  group.  L Y 294002  was 
shown to d i sp l ay  very l i t t l e  s e l ec t i v i t y  wi th in  the  PI 3K fami ly  and 
shown to lose  se l ec t i v i t y  for  PI 3K at c once n t r a t i ons  be tween 50 and 
100 pM in vivo  on rats  which  appear s  to para l l e l  the  e f fect  of  
L Y2 94 00 2  on P. f a l c i p a r u m  (32.14 ± 2 .80 pM)  ( Ja f fe  et al ,  2000).
In rats ,  ad mi n i s t r a t i on  of  LY294002  to t rea t  ovar i an  cancer  at a dose 
o f  100 mg/kg r e s u l t ed  in skin t ox i c i t y ,  in the  f o r m of  dry scaly skin 
and d e r ma t o l og i ca l  l es ions  ( Ja f fe  et al ,  2000) .  Thus  LY294002  
requ i res  ex t ens i ve  f u r t he r  p rec l i n i ca l  and c l in ica l  t e s t i ng  be fore  
c on s i de r i ng  its use in the  m a nag e me n t  o f  ma l a r i a  and cancer .  Less 
t ox ic  ana l ogues  o f  LY294002  may be usefu l  to screen for  an t i ma l a r i a l  
act ivi ty .
4.2 .3  An t i m a l a r ia l  e f fect s  o f  for sk o l i n  and 1 , 9 - d i de ox y f or sk o l i n
Fo rsk o l i n  was shown to e l eva t e  cAMP in many cel ls.  E l eva t ed  cAMP 
level s  were  shown  to ac t i va t e  pro t e in  k inase  B in a P I 3K i dependen t  
manner  ( Wo o dg e t t  et al,  1996).  In c on t r a s t  1 ,9 - d i d e ox yf o r sk o l i n ,  the  
iner t  a na l ogue  o f  fo r sko l in ,  has no e f f ec t  on the  cAMP levels  and is 
shown to have  lower  I C 50 va lues  c ompar ed  to for skol in .  Thi s  sugges t s  
tha t  the  e f fect s  o f  1 , 9 -d id e ox y f o r sk o l i n  may not  be s pec i f i c a l l y  on 
the expec t ed  t a rge t s .  Fo r sk o l i n  had a min imal  i nh ib i to r y  e f fect  on the  
P. f a l c i p a r u m  3D7 s t ra in  wi th an I C 50 va lue  o f  169.76 ± 2.41 pM 
over  a s ing l e  cycle  and 80.80 + 7.84 p M over  a double  cycle  of  DNA 
synthes i s .  H ow e v e r  its iner t  a na l ogue  1 , 9 - d i de oxyf o r sko l i n  had an 
I C 50 va lue  o f  42.45 ± 3.94 pM over  a s i ng l e  cycle  and 
28.53 ± 3.43 pM over  a double  cycle ,  which  is s imi l a r  to the 
i nh i b i t o r y  ef fect s  o f  LY29 4 0 02  and wor tmann in .  Fur t he r  
i n v es t i g a t i on  into the  an t i ma l a r i a l  e f fec t s  o f  1 , 9 - d i de oxyf o r sko l i n  
and o ther  de r iva t ives  may be wor thwhi le .
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H ow ev e r  t he  t ox i c i t y  da ta  o f  1, 9 - d i d e o xy f o r sk o l i n  should  be t aken  
into c ons i de ra t i on  where  doses  o f  16 pM were  shown to p o t e n t i a t e  
n e u r o t o x i c i t y  in rat  spinal  neurons  ( C he s n o y- Ma r ch a i s ,  2003).  
Al though  the s t ruc tu ra l  d i f f e r ences  be tween  1, 9 - d i d e o xy f o r sk o l i n  and 
fo r sko l i n  f avour  a n t i ma la r i a l  ac t i v i ty  it  also appear s  to change  the 
t oxic  potent i a l .  Fo r sk o l i n  was shown to i nd i ca t e  a low tox i c i t y  on 
whole  rabb i t  smooth  musc l e  cel ls  at c on ce n t r a t i on s  o f  2-10  pM,  
howe ve r  cau t i on  is to be taken in h y p o te ns i ve  pa t i en t s  as f o r sko l i n  
po t en t i a t e s  l ow b lood pressure .  Cau t ion  is al so to be t aken  in pa t i en t s  
su f f e r i ng  f rom pept i c  u lcer s  as f o r sko l i n  s t imul a t e s  gas t r i c  acid 
s ec r e t i on  (Seamons  & Daly,  1986).
4.3 C om p a r i s o n  o f  the se lected c omp o u nd s  wi th other  t herapeut i c  
drugs  used for  malar ia
The t es t ed  PI3K pro te in  k inase  i nh i b i t o r s  L Y2 9 40 0 2  and wor tmann in  
i nh ib i t ed  t he  g rowt h  of  P. f a l c i p a r u m  wi th  I C 50 va lues  in the 
mi c ro mo l a r  r ange  (20-200 pM).  In con t r a s t ,  drugs  used in the 
p r ophy l ax i s  and t r ea tme n t  o f  ma la r i a  i nh i b i t e d  the  g rowth  of  
P. f a l c ip a r u m  wi th I C 50 va lues  in the  n a n o mo l a r  range  (9 - 100nM)  
( F i gu r e  3.13) .  Th e re fo re  the  t h e ra p eu t i c  drugs  are st i l l  more e f fec t i ve  
aga ins t  P. f a l c i p a r u m  than the  P I 3K  i nh i b i t o r s  LY294002 ,  
wor t mann i n .  The iner t  f o r sko l i n  an a l og ue  1, 9 - d i de ox y fo r s ko l i n  was 
also less e f f ec t ive  c ompar ed  to t he  c l a s s i ca l l y  used drugs.  The high 
degree  of  h omol ogy  be tween  the  h uman  and Pf PI 3K ca t a ly t i c  domain 
may resu l t  in major  compl i ca t i ons  in d e ve lo p i n g  the PI3K spec i f i c  
pro t e in  k inase  inh ib i to r s  for  the  t r ea tme n t  of  malar ia .  A la rger  dose 
o f  the  PI 3K inh ib i to r s  would  have  to be admi n i s t e r ed  to e l imina t e  
ma la r i a  i n fec t i on  than  the dose  o f  drug presen t ly  used in the 
t r ea tme n t  o f  malar ia .  The  need to t r ea t  ma la r i a  wi th such high doses 
a l so r e su l t s  in the  p r o b l e m of  s pec i f i c i t y  of  act ion.  This  would  lead 
to an u n a c c e p t ab l e  p ro f i l e  o f  a dv e r se  e f fec t s  in pa t ient s .
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Al t hough  the  compounds  t e s t ed  were  less  po t en t  than  ch l o r o qu i ne  and 
quin ine ,  it may be benef i c i a l  to deve lop  de r i va t i ve s  o f  these  
compounds  for  f u r t he r  eva lua t ion .
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5.0 CONCLUSION
Signal  t r a ns d uc t i o n  pa thways  t r an s du ce  e x t r ace l l u l a r  s igna l s  into 
i n t r ac e l l u l a r  messages  tha t  cont rol  var ious  aspect s  o f  ce l l u la r  
func t ions .  P r o t e i n  k inases  are essent i a l  in s ignal  t r a ns duc t i on  
processes  tha t  re lay the  i n t r ac e l lu l a r  s ignal  to e f f ec t o r  p ro te ins  that  
r e gu l a t e  cel l  g rowth ,  d i f f e r en t i a t i on ,  su rv iva l  and the  cell  cycle.  
Severa l  s ignal  t r a ns d uc t i o n  pa t hways  have  been i den t i f i ed  in 
P. f a l c ip a r u m  and they inc lude  the  c AMP - de pe n de n t  pa thway ,  
c G M P - d e p e nd e n t  pa thway ,  p h o s p ha t i d y l i n o s i t o l  cycle ,  ca l c ium 
d ep en de n t  pa t hway  and the  M AP K  pa thways .  The  main a im of  this  
s tudy was to i den t i fy  and c lone  a P f P I3 K  h omo l og ue  in the  ma la r i a  
pa ras i t e ,  P. f a l c i p a r u m .
Severa l  componen t s  of  the  PI 3K p a thway  have  been i den t i f i ed  and 
c ha r ac t e r i s ed  in P. f a l c i p a r u m . These  i nc l ude  a d o wn s t r e am e f fec tor  
o f  PI3K,  pro t e in  k inase  B which has  been i den t i f i ed  in P. f a l c i p a r u m  
(Harmse ,  unpub l i shed ) .  Ano the r  p ro t e i n  k inase  do wn s t r e am of  prote in  
k inase  B, g l ycogen  syn t hase  k inase  3 was i den t i f i ed  in the  
P. f a l c i p a r u m  genome  da tabase .  P F E 0 7 6 5 w  a p u t a t i ve  PI 3K 
h o m o l o g u e  was i den t i f i ed  on c h r o mo s ome  5 in the  P l a smoDB.  This  
s tudy f ocused  on c loning  the  ca t a ly t i c  r eg ion ,  ve r i fy ing  par t  of  the 
Pf P I 3K s eq u en c e  h o mo l o g ue  found  in the  ma l a r i a  pa r a s i t e  and t es t i ng  
the  e f fec t  o f  s e l ec t ed  compounds  on P. f a l c i p a r u m .
A h o mo lo g y  based app r oach  was used to ob ta in  an open read ing  f r ame 
encod i ng  a p u ta t i ve  P f P I3 K  homol ogue .  The open r ead ing  f rame was 
used to des ign  spec i f i c  pr imers .  Res t r i c t i o n  e ndonuc l e ase  si tes were  
added to the  5 ’ends o f  the  p r i mer s  to f ac i l i t a t e  d i r ec t i ona l  c loning  
into an exp r e s s ion  vector .  A PCR p r o d uc t  o f  the  p red i c t ed  s ize 
(1 812 base  pa i r s )  was ob t a ined  u s ing  the  spec i f i ed  pr imers .  The 
c loned  s equence  was ve r i f i ed  by manua l  and au t oma t ed  sequencing .  
The P f P I3 K  inser t  was also s eq ue nc ed  wi th  vec tor  pr imers  and was
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found to be in f rame.  Pro te in  e xp r e s s io n  was i nduced  wi th I P TG and 
the  p ro t e in  pur i f i ed  by n i ck e l - a f f i n i t y  c hr oma t og r aphy .  The  pro t e in  
was sepa r a t ed  by SDS -P AGE,  t r a ns f e r r e d  to a PVDF membrane  and 
probed  wi th an an t i -Hi s  an t ibody.  Severa l  bands  were  ident i f i ed  
(68.5 KDa,  45 KDa  and 35 KDa) .  The  smal l e r  bands  could be 
t r unca t ed  pro t e in  whi l s t  the  band  at 68.5 KDa  is of  the  p red i c t ed  
size.  Howeve r ,  fu r ther  i nves t iga t i ons  and o p t i mi sa t i on  of  the  
e xp r e s s i on  is requ i red .  Sequence  ana lys i s  i nd i ca t ed  tha t  the  pu t a t i ve  
P f P I 3K  h omo l og u e  obt a ined  c on t a i ned  some ca t a l y t i c  s igna t ures  such 
as DR.X3N 12- 13DFG conse rved  in some p ro t e i n  k inase  ca t a ly t i c  
domains .  S t r uc t u ra l  mot i f s  typ i ca l  o f  P I 3Ks  were  i den t i f i ed  in the  
ana lys i s ,  in add i t i on  a l euc i ne  z i pp e r - l i k e  m o t i f  and pro l i ne  r ich 
m o t i f  were  i den t i f i ed .  Mos t  of  t he  c a t a ly t i c  mot i f s  of  
s e r i n e / t h r e on i n e  k inases  were  absent  s i nce  P I 3K is a l ipid kinase.
Ef fec t s  o f  s e l ec t ed  compounds  on the  3D7 s t ra in  was de t e r mined  
us ing  the t r i t i a t ed  h y p o xa n th i n e  i n c o r po r a t i o n  assay.  The  ef fect s  of  
the  i nh i b i t o r s  on the  P. f a l c i p a r u m  3D7 s t ra in  were  c ompar ab l e  to 
the  in v itro  e f fect s  on o ther  o rgan i sms  such as mammals .  LY294002  
and 1, 9 - d id e ox y f o r s ko l i n ,  an iner t  a na lo gu e  of  fo r sko l in ,  were  the  
mos t  po tent  aga ins t  P. f a l c i p a r u m  3D7 s t ra in .  The aden y l a t e  cyclase  
a c t i va t o r  f o r sko l i n  was the  l eas t  e f f ec t ive  aga ins t  P. f a l c i p a r u m . Of  
the  two P I 3K  inh i b i t o r s  t e s t ed  L Y2 9 4 00 2 ,  was three  t imes  more 
po t en t  than wor tmannin .
The p ro t e i n  k i na se  i nh i b i t o r  LY2 9 4 0 0 2  and wor t mann i n  had no e f fect  
on t he  i n fec t ed  and un i n f ec t ed  red b lood  cel l s ,  which r ema i ned  the 
same af ter  48 hours  of  exposure ,  t ho ug h  more  re f ined  methods  such 
as e l ec t ron  mi c r oscopy  would  need to be done to ver i fy  this  
obse r va t ion .  T r ophozo i t e s  were  obs er ved  to be smal l e r  compar ed  to 
the  u n t r ea t ed  cont ro l  paras i t es .
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F ur the r  i nv e s t i ga t i on s  in pro t e in  e xpre s s i on  expe r imen t s  and prote in  
k inase  ac t i v i t y  is r equ i r ed  to con f i rm the  f unc t ion  o f  the pu t a t i ve  
Pf PI 3K h omo l og ue  in P. f a l c i p a r u m . Based  on its f unc t ion  in o ther  
o rgan i sms ,  the  P f PI 3 K h o mo l og ue  may be i nvo lved  in a s ignal  
t r a ns du c t i on  pa thway  that  resu l t s  in cel l  su rv iva l ,  d i f f e r en t i a t i on  and 
apoptos i s .  P r o t e i n - p r o t e in  i n t e r ac t i ons  wi th P. f a l c i p a r u m  lysates  and 
fac tor s  i n f l uenc i ng  the enzyme ac t i v i t y  o f  expres sed  pro te ins  may 
c on t r i b u t e  to a t t a i n i ng  a spec i f i c  role  for  P I 3K in the  mala r i a  
paras i t e .  More  i nv e s t i g a t i o n  into the  s t r uc t u r e  o f  the  enzyme may be 
used to des ign  a more e f f ec t ive  and s pec i f i c  an t i ma l a r i a l  drug.
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